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A variety of tests are used in clinical practice to help the diagnostic process and so 
improve patient care. Many aspects of stroke management depend on accurate and 
rapid diagnosis. Brain imaging, including CT or MRI, is necessary to identify the 
location and extent of the cerebral lesion, and to determine the pathological type of 
stroke and its likely cause. Current treatments - such as thrombolysis - for ischaemic 
stroke have increased the need for clear evidence on which imaging test is optimal 
for diagnosis in the acute phase of stroke.  
 
Systematic reviews of diagnostic test accuracy may provide evidence on the best use 
of a diagnostic test in clinical practice and help clinicians to decide among alternative 
tests. The Cochrane Collaboration has recently included systematic reviews of 
diagnostic test accuracy within its remit. However, to prepare Cochrane systematic 
reviews of diagnostic test accuracy is challenging because the methods for such 
reviews are still in a state of flux.  
 
Materials and methods 
The research work undertaken for this thesis addresses four relevant methodological 
aspects of such reviews and, I hope, will contribute to informing the development of 




i) I assessed the quality of reporting of imaging studies in stroke medicine 
published between 1995 and 2008 with the current STAndards for the 
Reporting of Diagnostic accuracy studies (STARD) criteria;  
ii) I assessed the magnitude of publication bias in diagnostic accuracy 
studies in stroke medicine, by reviewing all diagnostic abstracts presented 
at two international stroke meetings between 1995 and 2004 and so 
evaluating the characteristics and findings of the identified abstracts; 
iii) I have evaluated the methods for preparing reviews of test accuracy by 
undertaking a pilot review according to the draft recommendations of the 
Cochrane Diagnostic Test Accuracy Working Group; 
iv) I conducted a survey to assess a) how well clinicians and health 
professionals interpret findings of Cochrane systematic reviews of 
diagnostic accuracy presented in summary documents; and b) what is the 




In conclusion, methodological issues concerning the validity and reliability of 
findings of studies included in systematic reviews of diagnostic accuracy remain of 
fundamental importance. More empirical evidence is needed to address potential 
biases such as reporting bias and publication bias. To allow dissemination of 
diagnostic reviews findings in clinical practice better ways of communicating main 





In the current literature, the quality of reporting and methodological quality of 
imaging studies for the diagnosis of stroke is less than satisfactory and leaves room 
for improvement. This is worrying, especially if current health imaging policies are 
in fact based on poor quality evidence and hence scarce health resources may not 
being deployed as effectively as they could be. 
10 
1. Introduction 
Good clinical care depends on good decision making by clinicians. Good decision 
making in health care should in turn be based on best evidence, which comes 
preferably from systematic reviews. Health care providers, policy makers, 
researchers and consumers need therefore somehow to keep up to date with the 
enormous volume of evidence that is rapidly accumulating in the medical literature.1 
Systematic reviews provide a concise, up to date and efficient synthesis of all the 
available relevant evidence.2 Since the results of systematic reviews are used to 
inform and guide decision making on health care, it is crucial that their methodology 
is precise, reliable, reproducible and makes every effort to avoid bias. Although the 
methods for preparing, assessing, and interpreting systematic reviews of 
interventions are well established; the methods for conducting systematic reviews of 
diagnostic accuracy studies are not yet fully developed.  
 
1.1 Evaluating diagnostic tests: methodological aspects 
In the medical field, diagnostic tests are used to reduce uncertainty about the 
presence or absence of target clinical conditions. Over the past few decades many 
new diagnostic technologies have been developed; in imaging methods, 
biochemistry-based test procedures, and genetics to name a few. Systematic reviews 
of diagnostic accuracy are therefore potentially useful in informing decisions about 
the use of particular diagnostic tests in clinical practice. ‘Diagnostic accuracy’ 
indicates the amount of agreement between the results of the index test and those of a 
reference standard, which is the best available method to establish the presence or 
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absence of the condition of interest or target condition. The optimal design for 
studies of diagnostic test accuracy is a cross-sectional study in which the 
participants’ test results are cross-classified against the results of the reference 
standard in order to distinguish individuals with the target condition from those 
without the target condition. A main objective of systematic reviews of diagnostic 
test accuracy is to compare the relative performance of two or more tests. Diagnostic 
tests can be compared in the same studies in the same patient populations (direct 
comparison) or in separate studies in different patient populations (indirect 
comparison). Systematic reviews of test accuracy that compare tests directly provide 
useful information to assist clinical decisions on whether one test is superior to its 
alternative tests or on whether a new test may replace an existing one. In Chapter 4 I 
report a pilot systematic review conducted according to the recommendations of the 
Cochrane Diagnostic Test Accuracy Working Group.  
 
Some of the key methodological challenges of conducting systematic reviews of 
diagnostic test accuracy are considered below. 
 
1.1.1 Electronic search strategies 
Although the clinical epidemiological methods for the evaluation of a diagnostic test 
are well established, the methods to synthesise the evidence from a series of test 
accuracy studies in a systematic review are not so well developed as those for 
systematic reviews of randomised clinical trials of interventions.3 Systematic reviews 
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of diagnostic test accuracy pose a number of methodological challenges. For 
example, searching the medical literature to identify studies of diagnostic accuracy is 
more challenging than for randomised controlled studies.4 Diagnostic accuracy 
studies are not uniformly and unequivocally indexed in major electronic databases 
such as MEDLINE and EMBASE. The MeSh heading ‘sensitivity and specificity’ 
was introduced in MEDLINE in 1991 to replace the previous term ‘sensitivity, 
specificity (epidemiology)’ that was introduced for the first time only in 1987. 
However, the term ‘sensitivity and specificity’ is often applied inconsistently and it 
may fail to identify all relevant diagnostic accuracy reports or, on the contrary, 
wrongly retrieve reports which are not diagnostic. The use of methodological search 
filters to restrict the search to reports of test accuracy are usually not recommended 
because they can miss potential relevant studies and may affect the sensitivity of the 
search.5  
 
In systematic reviews of randomised clinical trials the assessment of whether studies 
with positive results are more likely to be published than studies with negative results 
(publication bias) and the potential impact of this type of bias on the overall findings 
of the review have been extensively studied.6-10 In contrast to the substantial 
evidence available for randomised clinical trials, at present there is little evidence on 
publication bias in diagnostic research. The association between publication and 
positive findings has been demonstrated for randomised clinical trials by i) direct 
evidence which involved the follow up of cohort of studies registered by ethics 
committees; and ii) indirect evidence which included the observation of a high 
proportion of studies with positive findings in the published literature as well as the 
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association between sample size and effect size. The magnitude, determinants, and 
impact of publication bias for diagnostic accuracy studies have yet to be assessed. 
Location of a reliable datasource for diagnostic test accuracy studies it is, however, 
problematic as often diagnostic studies rely on data collected primarily as part of 
clinical care and do not require formal registration. Irwig and colleagues claimed that 
publication bias could be indeed more of a problem for studies of diagnostic test 
accuracy than for randomised clinical trials because of the absence of a clear record 
of attempted clinical evaluations.11 Moreover, the definition of what constitutes a 
‘positive result’ is more complex in studies of diagnostic test accuracy. Deeks and 
colleagues maintained, in fact, that the determinants of publication bias are likely to 
be different for diagnostic test accuracy studies as their statistical analyses involve 
the estimation of measures of accuracy (e.g. sensitivity and specificity) instead of the 
computation of a p-value following the formulation of a null hypothesis.12 
Furthermore, the methods we have from randomised controlled trials for evaluating 
publication bias do not seem to work well with test accuracy studies.12 In Chapter 3 I 
evaluated the scale of publication bias in studies of diagnostic test accuracy by 
assessing the full publication status of research initially presented as abstracts in 
scientific meetings. 
 
1.1.2 Quality of reports of diagnostic accuracy studies 
Studies of diagnostic accuracy may appear of poor methodological quality because 
they are either poorly reported or poorly conducted.13 Therefore, the assessment of 
the quality of reporting of primary studies together with the assessment of their 
methodological quality are crucial steps for identifying potential biases which might 
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affect the validity and generalisability of findings and conclusions of diagnostic 
accuracy reviews.  
 
1.1.3 Statistical methods for synthesising results 
Systematic reviews of diagnostic test accuracy differ from those of randomised 
controlled trials also regarding their summary statistics and the methods for pooling 
results across studies. There are many different ways for summarising test accuracy 
results in a systematic review. To synthesis diagnostic test results across studies is 
particularly challenging due to the fact that there is no a single measure to define 
‘accuracy’. In studies of diagnostic test accuracy two or more statistics are used to 
express the performance of a test: sensitivity and specificity, positive and negative 
predictive values, likelihood ratios of test results, or Receiver Operating 
Characteristics curve (ROC). The recommended method for synthesising data in the 
context of meta-analyses of diagnostic accuracy studies is the summary ROC curve 
(SROC) which, in contrast for example with the simple pooling of sensitivities and 
specificities, has the advantage to take into account the underlying relationship 
between these measures of accuracy. The most advanced methods for fitting 
summary ROC curves are the hierarchical summary ROC model and the bivariate 
random-effects model.14,15 These models allow for both within and between study 
variability, and also for a statistical correlation between pairs of sensitivity and 
specificity estimates across studies. The parameters estimate from either model can 
be used to fit a SROC curve and produce a summary operating point. However, both 
models are very complex, more accurate when the number of studies is large, and not 
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at all easy to use. They require statistical skills to be fitted and interpreted and 
sophisticated softwares, which allow fitting of mixed models. To synthesise and 
interpret results of studies of test accuracy is difficult and there is a clear need for a 
consensus on which method is the most appropriate for conducting meta-analyses.  
 
In this thesis I did not focus on the statistical aspects of the current recommended 
methods for synthesising diagnostic data. Nevertheless, I had to consider these 
methods in preparing the Cochrane systematic review presented in Chapter 4. 
 
1.1.4 Helping clinicians interpret summary findings 
The way in which the test accuracy results are synthesised in systematic reviews has 
important implications for clinical practice. There is evidence for example that 
clinicians may confuse measures of diagnostic accuracy.16 The main objective of 
systematic reviews of diagnostic accuracy is to help clinicians and health 
professionals to make informed decisions about the use of medical tests. The main 
findings of a systematic review are presented in a ‘summary’ that is simple, concise, 
and easy to interpret at the beginning of the review. Summaries aim at summarising 
the key features, results, and conclusions of systematic reviews and can be read as 
stand-alone documents.17 They can have a verbal structure (abstract) or a tabular 
format (summary of findings tables). The Cochrane Collaboration recommends now 
including ‘summary of findings’ tables in the structure of its reviews to provide 
information on the quality of evidence and main studies results.16 However, there is 
hardly any evidence in the literature on how clinicians and health professionals 
interpret the findings of systematic reviews of diagnostic accuracy summarised in 
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abstracts or summary of findings tables, and on their preferences as to the contents 
and format of these summary documents. 
 
1.2 Stroke diagnosis  
Much of stroke management is dependent on accurate diagnosis.  Many areas of 
stroke management (acute treatment, secondary prevention, and rehabilitation) 
require diagnostic methods that can be proven to be reliable, repeatable and valid; 
this applies equally to laboratory tests as to bedside clinical procedures. In particular, 
new treatments to be given in the first few hours after stroke onset depend clearly on 
accurate diagnosis to identify the nature and location of the cerebral vascular lesion 
and ensure appropriate interventions. A very wide range of diagnostic technologies is 
now employed in stroke medicine including CT and MRI scanning.  Some of these 
diagnostic technologies are not only expensive, but their availability varies across 
hospitals and countries.18 Developing diagnostic strategies that are not only cost-
effective but also appropriately and equitably available to the whole population 
(including remote and rural areas) is still a major challenge for any health care 
system.  Healthcare professionals and policy makers have to face regularly decisions 
concerning the best choice of diagnostic tests and interpretation of their findings. 
Inappropriate tests or wrong interpretations of their findings may lead to possible 
dangerous delays in making a correct diagnosis and therefore starting proper patient 





1.3 Imaging diagnosis in stroke medicine 
Recent technological developments in imaging have greatly contributed to the 
diagnosis of stroke by allowing visualization and characterisation of the brain 
vascular lesions, which may explain the patients’ stroke symptoms. Non-contrast or 
plain computed tomography (CT) is the most commonly used imaging method to 
assess patients with signs and symptoms of acute stroke. CT produces axial images 
of a number of sections through the whole brain. Signs of abnormality are shown on 
CT scans as abnormal tissue density and hyperattenuated artery.19,20 CT, when 
performed early after stroke onset, can accurately detect intracerebral haemorrhage. 
Although the capability of CT to detect ischaemic changes early after acute stroke 
has improved since the technology was first introduced in clinical practice, overall in 
the acute phase CT shows the appropriate ischaemic lesion in only half of the 
patients with an acute ischaemic stroke.21,22 Larger, more extensive ischaemic lesions 
are more likely to show than small ischaemic lesions.22,23 Therefore, an early 
‘negative’ CT for ischaemic signs or lesions does not rule out a stroke diagnosis in 
patients presenting with stroke neurological symptoms. CT is considered the first-
line investigation for stroke patients, as it is widely available in many hospitals, in 
many countries and is simple and quick to perform, even in uncooperative 
patients.24,25 Magnetic resonance imaging (MRI) is a non-invasive method to image 
the brain which employs radiofrequency radiation in the presence of magnetic 
fields.26 MRI is considered more sensitive than CT for detecting early ischaemic 
stroke (Figure 1.1).27 In particular, MR diffusion weighted imaging (DWI) has 
recently gained a major role in the evaluation of stroke patients due to the fact that it 
can show even very small ischaemic lesions within a few minutes of stroke onset.28-30  
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DWI measures the translational movement of water molecules and is usually 
performed by means of single shot echoplanar imaging (EPI). DWI is commonly 
interpreted in conjunction with an apparent diffusion coefficient (ADC) map, which 
is derived from DWI data and is displayed as a grey scale image.24 Abnormal 
diffusion is shown as a signal of hyperintensity and a reduced ADC.31 It is important, 
for correct interpretation of DWI images to view the DWI sequences together with 
the corresponding ADC map.  This enables the radiologist to distinguish between 
acute, subacute and chronic ischaemic lesions and high DWI signal that is not 
associated with restricted diffusion (this can occur if the T2 weighted images show a 
particularly intense signal - T2 ‘shine through’). In clinical practice DWI can also be 
used to detect the area of diffusion-perfusion mismatch representing the ischaemic 
penumbra (i.e. ischaemic tissue that is not destined become necrotic and hence has 
the potential to be saved by reperfusion therapy).32 Overall, MRI is considered useful 
to evaluate the extent, the anatomical distribution and age of ischaemic lesions.24 
However, MRI may fail to identify hyperacute intracerebral haemorrhage33 and the 
claim that MRI should be the preferred diagnostic imaging technique for the early 
diagnosis of patients with suspected acute stroke34 remains to be proven. 
Furthermore, large numbers of acute ischaemic patients either do not tolerate MRI or 




Figure 1.1. CT taken within a few hours of onset of stroke symptoms shows very subtle 
ischaemic changes. MR DWI performed shortly after CT shows clear high signal abnormalities. 
CT very subtle changes DWI obvious changes
 
 
1.4 The Cochrane Collaboration 
At present, the key international organisation which produces and promotes 
systematic reviews to help people making well-informed decisions about health care 
is the Cochrane Collaboration (www.cochrane.org). The Cochrane Collaboration 
recognised the methodological challenges posed by studies of diagnostic test 
accuracy and started to develop a programme of work to include systematic reviews 
of diagnostic accuracy within its remit in 2001, during the Cochrane Colloquium in 
Lyon. Soon after, a Cochrane Diagnostic Test Accuracy Working Group was formed 
by the Steering Group of the Cochrane Collaboration. The main remit of this 
Working Group was to develop the methodology and implement the publication of 
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systematic reviews of diagnostic test accuracy within the Collaboration. In October 
2007, during the Cochrane Colloquium in Sao Paulo, the implementation of 
systematic reviews of diagnostic test accuracy was officially launched 
(http://srdta.cochrane.org). In particular, the work of the Screening and Diagnostic 
Methods Group and of the Diagnostic Test Accuracy Working Group has provided 
inspiration and impetus for the completion of this thesis. 
 
1.5 Outline of the Thesis 
This thesis addresses specific methodological areas related to systematic reviews of 
diagnostic accuracy in stroke medicine: the quality of reporting of studies of 
diagnostic accuracy; the magnitude of publication bias in studies of diagnostic 
accuracy; methods for preparing reviews of test accuracy; and, interpretation of 
summary findings of Cochrane reviews of diagnostic test accuracy. 
Chapter 2 consists of a study that assesses the accuracy and completeness of 
reporting of diagnostic accuracy studies in stroke medicine using the current 
STAndards for Reporting of Diagnostic Accuracy (STARD) criteria. The chapter 
focuses, specifically, on the use of magnetic resonance imaging for the early 
diagnosis of ischaemic stroke. Chapter 3 consists of a study that assesses the scale 
of publication bias in studies of diagnostic test accuracy in stroke medicine. Chapter 
4 reports a systematic review of diagnostic test accuracy that evaluates two imaging 
methods for the early diagnosis of stroke. This systematic review served as a pilot 
review to test and evaluate draft methods proposed by the Cochrane Diagnostic Test 
Accuracy Working Group. Chapter 5 consists of a survey which aims to evaluate 
how clinicians and health professionals interpret findings of systematic reviews of 
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diagnostic test accuracy presented in two summary documents. Chapter 6 
summarises the main findings of this thesis, together with their implications for 





1. Egger M, Davey Smith G, O’Rourke K. Rationale, potentials, and promise of 
systematic reviews. In Egger M, Devey Smith G, Altman DG (Editors): 
Systematic reviews in health care. Meta-analysis in context. BMJ Publishing 
Group 2001 
 
2. Mulrow CD. Systematic reviews: rationale for systematic reviews. BMJ 
1994; 309: 597-9 
 
3. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. 
In: Egger M, Davey Smith G, Altman DG (editors), Systematic Reviews in 
Health Care. Mata-analysis in context. London (UK): BMJ Books 2001 
 
4. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. 
Developing optimal search strategies for detecting clinically sound studies in 
MEDLINE. J Am Med Inform Assoc 1994; 1: 447-58 
 
5. Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM, on behalf of the 
Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of 
diagnostic test accuracy. Annals of Internal Medicine 2008; 149: 889-97 
 
6. Dickersin K. The existence of publication bias and risk factors for its 




7. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in 
clinical research. Lancet 1991; 337: 867-72 
 
8. Dickersin K, Min YI. NIH clinical trials and publication bias. Online Journal 
of Clinical Trials 1993; 50: 4967 
 
9. Dickersin K, Olson CM, Rennie D, Cook D, Flanagin A, Zhu Q, Reiling J, 
Pace B. Association between time interval to publication and statistical 
significance. JAMA 2002; 287: 2829-31  
 
10. Liebeskind DS, Kidwell CS, Sayre JW, Saver JL. Evidence of publication 
bias in reporting acute stroke clinical trials. Neurology 2006; 67: 973-9 
 
11. Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for 
diagnostic test accuracy. Journal of Clinical Epidemiology 1995; 48: 119-30 
 
12. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias 
and other sample size effects in systematic reviews of diagnostic test 




13. Deville’ WL, Buntinx F. Guidelines for conducting systematic reviews of 
studies evaluating the accuracy of diagnostic tests. In Knottnerus JA (editor), 
The Evidence Base of Clinical Diagnosis. London (UK): BMJ Books 2002 
 
14. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis 
of diagnostic test accuracy evaluation. Statistics in Medicine 2001; 20: 2865-
84 
 
15. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman 
AH. Bivariate analysis of sensitivity and specificity produces informative 
summary measures in diagnostic reviews. Journal of Clinical Epidemiology 
2005; 58: 982-90 
 
16. Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G. Communicating 
accuracy of tests to general practitioners: a controlled study. BMJ 2002; 324: 
824-6 
 
17. Schunemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH 
on behalf of the Cochrane Applicability and Recommeandations Methods 
Group and the Cochrane Statistical Methods Group. Presenting results and 
‘Summary of Findings’ tables. In: Higgins JPT and Green S (editors), 
Cochrane Handbook for Systematic Reviews of Interventions. Chichester 
(UK): John Wiley & Sons, 2008  
 
25 
18. Kane I, Whiteley WN, Sandercock PAG, Wardlaw JM. Availability of CT 
and MR for assessing patients with acute stroke. Cerebrovascular Diseases 
2008; 25: 375-7 
 
19. Armstrong P, Wastie ML. Diagnostic Imaging. Oxford: Blackwell Scientific 
Publications, 1987 
 
20. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer 
reliability and outcome after thrombolytic treatment - systematic review. 
Radiology 2005; 235: 444-453; doi:10.1148/radiol.2352040262 
 
21. Warlow C, van Gijn J, Dennis M, Wardlaw J, Bamford J, Hankey G, 
Sandercock P, Rinkel G, Langhorne P, Sudlow C, Rothwell P. What 
pathological type of stroke is it, cerebral ischemia or hamorrhage? In: Stroke, 
A practical guide to management. 2nd Edition. Oxford: Blackwell Publishing, 
2008 
 
22. Wardlaw JM, West TM, Sandercock PAG, Lewis SC, Mielke O. Visible 
infarction on computed tomography is an independent predictor of poor 
functional outcome after stroke, and not of haemorrhagic transformation. 





23. Lindgren A, Norrving B, Rudling O, Johansson BB. Comparison of clinical 
and neuroradiological findings in first-ever stroke: a population-based study. 
Stroke, 1994; 25: 1371-7 
 
24. Rich PM, Jäger HR. Cerebrovascular disease and nontraumatic intracranial 
haemorrhage. In: Adam A and Dixon AK Editors. Diagnostic Radiology: A 
textbook of Medical Imaging. Fifth Edition, Vol. 2. Elsevier Limited, 2008 
 
25. Moustafa RR, Baron JC. Clinical review: Imaging in ischaemic stroke – 
implications for acute management. Critical Care 2007; 11: 227 
(doi:10.1186/cc5973) 
 
26. Wilkinson ID, Paley MNJ. Magnetic resonance imaging: basic principles. In: 
Adam A and Dixon AK Editors. Diagnostic Radiology: A textbook of 
Medical Imaging. Fifth Edition, Vol. 2. Elsevier Limited, 2008 
 
27. Keir SL, Wardlaw JM. Systematic review of diffusion and perfusion imaging 




28. Hjort N, Christensen S, Solling C, Ashkanian M, Wu O, Rohl L, Gydensted 
C, Andersen G, Ostergaard L. Ischemic injury detected by diffusion imaging 
11 minutes after stroke. Annals of Neurology 2005; 58: 462-65 
 
29. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, 
Rordorf G, Wang B, Sorensen AG, Koroshetz WJ. Diffusion-weighted MR 
imaging: diagnostic accuracy in patients imaged within 6 hours of stroke 
symptom onset. Radiology, 1999: 210: 155-62 
 
30. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute 
stroke. Lancet Neurology, 2006; 5: 755-68 
 
31. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, 
Warach S. Enlargement of human cerebral ischemic lesion volumes measured 
by diffusion-weighted magnetic resonance imaging. Annals of Neurology 
1997; 41: 581-9 
 
32. Kesavadas C, Fiorelli M, Gupta AK, Pantano P, Bozzao L, Kapilamoorthy 
TR. Diffusion weighted magnetic resonance imaging in acute ischemic 
stroke. Indian J Radiol Imaging 2003; 13: 433-40 
 
28 
33. Wardlaw JM, Farrall AJ. Diagnosis of stroke on neuroimaging. “Scan all 
immediately” strategy improves outcome and reduce costs. BMJ, 2004: 328: 
655-6 
 
34. Chalela JA, Kidwell CS, Nentwich LN, Luby M, Butman JA, Demchuk AM, 
et al. Magnetic resonance imaging and computed tomography in emergency 
assessment of patients with suspected acute stroke: a prospective comparison. 
Lancet 2007; 369: 293-8 
 
35. Hand PJ, Wardlaw JM, Rowat AM, Haisma JA, Lindley RI, Dennis MS. 
Magnetic resonance brain imaging in patients with acute stroke: feasibility 
and patient related difficulties. Journal of Neurology, Neurosurgery & 












2. The quality of reporting of diagnostic accuracy 
studies on the use of magnetic resonance imaging 




Effective and efficient management of patients with acute stroke relies heavily upon 
a rapid and reliable diagnostic process. Current imaging technology (e.g. MRI and 
CT) provides essential diagnostic information which contributes to optimal 
therapeutic choices. Diagnostic accuracy studies on imaging are used to assess the 
accuracy of a test in diagnosing the presence of a vascular brain lesion and 
distinguishing between ischaemic and haemorrhagic lesions. There is evidence in the 
literature that studies of diagnostic test accuracy may fail to fulfil essential 
methodological standards.1,2 Methodologically biased studies may affect estimates of 
diagnostic accuracy and provide misleading results. Lijmer and colleagues in 19993 
and Rutjes and colleagues in 20064 demonstrated that differences in study design and 
patient selection are associated with variations in the estimates of accuracy. Case-
control design, retrospective data collection, and non-consecutive inclusion of 
patients were amongst the characteristics associated with higher estimates of 
diagnostic accuracy. Methodological characteristics of diagnostic accuracy studies 
may, however, be difficult to ascertain if the quality of reporting is poor.  For studies 
of diagnostic test accuracy, complete and accurate reporting is an essential 
prerequisite on which to judge the potential occurrence of methodological flaws. 
Following the successful CONSORT initiative for enhancing the quality of reports of 
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randomised controlled trials,5 the STARD (STAndards for the Reporting of 
Diagnostic accuracy studies) group in 2003 published a statement to improve the 
accuracy and completeness of reporting of studies of diagnostic accuracy.6,7 The 
STARD statement consists of a checklist of 25 items and recommends the use of a 
flow diagram which provides the exact number of participants at each stage of the 
study. The STARD checklist has been published and promoted by several medical 
journals. Research studies have also been conducted to assess the quality of reporting 
of articles of diagnostic test accuracy published before 2003.8-10 Overall the quality 
of reporting varied greatly across STARD items. Two published reviews (one 
assessing all diagnostic articles published in journals with a high impact factor and 
one assessing diagnostic articles published in ophthalmic journals) found that only 
about 40% of the identified diagnostic articles reported on more than 50% of the 
STARD items. 8,9 Smidt and colleague11 have also assessed whether the quality of 
reporting of diagnostic accuracy studies has improved since publication of the 
STARD statement. They looked at the quality of reporting of all diagnostic accuracy 
studies published in 12 medical journals in 2000 (pre STARD) and 2004 (post-
STARD) and concluded that the quality of reporting of diagnostic accuracy studies 
has only marginally improved over time.11 
 
The purpose of this study was to evaluate the extent to which studies on diffusion-
weighted magnetic resonance imaging for the early diagnosis of stroke published 
between 1999 and 2008 comply with the STARD criteria and to explore whether the 
introduction of the STARD statement has contributed to a better quality of reporting.  
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2.2 Materials and Methods 
2.2.1 Study Selection  
I searched the MEDLINE and EMBASE electronic databases to identify reports 
published between 1999 and 2008 (five years before STARD publication and five 
years after STARD publication). Reports were included if 1) they focused on 
magnetic resonance imaging including diffusion-weighted sequences for the early 
detection of ischaemic vascular brain lesions, 2) they investigated patients suspected 
of stroke, 3) they were primary studies of diagnostic test accuracy. The search 
strategies were developed and tested in close collaboration with the Cochrane Stroke 
Group Trial Search Coordinator, Brenda Thomas, who is an internationally 
recognised expert in the field and has been working for the Cochrane Collaboration 
since 1996. The searches were limited to reports focused on human research, 
published in English or Italian. In particular, the language restrictions were applied a) 
because of the limited resources available (i.e. no funding for professional 
translations of abstracts or full papers; the Cochrane Stroke Group could not provide 
access to volunteer translations) and b) to follow the methods used in previous 
assessments of compliance with the STARD criteria, where selection of papers was 
restricted to the English language.8,9,11,12 
 
Details of the MEDLINE and EMBASE searches are reported in Appendix 1. 
 
All citations of all potential eligible reports were screened by a single reviewer 
(myself). Only full-text reports were deemed suitable for inclusion. 
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2.2.2 Data extraction 
The STARD checklist was used to assess the quality of reporting of all relevant 
reports of diagnostic accuracy. A single reviewer (myself) established whether each 
item of the STARD checklist was adequately described in the text of the identified 
reports.  Only the quality of reporting was assessed and not the risk of potential 
methodological biases. I was not blind to the source and details of publications. 
Studies of diagnostic accuracy were defined as studies in which the results of one (or 
more tests) were compared with those of a suitable reference standard in the same 
patient population.  Either clinical assessments accompanied by imaging follow-up, 
or autopsy findings were considered suitable reference standards.  
 
Following Wilczynski,12 for the purpose of this study item 13 (“Describe methods for 
calculating test reproducibility, if done”), item 23 (“Report estimates of variability of 
diagnostic accuracy between subgroups of participants, readers or centres, if done”), 
and item 24 (“Report estimates of test reproducibility, if done”) were removed from 
the STARD checklist as they all contain a hypothetical clause (“if done”). It was 
considered impracticable to establish for the identified diagnostic reports whether the 
lack of reporting was because the items were assessed but not reported or because 
they were simply not assessed.  Thus, only 22 of the original 25 STARD items were 
considered for this assessment. Equal weights were applied to each item in the list 
with the exception of items 8, 9, 10, and 11.  These four items concern the index test 
as well as the reference standard. Thus, each of them was split into two statements, 
one for the index test and one for the reference standard. Each statement was 
evaluated separately and was assigned a maximum score of 0.5 point (see Table 2.2). 
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Reports published between 1999 and 2003 (pre STARD checklist) were evaluated 
separately from reports published between 2004 and 2008 (post STARD checklist). 
 
2.2.3 Statistical Analysis 
For each individual item of the STARD checklist the total number of reports that 
adequately described the elements needed to satisfy that item was calculated for the 
years 1999-2003 and for the years 2004-2008. For each item, the percentage 
difference between pre- and post-STARD studies was calculated.  For each report a 
total STARD score was calculated by summing up the number of all reported items 
(0-22 score range). Higher score indicated better quality of reporting. The overall 
mean scores and standard deviations of reports published 1999-2003 and reports 
published 2004-2008 were calculated. The difference in the overall mean score 
between pre-STARD reports and post-STARD reports was calculated by means of a 
two-tailed t-test for independent samples. Statistical significance was set at p = 0.05. 
The analyses were carried out using MINITAB (MinitabR 15.1.20.0.). 
 
2.3 Results 
The search strategies identified 2408 citations. After screening the titles and abstracts 
59 reports were considered potentially relevant and retrieved in full. Thirty-four 
reports were subsequently excluded because they did not meet the inclusion criteria. I 
assessed a total of 25 diagnostic reports published in 14 different journals (Table 
2.1). Eighteen reports were published between 1999 and 2003 and seven reports 
between 2004 and 2008. The mean 2-year impact factor of journals that published 
 
34 
reports between 1999 and 2003 was similar to that of journals that published reports 
between 2004 and 2008 (2.969 versus 3.246). Twenty-four of the assessed reports 
were cohort studies and one was a case-control study (published in 2001). The 
quality of reporting of the individual STARD items according to years of publication 
is shown in Table 2.2.  
 
There was a wide variation in the quality of reporting of individual STARD items (0-
100%). At an initial descriptive assessment, 10 of the 26 STARD items evaluated 
(items 8, 9, 10 and 11 counted twice) were more frequently reported in diagnostic 
reports published between 1999 and 2003, whilst 14 were more frequently reported 
in reports published between 2004 and 2008. Item 25 (discussion on applicability of 
results) and item 8 (technical specification of the index test – i.e. magnetic resonance 







































































































Note: mean 2-year impact factor for journals that published 1999-2003 reports = 2.96;9 mean 2-year 





Table 2.2. Reporting of individual STARD items in diagnostic accuracy reports published 













2004 -2008  







Title abstract and keywords 
1 Identify the article as a study of diagnostic 








2 State the research questions or study aims, such as 
estimating diagnostic accuracy or comparing 








3 Describe the study population: The inclusion and 
exclusion criteria, setting and locations where the 







4 Describe participant recruitment: Was recruitment 
based on presenting symptoms, 
results from previous tests, or the fact that the 








5 Describe participant sampling: Was the study 
population a consecutive series of participants 
defined by the selection criteria in items 3 and 4? If 







6 Describe data collection: Was data collection 
planned before the index test and reference standard 















8 Describe technical specifications of material and 
methods involved including how and when 
measurements were taken, and/or cite references for 
index tests and reference standard. 
 
a) for index test 
 



















9 Describe definition of and rationale for the units, 
cut-offs and/or categories of the results of the index 
tests and the reference standard. 
a) for index test 
 
















10 Describe the number, training and expertise of the 
persons executing and reading the index tests and the 
reference standard. 
a) for index test 
 























Table 2.2. Reporting of individual STARD items in diagnostic accuracy reports published  
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11 Describe whether or not the readers of the index 
tests and reference standard were blind (masked) to 
the results of the other test and describe any other 
clinical information available to the readers. 
a) for index test 
 



















12 Describe methods for calculating or comparing 
measures of diagnostic accuracy, and the statistical 









14 Report when study was done, including beginning 








15 Report clinical and demographic characteristics 
of the study population (e.g. age, sex, spectrum of 
presenting symptoms, comorbidity, current 







16 Report the number of participants satisfying the 
criteria for inclusion that did or did not undergo the 
index tests and/or the reference standard; describe 
why participants failed to receive either test (a flow 







17 Report time interval from the index tests to the 









18 Report distribution of severity of disease (define 
criteria) in those with the target condition; other 








19 Report a cross tabulation of the results of the 
index tests (including indeterminate and missing 
results) by the results of the reference standard; for 
continuous results, the distribution of the test results 







20 Report any adverse events from performing the 








21 Report estimates of diagnostic accuracy and 
measures of statistical uncertainty 







22 Report how indeterminate results, missing 






















About 70% of reports in 1999-2003 and 2004-2008 were identified as “diagnostic” 
mainly due to information contained in their abstracts. Only 33% of reports in 1999-
2003 and 14% in 2004-2008 included diagnostic terms (e.g. ‘diagnosis’, ‘sensitivity’, 
‘diagnostic accuracy’) in their titles. Items related to the description of results were 
poorly reported (< 30%) in both diagnostic reports pre-STARD and diagnostic 
reports post-STARD. In particular, reports lacked several important items: a cross 
tabulation of results of the index test by the results of the reference standard; a 
description of how indeterminate results were handled; a description of diagnoses in 
patients without the target condition; and a description of any adverse events related 
to performing the index test or the reference standard (see Table 2.2). About 45% of 
the diagnostic reports published pre- and post-STARD lacked a detailed description 
of the study population in which the imaging tests were administered (item 4) and 
about 55% failed to describe adequately the clinical and demographic characteristics 
of the patient population (item 15). The participant sampling was more frequently 
reported in studies post-STARD (86%) compared to studies pre-STARD (28%). 
None of the assessed diagnostic reports, however, included a flow diagram of study 
participants (as recommended in item 16 of the list). The methods for calculating or 
comparing measures of diagnostic accuracy were reported in only 17% of pre-
STARD studies and 43% of post-STARD studies and estimates of diagnostic 
accuracy with 95% confidence intervals were reported in 50% of pre-STARD studies 
and 71% of the post-STARD studies. The time interval from imaging tests and 
reference standard was reported in 33% of pre-STARD studies and 43% of post-
STARD studies. The maximum number of reported items in a single diagnostic 
report was similar for pre- and post-STARD reports (16 vs 17). 
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Table 2.3 shows that the mean total number of reported STARD items for diagnostic 
reports published between 1999 and 2003 was 12.83 (SD 2.54) with a range of 8-16 
and for reports published between 2004 and 2008 was 14.43 (SD 2.35) with a range 
of 9.5-17. The mean difference was not statistically significant (p = 0.165).  
 



























p = 0.165 




To my knowledge this is the first study that has appraised the quality of reporting of 
diagnostic accuracy studies of diffusion-weighted resonance imaging for the 
diagnosis of stroke. The topic is clinically relevant, and is the subject of ongoing 
research to determine the cost-effectiveness of this imaging test, which is expensive 
and has only limited availability in many centres in the UK.13 It is therefore of 
considerable interest to assess the quality of the evidence upon which current NHS 
policy is based. This study indicates that the quality of reporting in diagnostic 
accuracy studies of imaging in this aspect of stroke medicine is modest and that there 
is a wide variation in the quality of reporting of individual STARD items. The mean 
number of reported STARD items in diagnostic reports published between 2004 and 
2008 (14.43) was not significantly different to that of diagnostic reports published 
 
40 
between 1999 and 2003 (12.83). These findings are in line with the results on quality 
of reporting from current diagnostic research and other clinical specialities.9,11,12,14 
Smidt and colleagues found that, in journals with a high impact factor (>4), the 
quality of reporting of diagnostic accuracy improved only slightly in 2004, after 
publication of the STARD checklist.11 More recently Wilczynski assessed diagnostic 
studies published in 12 journals in 2001, 2002, 2004, and 2005 and found that after 
publication of the STARD checklist the quality of reporting remained similar to the 
pre-STARD standards.12 Similarly, Coppus and colleagues evaluated the extent to 
which test accuracy studies published in two major reproductive medicine journals in 
1999 and 2004 adhered to the STARD criteria. They did not find a significant 
improvement in the number of reported items for the reports published after 
introduction of the STARD statement.14  
 
The current study assessed reports on magnetic resonance imaging for the diagnosis 
of stroke published five years before STARD publication (1999-2003) and five years 
after STARD publication (2004-2008) but failed to detect a statistically significant 
overall improvement in the quality of reporting.  The lack of improvement observed 
in this study may be explained by the very small sample of diagnostic reports 
identified in the literature. In particular, only seven reports were identified for the 
period 2004-2008, after the STARD publication, compared with 18 reports for the 
period 1999-2003, pre-STARD. The descriptive assessment of individual STARD 
items showed that for 10 items the quality of reporting appeared slightly worse after 
publication of the STARD checklist (see Table 2.2). This may indicate that the 
design principles of a high quality diagnostic accuracy report in stroke and imaging 
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journals are not yet uniformly established or that the editorial control on the quality 
of diagnostic test accuracy reports is weak. Two of the 14 journals considered in this 
study had reports published pre- and post-STARD publication but the number of 
reported items was the same in pre- and post-STARD reports (13.5 versus 13.5). 
More interesting, only two of the six journals where the seven post-STARD reports 
were published include the STARD checklist in their instructions for authors.  Not 
even the two reports published in the journals which require application of the 
STARD criteria actually mentioned the STARD checklist in their methods section. 
Although this assessment is based on small numbers of reports, it is worth noticing 
that the range of the scores of the two studies published in the journals adopting the 
STARD checklist (range 15-17, average: 16) overlapped that of the five reports 
published in the journals which did not adopt STARD (range 9.5-15.5, average: 
13.6). The lack of improvement in the quality of reporting and the fact that the 
STARD checklist is not mentioned in the methods section of diagnostic reports 
published in journals which adopt the list may suggest that the editors and peer 
reviewers have not so far been successful in implementing the STARD guidelines for 
diagnostic research.  
 
The quality of reporting in studies of diagnostic accuracy is crucial for evaluating the 
validity and generalizability of the results and for revealing potential methodological 
flaws in the study design and conduct.  It is surprising that about 50% of diagnostic 
reports failed to provide a detailed description of the study inclusion and exclusion 
criteria and of the clinical and demographic characteristics of the participants. For 
imaging studies in stroke medicine this may imply potential spectrum bias and may 
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seriously hamper the applicability of findings in clinical practice. Moreover, none of 
the assessed reports included a flow diagram to illustrate the design of the study even 
though this is strongly recommended by the STARD group.6,8 Overall results were 
scantily reported in both reports published pre-STARD and reports published post-
STARD. Even though estimates of diagnostic accuracy and confidence intervals 
were better reported after STARD publication (71% versus 50% in pre-STARD 
reports) I believe that this is far from satisfactory. It is indeed very worrying that of 
the seven post-STARD reports: two failed to report estimates of accuracy and 
measures of statistical uncertainty (i.e. confidence intervals); four did not describe 
the methods used for calculating measures of diagnostic accuracy; and, five did not 
provide a cross-tabulation of test results.  
 
About 70% of reports in 1999-2003 and in 2004-2008 were identified as studies of 
diagnostic accuracy because the diagnostic terms (i.e. sensitivity, diagnosis, 
accuracy) appeared in the abstract. Diagnostic terms were only rarely used in the 
titles of reports. The STARD group recommends the use of the term ‘diagnostic 
accuracy’ as publication type in the title and abstract of reports that compare the 
results of one or more test versus a reference standard.6 They also recommend the 
term ‘post-test probability’ as a MeSH term in addition to ‘sensitivity and 
specificity’.8 The MeSH heading ‘sensitivity and specificity’ was revised in 
MEDLINE in 1991 to facilitate retrieval of diagnostic studies. However, the use of 
this heading is still far from optimal as they may fail to allow the retrieval of studies 
of diagnostic accuracy or wrongly retrieve reports that are not diagnostic.15,16   
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The current study has some limitations. The identification of studies of diagnostic 
accuracy in the literature is difficult.17 Even though I searched MEDLINE and 
EMBASE with comprehensive search strategies I cannot exclude the possibility I 
have missed potentially relevant studies. I chose to restrict the scope of this study to 
the topic of the Cochrane review for two reasons. Firstly, the diagnostic literature in 
stroke is very substantial (hence a very broad review might have not been feasible), 
and secondly, this search would place the methodological quality of the studies of 
my Cochrane review in an appropriate context. As it turned out (slightly to my 
surprise, given the wide use of the technology in stroke care) the searches identified 
only a small number of diagnostic reports on magnetic resonance imaging for acute 
stroke patients. Therefore, the findings of this study are greatly limited by the small 
sample of suitable studies available. However, it is worth noting that the findings in 
this field are comparable to those in other fields of medicine. Table 2.4 summarises 
the outcome of published reviews assessing the quality of reporting of diagnostic 
accuracy studies before and after the STARD publication. These studies used a 
methodology similar to my own. From the table it is clear that, although their sample 
sizes and periods of assessment varied, they show overlapping results, indicating that 
the quality of reporting is only slightly but not significantly improved after 
publication of the STARD statement, and that the magnitude of this improvement is 
comparable between studies. 
 
Because of resource constraints, only one reviewer (myself) was available to assess 
the identified diagnostic reports using the STARD checklist and therefore evaluation 
of the reproducibility of the list proved impossible. Substantial disagreement has 
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been, however, documented for some of the STARD individual items.18 Some 
STARD items are open to interpretation and cover multiple aspects of the same 
domain. There is therefore the risk to process the same item in slightly different way 
across studies. This risk is likely to be higher if the assessment is carried out by a 
single reviewer. 
 
Table 2.4. Results of research studies assessing the quality or reporting pre- and post-STARD 
publication 
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In conclusion, in stroke medicine, diagnostic accuracy reports on magnetic resonance 
imaging for detection of stroke lesions were not uniformly reported and there is still 
ample room for improvement. The methodology of diagnostic research has greatly 
improved over the past seven years, also thanks to the efforts and enthusiasm of the 
Screening and Diagnostic Methods Group within the Cochrane Collaboration. If the 
scientific community believes that STARD is an achievement and a way forward to 
improve the quality of reporting of diagnostic studies, we all should make a clearer 
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effort to implement its guidelines, from authors, to reviewers, editors, professional 
bodies. 
 
The STARD checklist provides a useful guide for designing, writing and reviewing 
diagnostic reports. Editors and peer reviewers should enforce the use of the STARD 
checklist in all diagnostic manuscripts they consider for publication. In particular 
they should encourage studies’ authors to use the term ‘diagnostic accuracy’ in the 
title of their reports more consistently, include a flow diagram to provide the exact 
number of participants at each stage of the study, and provide a clear description of 
findings including a cross-tabulation of tests results. 
 
2.4.1 Implications for researchers 
 There is a need for authors of individual studies to adhere better to STARD 
criteria when reporting their methods and results. 
 Research funding and ethical approval agencies should consider making 
adherence to STARD guidelines a mandatory requirement for funding or ethical 
approval for new studies of diagnostic test accuracy. 
 
2.4.2 Implications for Cochrane diagnostic test accuracy (DTA) 
reviews and DTA methods groups 
 The Cochrane Diagnostic Handbook should provide guidance for review authors 
on a) how to assess the quality of reporting and b) how to incorporate the quality 
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of reporting in the exploration of sources of heterogeneity between studies in 
systematic reviews of diagnostic test accuracy.  
 
2.4.3 Implications for journal editors 
 Journal editors should adopt and implement the STARD criteria in their 
instructions for authors. 
 Journal editors should not accept manuscripts reporting studies of diagnostic 
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3. Is there bias in the process of publication of 




Publication bias is defined as the ‘tendency to publish research results based on the 
strength and direction of a study’s findings’.1 It has been demonstrated that 
publication of both observational and experimental studies is influenced by the 
characteristics of the study, and research findings are less likely to be published if 
they are shown to be negative rather than positive or if they are based on small 
patient populations.2-5 The term ‘publication bias’ is also used in the literature to 
refer to ‘other biases related to the time, type and language of publication, and 
multiple publications’.6 Publication and other related biases may lead to an 
overestimation of the magnitude of treatment effects and consequently may affect 
decisions about patient management. They also represent a serious threat to the 
reliability of systematic reviews which focus primarily on evidence from the 
published literature. Whilst there is a substantial literature on publication bias in 
systematic reviews of randomised controlled trials, there is little empirical evidence 
on the frequency and determinants of publication bias in systematic reviews of 
studies of diagnostic test accuracy.7 Determinants of publication bias in studies of 
diagnostic test accuracy are likely to differ from those in clinical trials.8 Since many 
aspects of stroke management (e.g. acute treatment, secondary prevention, 
investigation of complications) depend on the results of diagnostic tests, we 
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considered it important to determine whether or not there was evidence of 
publication bias.  
 
Publication bias in randomised controlled clinical trials has been evaluated by tracing 
cohorts of trials identified from ethics committees, and investigating determinants of 
publication within the cohort.1-4 Analogous cohorts of studies of diagnostic test 
accuracy are more difficult to be identified as formal registration of diagnostic 
research and consequently ethical approval has not uniformly been required. I have 
followed an alternative approach of a cohort of studies at a point further down the 
research process, where they are presented as conference abstracts, and investigating 
determinants of future full publication. Although this approach does not capture the 
full magnitude of publication bias, I hypothesize that the determinants of full 
publication in this stage would be similar. 
 
I therefore sought (i) to assess publication bias by determining what proportion of 
studies of diagnostic accuracy presented as abstracts at international stroke meetings 
were subsequently published in full in peer-reviewed journals and (ii) to assess 
which factors were predictive of time to publication. 
 
I focused on abstracts presented at international stroke meetings as ‘stroke’ is the 
underlying disease theme of this methodological thesis. I did not consider abstracts 
presented at international imaging conferences because a) they usually cover a 
variety of different clinical conditions, and individual studies might contain a 
mixture of stroke and non-stroke cases, which would have introduced unwanted 
 
52 
heterogeneity to the data set; b) hand-searching of proceedings from imaging 
conferences would have enormously broadened the scope of this study and hence 
required for greater resources than were available. 
 
3.2 Methods 
I reviewed all proceedings of the International Stroke Conference and the European 
Stroke Conference between 1995 and 2004. All abstracts submitted to both stroke 
conferences were peer reviewed blind to authorship prior to acceptance. Acceptance 
rates varied from year to year, with about 60% of all submitted proceedings accepted 
for presentation in most recent years.9 These proceedings were published as abstracts 
in special issues of Stroke and Cardiovascular Diseases. Abstracts were selected for 
inclusion only if they reported findings of studies of diagnostic test accuracy. Studies 
of diagnostic test accuracy were defined as studies assessing the diagnostic 
performance of a single test or two or more tests against a reference standard.  I 
extracted information on study characteristics from selected abstracts. For each 
relevant abstract the following information was recorded: sensitivity and specificity 
values, clinical utility of observed results, retrospective versus prospective method of 
patient recruitment; number of authors, region of origin of the corresponding author, 
number of clinical centres, sample size, type of test performed, blinding of test 
results, if there was assessment of inter-observer agreement, and congress 
presentation (abstracts presented at the International Stroke Conference versus 
abstracts presented at the European Stroke Conference). Details on whether or not 




According to the conclusions reported by the original authors and, if given, the 
estimates of sensitivity and specificity, I categorised the clinical utility of test results 
as ‘accurate’, ‘possibly useful’, or ‘non-informative’. Test results were classified as 
‘accurate’ if the diagnostic accuracy of the test(s) under investigation was high 
enough to recommend its use in clinical practice. Test results were classified as 
‘possibly useful’ if the test(s) under investigation proved to have a good sensitivity 
but not necessarily a good specificity (and vice versa) or if the test(s) proved to 
perform well only in certain circumstances (e.g. in severe patients; or patients with a 
particular type of stroke or cerebrovascular disease). Test results were classified as 
‘non-informative’ if the accuracy of the test under investigation was not good enough 
to recommend its use in clinical practice or - for comparative studies - if the accuracy 
of the experimental test was equivalent to or not better than that of an existing 
alternative test. Furthermore, whenever it was possible, Youden’s Index, a measure 
of test performance (sensitivity + specificity - 1), was calculated. According to the 
affiliations reported in the abstracts, I grouped abstracts’ authors in three categories: 
authors from English speaking countries (i.e. Australia, Canada, New Zealand, UK, 
and USA), authors from European countries other than UK, and authors from Asia 
and South America.   
 
I searched MEDLINE and EMBASE electronic databases up to November 2006 to 
identify all study reports published in full in peer-reviewed journals. Searches were 
performed using initially the lead author’s surname and initials. If no subsequent 
publication was identified, additional searches were performed using the surname 
and initials of the other authors or appropriate keywords from the title of the abstract. 
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The date and journal of publication were noted. For abstracts for which a full-text 
publication could not be located with confidence in MEDLINE or EMBASE, a 
questionnaire was sent or e-mailed to the first author. If the post or e-mail address of 
the first author was not available the questionnaire was sent to another author of the 
abstract. The questionnaire asked whether the study had been published or whether a 
manuscript was submitted, rejected, planned to be submitted, or no longer planned to 
be completed. If it had been published, authors were asked to provide a full citation 
of the publication. Studies were considered unpublished when no articles could be 
located in the international published literature and either the contacted authors 
confirmed no publication status or no questionnaire was returned. 
 
3.3 Statistical analyses 
A Kaplan-Meier survival analysis was conducted to examine the relationship 
between abstract presentation and time to publication. Potential factors predictive of 
time of publication were examined - one at a time - using univariate Cox regression 
analyses and results were expressed as hazard ratios. Time to publication was defined 
as the time from the date the study abstract was published in Stroke or 
Cerebrovascular Diseases to the date of the first peer-reviewed full-publication 
identified in the literature. Studies whose findings were published before abstract 
presentation were excluded from the survival analysis. Unpublished studies were 
censored at the time the last literature search was performed (i.e. November 2006). 
The study factors included in the model were the following: type of study design, 
number of authors, multi-centre status, sample size, blinding of tests results, inter-
observer agreement, type of diagnostic test, clinical utility of results, Youden’s 
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Index, and region of origin of the corresponding author. All p values were two tailed 
with a significance level of 0.05. Missing data were excluded from the analysis. 
Statistical analyses were performed using SAS 9.1 for Windows. 
 
3.4 Results 
One hundred and sixty abstracts met the specified inclusion criteria. Seventy-six 
percent (121) of all abstracts did not report on blinding and 65% (104) did not 
mention study design. Approximately half of all abstracts did not provide estimates 
of sensitivity and specificity. Eighty-eight percent (141) reported ‘positive’ 
diagnostic test results whilst only 6% (9) reported ‘non-informative’ test results.  
 
I was able to locate a full-text publication for 117 abstracts in MEDLINE or 
EMBASE. Study authors completed 15 questionnaires (35%) out of the 43 sent for 
unpublished studies. Authors’ responses to the questionnaire indicate that four 
abstracts were subsequently published in full. Thus a total of 121/160 (76%) 
diagnostic stroke abstracts were published as full-text reports.   
 
Of the remaining 11 completed questionnaires, six authors stated that an original 
manuscript was initially rejected and a new manuscript was in preparation, four 
authors had not yet prepared or had no intention to submit a full-text manuscript, and 
one author stated that several manuscripts were published but was unable to provide 
precise information on the full-text publication related to the abstract presentation. 




Table 3.1. Study characteristics reported in diagnostic abstracts on stroke  
Study characteristics Total no. of abstracts (%) 
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Region of origin of corresponding author 
Australia, Canada, NZ, UK, USA 
Europe (except UK) 
Asia and South America 
 
Congress presentation 
International Stroke Conference (USA) 




























* See ‘Methods’ section for definitions 
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3.4.1 Abstracts published in full 
Amongst the 160 identified diagnostic abstracts, 121 (76%) were subsequently 
published in full. The characteristics of the abstracts published in full are shown in 
Table 3.1. Fifty two percent of the abstracts subsequently published in full were 
originally presented at the International Stroke Conference whilst 48% were 
presented at the European Stroke Conference. In 55% of the abstracts subsequently 
published in full, the corresponding author was affiliated with a non-English 
speaking European institution whilst 45% of published articles generated from an 
English speaking institution (i.e. UK, United States, Canada, New Zealand, or 
Australia). Within the non-English speaking European countries, the highest number 
of abstracts subsequently published in full came from Germany (42 out of 62), whilst 
amongst the English-speaking countries, the USA had more published articles (n= 
33) than UK (n= 11), Canada (n= 6), Australia (n= 3) or New Zealand (n= 1). 
Abstracts were published as papers in 35 different refereed journals (see Table 3.2). 
The top three journals where abstracts were published were: Stroke (n = 39), 
Cerebrovascular Diseases (n = 11), and Journal of Neuroimaging (n = 11). 
 
Amongst the abstracts on diagnostic tests published in full, 13% (16/121) were 
published before abstract presentation, 62% (75/121) were published between 0 and 
24 months after presentation, 8% (10/121) between 24 and 36 months, and 17% 
(20/121) after this time. Median time to publication, excluding abstracts published 
before meetings presentation, was 16 months and the mean time to publication was 
20 months. The cumulative publication rate is illustrated by the Kaplan-Meier 
survival curve in Figure 3.1.  
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Table 3.2. Journals in which full-text reports were published 
Journal Full-text 
papers 
Journal  Full-text 
papers 
Stroke 39 Australian Prescriber 1 
Cerebrovascular Diseases 11 Brain 1 
Journal of Neuroimaging 11 Canadian Journal of Neurological 
Sciences 
1 
Journal of Neurology, Neurosurgery, 
and Psychiatry 
8 European Journal of Neurology 1 
American Journal of Neuroradiology 8 European Radiology 1 
Journal of Neuroradiology 3 Journal of Cerebral Blood Flow & 
Metabolism 
1 
Neurology 3 Journal of Computed Assisted 
Tomography 
1 
Archives of Neurology 3 Journal of Magnetic Resonance 
Imaging 
1 
Radiology 3 Journal of Neurological Sciences 1 
Journal of Neurosurgery 3 Journal of Stroke & Cerebrovascular 
Diseases 
1 
Acta Neurologica Scandinavica 2 Journal of Ultrasound in Medicine 1 
European Neurology 2 JAMA 1 
Radiologe 2 Klinische Neuroradiologie 1 
Ultrasound in Medicine and Biology 2 Neurosurgery 1 
Acta Clinica Croatica 1 Physiotherapy Research International 1 
Acta Radiologica 1 Prehospital Emergency Care 1 
Age and Ageing 1 Rinsho Shinkeigoku 1 





3.4.2 Study characteristics and publication 
The results of the univariate Cox regression analyses for the association between 
study characteristics and publication status are shown in Table 3.3. The hazard ratio 
for publication for studies in which inter-observer agreement was assessed compared 
to studies in which no inter-observer agreement was reported was 2.10 (95% CI 1.21 
to 3.64) (P= 0.02). No other potential predictor was statistically significantly 
associated with full-text publication. In particular, the clinical utility of results, and 
Youden’s Index had no statistically significant influence on publication. There was a 
non-significant trend for smaller studies to be more likely to be published than larger 
ones (p = 0.09). 
 
Figure 3.1. Analysis of time to full publication of 121 diagnostic studies published as abstracts.  
Kaplan-Meier survival analysis. The line does not cross the vertical axis at 0%, as 16 papers 
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1.52 (0.95 to 2.43) 
1.18 (0.53 to 2.64) 
comparator 
 




1.03 (0.95 to 1.13) 
 







1.07 (0.56 to 2.06) 
comparator 
Sample size (per 100 patients) 
 
0.09 0.90 (0.77 to 1.05) 
Blinding of test results 
Blinded 
No blinding reported 
 
0.15  




Not stated if assessed 
 
0.02  
2.10 (1.21 to 3.64) 
comparator 





1.34 (0.74 to 2.40) 
comparator 






1.08 (0.50 to 2.33) 
0.70 (0.28 to 1.72) 
comparator 
Youden’s Index 
Youden’s Index score 
Youden’s Index missing 
 
0.91  
0.71 (0.15 to 3.33) 
1.03 (0.69 to 1.53) 
Region of origin of corresponding 
author 
Europe (except UK) 
Asia and South America 






1.14 (0.76 to 1.68) 
0.50 (0.18 to 1.40) 
comparator 
Congress presentation 
International Stroke Conference (USA) 
European Stroke Conference 
 
0.13  
1.35 (0.92 to 1.99) 
comparator 
 






In systematic reviews it is crucial to identity all relevant published studies in the 
literature and minimize possible publication and related biases. There is significant 
empirical evidence of publication biases for randomised clinical trials. However, 
publication and related biases for studies of diagnostic accuracy have not been 
investigated to any great extent, including in the field of stroke, where diagnostic 
testing plays a major role in clinical practice. This study examined the frequency and 
determinants of publication of studies of diagnostic accuracy based on a large sample 
of abstracts presented at two major scientific stroke meetings. Abstracts varied in 
terms of study characteristics and methodological quality. In particular, 76% of all 
abstracts did not report on blinding, 65% on type of study design, and about half on 
measures of diagnostic accuracy.   
The findings of this study indicate that approximately 60% of diagnostic abstracts 
presented at international stroke meetings are published in refereed journal within 
two years from presentation and 70% were fully published within three years. The 
mean time of approximately 1.5 years to publication reflects most likely the peer 
review process that scientific data must undergo in order to be published. The 
publication rate of abstracts in our study is consistent with that reported by a recent 
study which assessed the frequency of non-publication of abstracts presented at the 
2000 Annual Stroke Conference of the American Stroke Association. The study’s 
authors included a broad class of stroke studies and did not focus specifically on 
diagnostic studies of test accuracy. They found, however, that overall 62.3% of all 
2000 abstracts resulted in full-text publications, with a median time to publication of 
15 months. No positive-outcome bias was detected across stroke studies.10 
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In this study the most important factor to be associated to full publication was the 
reporting of inter-observer agreement between test readers. This is likely to be 
explained by the overall higher methodological quality of investigations reporting 
information on inter-observer agreement. Interestingly, I found no evidence that full 
publication of diagnostic abstracts was influenced by the clinical utility of the 
findings. In particular, higher values of sensitivity and specificity results were not 
significantly associated with full publication. However, it is worth noticing that the 
median value of both sensitivity and specificity for all published studies was 0.91. 
Whilst this result could simply mean that the diagnostic tests applied in stroke 
medicine really are highly sensitive and specific, other explanations are possible. 
Firstly, authors might only submit a diagnostic abstract for presentation if the study 
showed high ‘accuracy’ or ‘positive results’. Indeed the majority of abstracts (88%) 
had ‘positive’ diagnostic test results and only 6% had ‘non-informative’ diagnostic 
test results. I suspect, but of course cannot confirm, that authors of ‘non-informative’ 
studies of diagnostic accuracy would be less likely to submit their work as an 
abstract than authors of ‘non-informative’ randomised controlled trials. 
Alternatively, this may reflect a bias in the selection process of abstracts for 
presentation to international stroke meetings.  
 
Youden’s Index did not seem to predict publication in our study. However, in the 
analyses I had aggregate data across all types of test. This is not ideal, since 




I was surprised to note the tendency for smaller studies to be published in full. This is 
a marked contrast with the direction of publication bias in reports of clinical trials, 
where smaller studies are less likely to be published in full. However, as the 
difference did not reach statistical significance, this finding may purely be due to 
chance. On the other hand, it has been suggested that, in diagnostic research, smaller 
studies may be coupled with better methodology.8 Jon Deeks maintains for example, 
that “large retrospective studies in which investigators obtain test results from 
clinical databases may be more biased than smaller prospective studies in which 
clinicians carefully recruit patients presenting with a specific clinical problem”. In 
diagnostic research large studies are usually retrospective as large prospective studies 
(for example on new imaging tests) are expensive, difficult to perform, and currently 
not seen as priority. It is also likely that participants in larger diagnostic studies, 
rather than in smaller studies, are verified by different reference standards (i.e. 
verification bias) due to inadequate resources or practical problems.8 To examine 
further whether smaller studies might be of higher quality, I used the impact factor of 
the journal in which the full report was published as a surrogate marker of study 
quality. I have not found any clear relation between sample size of published studies 
and journal impact factor (Figure 3.2). Further evidence from future research is 
needed to clarify whether smaller studies of diagnostic accuracy are more likely to be 
published in full. In particular, it would be worth investigating the presence of 
publication bias in small and large studies after adjusting for the quality of individual 
studies. I did not find any significant association between either the region of origin 
of the corresponding author or the numbers of authors and full publication status on 
the univariate regression analyses. 
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Figure 3.2. Scatter plot of sample size versus journal impact factor for the 121 abstracts 



























Possible limitations of this study include the low response rate in the authors’ survey 
(32%). There are several reasons for failing to publish a full-text manuscript 
following a conference presentation. Undoubtedly the reviewing process for a full 
publication is much more challenging than vetting for a conference presentation. 
Moreover, it should be noted that training programmes underwrite the costs of 
attending a conference only if one submits an abstract;11 indeed in several institutions 
this is true independently of the status of the author. Hence, authors may put some 
effort in submitting their abstract but not pursue it afterwards. In fact, 4 out of the 11 
of authors who replied to our questionnaire admitted that they had no intention of 
preparing a full-text publication. Alternatively, the 28 authors who did not reply to 
our questionnaire could have been the same authors who saw their papers rejected 
due to a publication bias. However, most (26/28) of these authors reported ‘accurate’ 
diagnostic test results in their abstract. I was also not able to assess the extent of a 
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possible bias in the selection of abstracts for presentation. The presence of a positive-
outcome bias has been previously documented in both the submission and the 
selection processes of studies presented at scientific meetings.12 Future creation of a 
prospective register for diagnostic studies (as are being created for randomised 
clinical trials) would allow evaluation of publication bias at all stages, but may fail to 
include diagnostic studies which are undertaken using retrospective designs. 
 
To assess the methodological quality of abstracts was challenging due to the limited 
information given and the absence of a standard reporting structure. Essential 
information was missing in many abstracts, possibly due to the space restrictions. In 
particular, several abstracts failed to include methodological factors that become 
crucial in the quality assessment of diagnostic studies as defined by the STARD 
criteria such as inclusion of consecutive patients, a clear description of both the 
experimental tests and the reference standard, together with information on type of 
study design, patient sample, blinding of tests readers, and measures of test 
performance.13 Therefore, in assessing the quality of abstracts I may have run the risk 
of judging the quality of what was reported rather than the quality of what was 
actually done. There is no evidence suggesting that high quality work was 
undermined by poor abstracts. Indeed, there may be an association between poor 
quality work and overestimation of test accuracy, which could lead to an association 
between poor reporting and overestimates of test performance.  
 
In conclusion, these results provide some reassurance that for abstracts submitted to 
major stroke conferences, there is no evidence of substantial bias in the publication 
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once an abstract has been accepted for publication. It seems likely that if publication 
bias is present, it is more likely to occur at the level of abstract submission or 
selection. 
 
3.5.1 Implications for future research 
 Further research is needed to provide additional empirical evidence on the size 
and direction of publication bias in diagnostic research. In particular, further 
studies are needed to confirm or refute the findings of this study in other clinical 
areas. Further studies should also investigate whether publication bias is more 
likely to occur at the level of abstract submission or selection. 
 Further empirical evidence is needed to inform the development of search 
strategies to identify studies to be included in systematic reviews of diagnostic 
test accuracy. 
 Further research is needed to develop graphical and statistical methods for 
detecting publication bias in systematic reviews of diagnostic test accuracy.  
 Further research should also develop methods for reducing publication bias such 
as the registration of all diagnostic studies in publicly accessible databases, 
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4. Magnetic resonance imaging versus computed 
tomography for detection of acute vascular lesions in 
patients presenting with stroke symptoms 
 
4.1 Background  
4.1.1 Target condition being diagnosed  
Stroke is the third leading cause of death in Western societies and the leading cause 
of long-lasting severe disability.1 The overall incidence of stroke is about 2.4 per 
1000 population, with modest geographical variations.2 
 
The two main categories of stroke are ischaemic and haemorrhagic. The latter occurs 
when a blood vessel in the brain ruptures causing bleeding either within the brain 
(intracerebral haemorrhage) or between the brain and the thin membrane that 
surrounds the brain (subarachnoid haemorrhage). Haemorrhagic strokes account for 
about 20% of all strokes. An ischaemic stroke occurs when an artery in the brain 
becomes blocked and blood flow suddenly decreases or stops causing a brain 
infarction. It is the most common form of stroke and accounts for about 80% of all 
strokes. 
 
According to the location of the vascular event, ischaemic strokes may be classified 
as: (1) lacunar syndromes (LACS); (2) posterior circulation syndromes (POCS); (3) 
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total anterior circulation syndromes (TACS); and (4) partial anterior circulation 
syndromes (PACS).3 
 
A transient ischaemic attack (TIA) starts suddenly, like a stroke, but symptoms last 
only for a short period of time (usually minutes or hours) and then resolve without 
leaving any noticeable sign or deficit. Symptoms of a TIA disappear completely 
within 24 hours from onset but they are associated with a high risk of a subsequent 
stroke, especially within the first few weeks (8% to 11.5% within the first seven 
days).4 
 
Stroke is usually diagnosed by a combination of clinical examination and imaging 
procedures, though it is accepted that some patients with a clinically definite stroke 
may have normal brain imaging appearances. 
 
An accurate and timely diagnosis is crucial in acute stroke both for decision-making 
and for establishing appropriate patient management. The continuing advances in 
neuroimaging techniques and the advent of thrombolytic therapy and other 
emergency neurointerventional procedures for ischaemic stroke (for example 
mechanical clot retrieval and intra-arterial thrombolysis), whose efficacy is greatest 
when given within a few hours of stroke onset,5,6 have increased the need for a rapid 
and reliable diagnosis. The main objectives of neuroimaging in acute stroke are to 
distinguish between stroke and non-stroke lesions (for example brain tumour, 
abscess), to distinguish haemorrhagic from ischaemic stroke, and to identify the 
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anatomic localisation of the vascular lesion. In particular, positive signs of acute 
cerebral ischaemic lesions on imaging may contribute to diagnosis within the first 
few hours. For example, if the clinical symptoms and radiological localisation of 
stroke match, or if the scan gives a clue to aetiology (such as the hyperdense artery 
sign suggesting large artery occlusion), this may give clinicians greater confidence to 
administer thrombolysis. However, it is not known whether the appearance of the 
acute ischaemic lesion influences stroke treatment, management, or outcome. 
 
4.1.2 Index test(s)  
Non-contrast computed tomography (CT) is a cost-effective and widely used 
neuroimaging method for the initial evaluation of patients presenting with stroke 
symptoms.7 In particular in the acute phase of stroke, when patients are scanned 
within a few hours of symptom onset, CT is quick to perform, easy to tolerate, and is 
known to be very reliable for the detection of intracerebral haemorrhage. Early 
detection of haemorrhage is essential since the presence of blood in the brain or 
subarachnoid space is the main contraindication both for the administration of 
antiplatelet, anticoagulants, or thrombolytic therapy.8 In contrast, the initial signs of 
cerebral infarction on CT can be subtle and consequently difficult to detect. It is now 
widely recognised that patients with an acute ischaemic stroke (especially lacunar 
stroke and stroke in the brainstem) can have normal CT appearances. 
 
Magnetic resonance imaging (MRI) with diffusion-weighted sequences (DWI) has 
been increasingly used in the assessment of patients with stroke and TIA because of 
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its sensitivity in detecting the early changes associated with ischaemia,9 especially in 
patients with mild events or with small infarcts (for example lacunar or brainstem 
infarcts). On the other hand, the detection of acute cerebral haemorrhage on MRI is 
not as straightforward as on CT. There have been suggestions that MR gradient-echo 
sequences (GRE) can be as sensitive as CT for excluding intracerebral haemorrhage 
before the administration of thrombolysis.10-13 However, the utility of routine MRI to 
replace CT as the primary imaging for patients with suspected acute stroke has yet to 
be fully demonstrated. Moreover, in many countries, MRI is not available for stroke 
patients in many hospitals, it is contraindicated in patients with pacemakers and 
metal implants, and severely ill or confused patients may not tolerate MR scanning. 
 
We therefore conducted a systematic review of the literature to estimate the accuracy 
of DWI compared with CT for the diagnosis of acute ischaemic stroke and to assess 
the accuracy of MRI (all feasible sequences, for example diffusion-weighted, 
gradient-echo sequences) for the early detection of haemorrhagic stroke. 
We restricted the scope of this review to assess the diagnostic accuracy of both CT 
and MRI in patients suspected of acute stroke. We did not address the issue of the 
use of imaging methods (such as perfusion-diffusion mismatch) to identify acute 
stroke patients who might benefit from thrombolytic therapy outside the 
conventional therapeutic time window. Nor did we address the consequences of 





4.2 Objectives  
4.2.1 Primary objectives 
 To compare MR diffusion-weighted images (DWI) and CT scans with respect 
to the accuracy of the localisation of acute ischaemic lesions. In particular, the 
review aimed to assess whether DWI could be considered superior to CT for 
the detection of acute ischaemic lesions within 12 hours (replacement of CT 
with DWI) or as an additional investigation for patients with negative or 
inconclusive CT scans. 
 To assess the accuracy of MRI for the detection of acute haemorrhagic lesions 
within 12 hours.  
The 12 hours time window was selected because this is the time when 
antithrombotic or thrombolytic therapy is most likely to be beneficial for patients 
with ischaemic stroke (and hence the reliable exclusion of haemorrhage is a 
clinically urgent priority). The choice of this time window is, however, 
necessarily arbitrary. At the time this review was planned, intravenous 
thrombolytic therapy was approved for use within 3 hours, but studies seeking to 
extend this time window to 9 hours (and possibly further) were already 
underway. Other acute stroke studies were recruiting to later time windows - 24 
or 48 hours (e.g. the ENOS trial http://www.enos.ac.uk/). We opted for a time 
window of 12 hours because sufficient published acute stroke studies had an 
inclusion window of 12 hours. An unduly restrictive time window would have 
further limited the number of studies eligible for inclusion. Although 
thrombolytic therapy is one of the most important therapies, others such as intra-
 
75 
arterial thrombolysis, novel thrombolytic agents, hypothermia, and 
neuroprotective drugs may have a therapeutic window of 12 hours or longer and 
therefore the choice of a wider time window is likely to have a greater clinical 
relevance. This choice has been further supported by recent published evidence-
based guidelines which have adopted the same 12 hour cut off for DWI studies.14 
Besides, in clinical practice clinicians need to diagnose people even if they are 
not going to treat them, so including studies across a range of times is more 
relevant to determining diagnostic accuracy. 
 
4.2.2 Secondary objectives  
As imaging results may vary depending upon the technical characteristics of the 
imaging test and the time when the imaging test is performed, we planned to analyse 
diagnostic data according to: 
 the time of imaging from onset of symptoms (e.g. patients scanned within three, 
six, and 12 hours of symptoms onset); 
 choice of imaging test for detection of haemorrhagic stroke (e.g. diffusion-
weighted sequences, gradient-echo sequences). 
 
4.2.3 Investigation of sources of heterogeneity  
We were not able to investigate methodological and clinical sources of heterogeneity 




4.3 Methods  
4.3.1 Criteria for considering studies for this review  
4.3.1.1 Types of studies  
We aimed to include studies published in any language. However, we did not include 
non-English articles for which a full-text translation or evaluation could not be 
obtained. For the detection of ischaemic lesions, studies were eligible if: 
i) both DWI and CT were evaluated in the same patient population (direct 
comparison) against an acceptable reference standard (as defined later), or if patients 
were randomised within a study to DWI or CT; 
ii) clinical and imaging assessments were performed within 12 hours of onset of 
symptoms; 
iii) the absolute numbers of observations of true positives, false positives, false 
negatives, and true negatives were available or derivable from the data reported in 
the primary studies. 
For the detection of haemorrhagic lesions, studies were eligible if: 
i) MRI sequences were evaluated against a clinical diagnosis of stroke supported by 
CT findings (reference standard) in cross-sectional studies; 




iii) the absolute numbers of observations of true positives, false positives, false 
negatives, and true negatives were available or derivable from the data reported in 
the primary studies. 
 
We included both prospective and retrospective studies. 
 
We excluded studies that focused on patients presenting exclusively with a clinical 
syndrome suggesting either subarachnoid haemorrhage or isolated intraventricular 
haemorrhage since they are very distinctive clinical syndromes not directly relevant 
to patients presenting with the focal neurological deficits of acute stroke. 
 
We also excluded studies that: addressed specific anatomical, metabolic, 
microvascular, or volumetric aspects of stroke; focused on specific technical aspects 
of CT and MRI; analysed perfusion versus diffusion imaging differences in patients 
with acute cerebral ischaemia. 
 
Where investigators published several reports based on data from a single study 
population, we selected the updated or most complete report. 
4.3.1.2 Participants  
Adult patients with clinical symptoms suggestive of acute stroke, including patients 
in whom the subsequent diagnosis proved to be TIA. 
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4.3.1.3 Index tests  
 DWI and CT performed within 12 hours of onset of symptoms for the detection 
of ischaemic brain lesions (CT is regarded here as the alternative test for 
detection of ischaemic lesions). 
 MRI (all suitable sequences) performed within 12 hours of onset of symptoms 
for the detection of haemorrhagic brain lesions. 
4.3.1.4 Target conditions  
 Acute ischaemic stroke 
 Acute haemorrhagic stroke 
4.3.1.5 Reference standard 
A single 'gold standard' for the diagnosis of stroke does not exist. In clinical practice 
however, expert assessment based on the combination of clinical features, imaging 
appearances, laboratory tests, and clinical follow up does provide the most 
comprehensive diagnosis. A diagnosis of stroke based only on the clinical and 
imaging data available to the clinician within the first few hours is unlikely to be 
sufficiently accurate. 
For the diagnosis of acute ischaemic stroke we considered an acceptable reference 
standard to be: a combination of clinical and imaging information supported by 
clinical or imaging follow up (CT or MRI) or autopsy. Any elaboration of this 
definition was however deemed suitable for inclusion (e.g. studies that relied 
exclusively on a clinical diagnosis or exclusively on a CT or MRI follow up). 
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For the diagnosis of acute haemorrhagic stroke we considered a valid reference 
standard to be: a clinical diagnosis supported by CT or autopsy. 
 
Note: in some studies, patients whose symptoms lasted less than 24 hours, but who 
had evidence of an ischaemic lesion on imaging, were counted as having had strokes 
and hence analysed as true positive cases. In other studies, however, patients with 
symptom duration less than 24 hours and an ischaemic lesion on imaging were 
analysed as being false positive cases. 
 
4.3.2 Search methods for identification of studies  
4.3.2.1 Electronic searches  
We identified eligible studies by searching the following electronic databases: 
 Cochrane Stroke Group Trials Register (last searched by the Trials Register 
Administrator in March 2009); 
 Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane 
Library Issue 1, 2009); 
 MEDLINE - Ovid (from January 1995 to March 2009); 
 EMBASE - Ovid (from January 1995 to March 2009); 
 MEDION (last searched in March 2009 using the 'Systematic Reviews and 
Diagnostic Studies' search filter, the ICPC code = 'Neurological' and the 
signssymp = 'Medical Imaging'). 
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4.3.2.2 MEDLINE and EMBASE searches 
We searched indexed records which appeared in MEDLINE (January 1995 to March 
2009). The choice of this time period was justified by the introduction in the early 
1990s of MR diffusion-weighted and gradient-echo sequences into clinical practice. 
The MEDLINE search strategy included both subject headings (MeSH terms) and 
text words for the target condition (stroke) and the imaging techniques under 
investigation (MRI and CT). We also included a methodological filter for studies of 
diagnostic accuracy. Our methodological filter was based on the diagnostic 
component of the search strategy developed and validated by Astin and colleagues to 
identify diagnostic accuracy studies on imaging.15 We did not apply any language 
restrictions. We adapted the MEDLINE search to search EMBASE. In particular, we 
'translated' the MEDLINE MeSH terms into the corresponding terms available in the 
EMTREE vocabulary. Full details of both the MEDLINE and EMBASE search 
strategies together with a brief summary of the MEDLINE search strategy are 
presented in Appendix 2. We imported all citations identified by the MEDLINE and 
EMBASE search strategies into the Reference Manager bibliographic database.16 
4.3.2.3 Searching other resources  
We handsearched all proceedings of the International Stroke Conference and the 
European Stroke Conference (1995 to 2004). These proceedings were published as 
abstracts in special issues of two peer-reviewed journals: Stroke and 
Cerebrovascular Diseases. We also searched the following websites using terms for 
the target condition (stroke, acute stroke) and for the two imaging techniques under 
investigation (magnetic resonance imaging, computer tomography): 
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 American College of Cardiology - ACC (www.acc.org) (last searched March 
2009); 
 American College of Radiology - ACR (www.acr.uk) (last searched March 
2009); 
 American Heart Association - AHA (www.americanheart.org) (last searched 
March 2009); 
 American Stroke Association - ASA (www.strokeassociation.org) (last searched 
March 2009); 
 Department of Radiology & Diagnostic Imaging - University of Alberta, Canada 
(www.radiology.med.ualberta.ca) (last searched March 2009); 
 National Institute of Neurological Diseases and Stroke - NINDS 
(www.ninds.nih.gov) (last searched March 2009); 
 National Stroke Association - NSA (www.stroke.org) (last searched March 
2009); 
 Royal College of Physicians (www.rcplondon.ac.uk) (last searched March 2009); 
 Royal College of Radiologists - RCR (www.rcr.ac.uk) (last searched March 
2009); 
 Scottish Intercollegiate Guidelines Network - SIGN (www.sign.ac.uk) (last 
searched March 2009). 
We perused the reference lists of all relevant articles to identify further published 
studies for possible inclusion in the review. We also contacted experts in the field to 




4.3.3 Data collection and analysis  
4.3.3.1 Selection of studies  
One author (MB) initially screened the titles and abstracts of the search results and 
retrieved all potentially relevant reports in full. Three review authors (MB, MGC, 
ER) independently reviewed all relevant reports according to the pre-defined 
inclusion criteria. We resolved any disagreements by consensus or arbitration. The 
same three authors extracted data from the selected reports. 
4.3.3.2 Data extraction and management  
We designed a data abstraction form specifically to collect details from selected 
studies (see Appendix 3). We recorded the following information for each individual 
study (without concealing the study authorship or other publication details): journal 
name, year of publication, study design and method of recruitment (systematic 
review, randomised controlled trial, cross-sectional survey; prospective study, 
retrospective study), setting, number and characteristics of participants (age, sex, 
ethnicity, previous history of stroke, concomitant diseases), classification of stroke, 
definition of abnormal CT and MR images, time of imaging, the reference standard 
by which the final diagnosis was established, time interval from index test and 
comparator tests, time interval from index test(s) and established diagnosis of stroke, 
technical characteristics of MRI and CT, information related to the clinicians who 
read and interpreted imaging results (background speciality, level of expertise) and to 
the clinicians who established a clinical diagnosis of stroke. We resolved any 




4.3.3.3 Assessment of methodological quality  
Four authors (MB, MGC, ER, NA) independently assessed the methodological 
quality of each included study using the QUality Assessment of Diagnostic Accuracy 
Studies (QUADAS) tool developed by the NHS Centre for Reviews and 
Dissemination at the University of York, UK.17 The QUADAS tool is structured in a 
series of questions which should be answered 'yes', 'no', or 'unclear', and aims to 
evaluate the presence of spectrum bias, bias associated with the choice of reference 
standard, disease progression bias, verification bias, review bias, clinical review bias, 
incorporation bias, and bias associated with study withdrawals and indeterminate 
results. In particular, we considered a representative spectrum of patients to be: 
female and male patients of all ages presenting with mild, moderate, or severe stroke 
symptoms; with or without previous history of stroke; scanned within a few hours of 
onset of symptoms. We defined an appropriate reference standard likely to correctly 
classify the target condition as: an expert clinical assessment coupled with clinical 
and imaging follow up. We also considered up to seven days an acceptable time 
period between MRI and CT for the detection of haemorrhagic stroke. For ischaemic 
stroke we accepted any time period reported by the studies’ investigators between 
CT and MRI, and the follow up reference test. We also decided to add to the 
recommended QUADAS questions the following items pertinent to the purpose of 
this systematic review: expertise of the person interpreting the imaging results; 
whether the scans were read blind to clinical information; and whether the sequence 
of imaging tests was determined at random (the modified QUADAS checklist is 
reported in Appendix 4). As regards the expertise of the person interpreting imaging 
results, we distinguished radiologists and neuroradiologists, who by definition are 
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experts in reading imaging test results, from neurologists, geriatricians, and general 
medicine doctors. We resolved any disagreements by consensus or arbitration. For 
each individual study we tabulated the agreed results of the quality assessment. 
4.3.3.4 Statistical analysis and data synthesis  
We extracted or derived indices of diagnostic performance from data presented in 
each primary study for each imaging test. We constructed 2 X 2 contingency tables 
of true positive cases, false positive cases, false negative cases, and true negative 
cases. We considered patients with ischaemic stroke as false positives or true 
negatives when analysing the performance for detecting haemorrhagic stroke, and we 
counted patients with haemorrhagic stroke as false positives or true negatives when 
analysing the performance for detecting ischaemic stroke. We calculated sensitivity 
and specificity with 95% confidence intervals (CI) for each imaging test in each 
study. We tabulated results for studies on ischaemic stroke separately from those for 
studies on haemorrhagic stroke. 
 
We drew forest plots to show the variation of sensitivity and specificity estimates 
together with their 95% CI. For studies on ischaemic stroke where DWI was 
compared with CT versus a reference standard of clinical diagnosis and imaging 
follow up we also plotted the imaging test results on a receiver operating 
characteristic (ROC) plot of true positive rate (sensitivity) against false positive rate 




We explored the heterogeneity of the sensitivity and specificity estimates amongst 
studies on ischaemic stroke by examining both the forest plots and the ROC plot. As 
almost all estimates of specificity were at 'ceiling level' (specificity of 1) there was 
no evidence of heterogeneity and it was not possible to use statistical methods that 
rely on estimating correlations between sensitivity and specificity to enable 
estimation of a summary ROC curve.18,19 Rather, we separately pooled estimates of 
sensitivities and specificities across the studies. For CT sensitivity and DWI 
sensitivity and specificity we undertook meta-analyses using maximum likelihood 
estimation of a random-effects model to pool logit transformed proportions and allow 
for within-study binomial variation. We computed confidence intervals using 
MCMC sampling. We used a fixed-effect analysis to estimate the pooled specificity 
of CT as a specificity of 1 was observed in every study (score method was used to 
compute confidence intervals). We used the DiagMeta package within the R software 
(The R Foundation for Statistical Computing Version 2.7.1) to carry out the 
analyses. We were not able to perform a formal statistical comparison between tests 
due to the zero cell issues and small sample sizes. An informal comparison between 
tests was made by meta-analysing each test separately and examining the results. As 
all studies in the analysis evaluated both tests in all patients this comparison should 
not be biased by differences between the studies.  
 
We did not include study-level covariates in the analyses to assess factors that might 
have contributed to heterogeneity (such as time of imaging) as in small meta-
analyses this is likely to produce unreliable estimates. 
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We did not calculate overall estimates for studies on haemorrhagic stroke as we only 
identified two small studies of such different methodological quality that formal 
meta-analysis was not appropriate.  
 
4.4 Results  
4.4.1 Results of the search  
The MEDLINE and EMBASE searches identified 9961 citations. Of these, we 
considered 112 relevant to the purpose of our review and we retrieved the full-text 
articles (Figure 4.1). We subsequently excluded 103 articles (see the Characteristics 
of excluded studies table in Appendix 3). The most common reason for exclusion 
was that the study was either not a primary diagnostic study of test accuracy or it did 
not involve appropriate test comparisons. Eight studies, published in nine reports,20-28 
with a total of 306 participants fulfilled our inclusion criteria. Six studies focused on 
the comparison between DWI and CT for the detection of ischaemic lesions,20-25 one 
study estimated the accuracy of MRI for detection of haemorrhagic lesions,26 and one 
study assessed the use of MRI compared with CT for detection of both ischaemic and 
haemorrhagic lesions.27 Thus, seven studies contributed to the assessment of acute 
ischaemic stroke and two studies contributed to the assessment of haemorrhagic 





























Patients with suspected 
acute ischaemic stroke in 
the middle cerebral artery 
territory who were studied 
with both DWI and CT 
within 6 hours of symptom 
onset 








Scale score: 5.8 
(range 1.5 to 11) 








None of the patients were 
treated with thrombolysis 
One patient was unable to 




Patients with suspected 
acute ischaemic stroke who 
underwent imaging within 
12 hours of symptom onset 
15 stroke patients 
(40% men) 
Mean age 67.6 
years (range: 54 to 
81 years) 





DWI versus CT CT at 8 days Haemorrhage excluded 
Severity of stroke not reported 
Stroke vascular territory not 
specified 
One patient could not undergo 
MRI because of agitation 
Chalela 
2007 
Patients with suspected 
acute stroke who 
underwent both DWI and 
CT within 3 hours of 
symptom onset 
Patients selection was not 




Median age 76 
years (range 21 to 
100 years) 
Median score at 
NIHSS = 3 (range 
0 to 37) 
Prospective Acute stroke 
Final diagnosis 





DWI versus CT 
for detection of 
ischaemic stroke 
MRI sequences 
for detection of 
haemorrhagic 
stroke 
Imaging None of the patients were 
treated with thrombolysis 
TIAs with imaging evidence of 
infarction were counted as true 
positive cases 
The distribution of patients was 
skewed towards mild cases 
Patients who could not tolerate 
MRI or with uninterpretable 
imaging results were excluded 
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Table 4.1. Characteristics of included studies – continued 
Study ID Clinical features 
and setting 










Patients with suspected 
ischaemic stroke and with a 
negative or inconclusive CT 
scan and for whom MRI was 
deemed essential for 
establishing proper 
management 
Imaging was performed 
within 6 hours of symptom 
onset 
Most of the patients had a 
stroke in the MCA territory 
22 patients 
(55% men) with 
acute stroke 




















Severity of stroke not 
reported 
Three patients were 
excluded because they did 
not undergo CT 
Oppenheim 
2005 
Patient details were 
retrospectively extracted 
from the acute stroke 
database of 2 university 
hospitals which used MRI as 
the first imaging modality 
for patients reaching hospital 
within 6 hours of symptoms 
onset 
Only patients with a stroke 
severity of ≥ 3 points on the 
NIHSS were deemed 
suitable for inclusion 
86 patients 

























Only a minority of patients 
had a CT scan and the 
diagnosis of acute 
intracerebral haemorrhage 








Table 4.1. Characteristics of included studies – continued 
Study ID Clinical features 
and setting 











Patients with acute ischaemic 
stroke in the middle cerebral 
artery territory for whom DWI 
and CT were performed 
within 6 hours of stroke onset 
and with a time interval of less 




Mean age: 62.8 
years (range: 35 
to 89 years) 
Mean NIHSS 
score: 13.3 
























Patients with suspected stroke 
for whom imaging was 
performed within 12 hours of 
symptoms onset 
Patients with intracerebral 
haemorrhage were excluded 
11 patients 
(73% men) with 
acute ischaemic 
stroke 
Mean age: 64 
years (range 47 









MR imaging Haemorrhage excluded 
Severity of stroke not 
reported 
Stroke vascular territory 
not specified 
Urbach 
2000 Patients with acute ischaemic 
stroke in the middle cerebral 
artery territory for whom DWI 
and CT were performed 
within 6 hours of stroke onset 
30 patients 
(60% men) with 
acute ischaemic 
stroke 
Mean age: 52 
years (range 18 













Severity of stroke not 
reported 
CT: computed tomography; DWI: diffusion-weighted magnetic resonance imaging; GRE: gradient-echo; MCA: middle cerebral artery; MR or MRI: magnetic 
resonance imaging; NIHSS: National Institute of Health Stroke Scale; TIA: transient ischaemic attack.
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4.4.2 Methodological quality of included studies  
4.4.2.1 Studies on ischaemic stroke  
Seven studies compared CT with DWI in the same patients for the detection of acute 
cerebral ischaemia. The total number of assessed patients was 226. Sample size 
ranged from 11 to 90 patients (mean 32 patients). The reported mean age was 65.1 
years (range 21 to 100 years). The proportion of men ranged from 40% to 73%, with 
no information on gender distribution in one study. Only three studies clearly 
reported stroke severity and only three reported the number of patients who were 
excluded because they could not tolerate MRI. CT and DWI were performed within 
three hours of symptoms onset in one study, within six hours in four studies, and 
within 12 hours in the two remaining studies. In all but one study CT was performed 
before DWI. In five studies the average delay between CT and DWI was 55.3 
minutes (SD 24.4 minutes). One study reported that the median interval between the 
two imaging techniques was 34 minutes, and the remaining study did not provide this 
information but stated that the interval between DWI and stroke onset was 4.2 hours. 
In four studies selection of patients was restricted to middle cerebral artery stroke; in 
two studies the stroke vascular territory was not given even though it is likely that 
they predominantly enrolled patients with anterior circulation stroke; and in one 
study patients were not selected according to the type of stroke. 
 
The quality of the seven included studies varied (Figure 4.2 and Figure 4.3). Four 
studies collected patients’ data prospectively (132 patients in total) and three studies 
retrospectively (94 patients in total). In all three retrospective studies the original MR 
 
92 
and CT images of acute stroke, obtained from the patients’ hospital records, were 
reviewed de novo by the study investigators. In these three studies, even though brain 
images were reviewed de novo, there was still a risk of bias due to the retrospective 
selection of patients' records. Four studies clearly described their inclusion criteria 
but only one study appeared to include a representative spectrum of stroke patients (a 
consecutive series of patients referred to hospital because of a clinical suspicion of 
stroke and irrespective of gender, age, previous medical history, co-morbidity, 
symptom severity, or final diagnosis) (90 patients).27 However, the extremely mild 
strokes and the absence of any stroke mimics in this study indicated that some 
clinical exclusion criteria must have been applied after hospital admission and before 
study inclusion and scanning. Furthermore, in this study patients presenting with TIA 
but in whom DWI showed a new ischaemic lesion had their diagnosis changed to 
stroke (incorporation bias). In all the included studies the reference standard for 
diagnosis of stroke was a clinical diagnosis supported by imaging follow up. The 
reference standard was independent of the index text in six studies (the acute images 
were not used in the final diagnosis). Readers of DWI and CT acute images were 
reported to be blind to patients' clinical details and final diagnosis in only three 
studies. Information on blinding of the reference standard results was not clearly 
reported in five studies and in two studies interpretation of the follow up images was 
not blind to the findings of the acute images. Information on the expertise of 
clinicians reading imaging results was available in all but one study. None of the 








Figure 4.3. Methodological quality summary: review authors' judgment on each  




4.4.2.2 Studies on haemorrhagic stroke  
The characteristics of the two studies assessing the use of acute MRI for detection of 
haemorrhagic lesions are summarised in Table 4.2. 
The prospective study by Chalela and colleagues27 compared non-contrast CT with 
MRI (diffusion-weighted and susceptibility-weighted images) in 450 patients 
referred for emergency assessment of suspected stroke, 90 of whom were scanned 
within three hours from the onset of symptoms. The patients’ median severity score, 
assessed by the National Institute of Health Stroke Scale (NIHSS), was 3 (range 0 to 
37) indicating the presence of predominantly mild stroke deficits. The proportion of 
patients with primary cerebral haemorrhage was 13% (12/90). Overall the proportion 
of patients who could not tolerate MRI, amongst a predominantly mild stroke 
population, was 11% (49/450). 
 
The retrospective study by Oppenheim and colleagues26 used data extracted from the 
acute databases of two university hospitals to evaluate the accuracy of five MR 
sequences (T1, GRE, FLAIR, T2-EPI, and DWI) to identify within 86 stroke patients 
those with (43 patients) and without (43 patients) intracerebral haemorrhage. Patients 
were included if they presented with a stroke severity score of ≥ 3 points on the 
NIHSS and if they underwent imaging within six hours of stroke onset. The patients’ 
final diagnosis incorporated all clinical, pathological, and imaging investigations. 
However, as only a small number of patients     
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Table 4.2. Characteristics and diagnostic results of the two included studies on haemorrhagic stroke  




Age (range) Stroke severity Time of imaging MRI results (95% CI) 




90 Median 76 y 
(21 to 100 y) 
Median score at NIHSS 
= 3 (range 0 to 37) 
Within 3 hours of stroke 
onset 
GRE and DWI sensitivity 0.83 
(0.52 to 0.98) 
GRE and DWI specificity 1.00 





82 Mean 68.8 y Mean score at NIHSS = 
11.25 
Within 6 hours of stroke 
onset (mean time 2.6 hours) 
DWI sensitivity 1.00 
 (0.91 to 1.00) 
DWI specificity 1.00  
(0.91 to 1.00) 
GRE sensitivity 1.00  
(0.91 to 1.00) 
GRE specificity 0.98  
(0.87 to 1.00) 
Note: *: prospective **: retrospective; 95% CI: 95% confidence intervals; DWI: diffusion-weighted imaging; GRE: gradient-echo; MRI: magnetic resonance 
imaging; NIHSS: National Institute of Health Stroke Scale 
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underwent CT, the reference standard was highly inconsistent and the final diagnosis 
of intracerebral haemorrhage was primarily based on multisequence MRI 
(incorporation bias). Not all patients completed all five MR sequences and we 
assessed results from 82 patients who completed both the gradient-echo and 
diffusion-weighted sequences. Figure 4.4 summarises the results of the quality 
assessment of the two studies on haemorrhagic stroke. Only five of the 15 QUADAS 
items were met by both studies. Information on the spectrum of patients was not 
clearly reported in the Oppenheim study.26 In both studies the reference standard was 
a final clinical diagnosis of haemorrhagic stroke supported by all available imaging 
investigations including the acute images. However, in both studies it was unclear 
whether all patients were verified by the same reference standard and there was clear 
evidence of incorporation bias as MRI findings contributed to the final diagnosis. In 
both studies the follow up images were not read blind to the findings of acute 
images. The reading order of MRI examinations was determined at random only in 
the Oppenheim study.26 
Figure 4.4. Methodological quality summary: review authors' judgement on each  




4.4.3 Findings  
4.4.3.1 Studies on ischaemic stroke 
Figure 4.5 shows the forest plots of the sensitivity and specificity estimates for DWI 
and CT for the seven studies that assessed patients with ischaemic stroke. Sensitivity 
estimates for DWI ranged from 0.73 to 1.00 (median 1.00) and the sensitivity 
estimates for CT ranged from 0.11 to 0.75 (median 0.45). Specificity estimates for 
DWI ranged from 0.86 to 1.00 (median 1.00) whilst specificity estimates for CT 
were all at 'ceiling level' (1.00 specificity). The pairs of observed values of sensitivity 
and specificity for DWI and CT are presented in a ROC space in Figure 6. The 
pooled estimates for DWI sensitivity and specificity were 0.99 (95% CI 0.23 to 1.00) 
and 0.92 (95% CI 0.83 to 0.97) respectively, whilst the pooled estimates for CT 
sensitivity and specificity were 0.39 (95% CI 0.16 to 0.69) and 1.00 (95% CI 0.94 to 
1.00) respectively. 
4.4.3.2 Studies on haemorrhagic stroke 
As data for the assessment of haemorrhagic stroke were derived from only two 
studies of low methodological quality with clear evidence of incorporation bias, we 
did not perform a meta-analysis of measures of test accuracy. The findings of the two 
studies suggested that MRI sequences may distinguish between patients with and 
without acute intracerebral haemorrhage with reasonably high sensitivity and 





Figure 4.5. Forest plots of sensitivity and specificity estimates for DWI and CT studies on 
ischaemic stroke. The squares represent each individual study; the black horizontal lines 
represent the 95% CIs.  
 
Note: TP = true positives; FP = false positives; FN = false negatives; TN = true negatives. The 
‘Sensitivity’ and ‘Specificity’ columns list the numerical values of sensitivity and specificity estimates with 
95% CIs for each study  
 
Figure 4.6. ROC plot of sensitivity versus specificity for the seven studies that compared DWI 





The Chalela study27 showed a sensitivity of 0.83 (95% CI 0.52 to 0.98) and a 
specificity of 1.00 (95% CI 0.95 to 1.00) for gradient-echo and diffusion-weighted 
MRI in patients assessed within three hours of stroke, versus CT and clinical 
assessment. The sensitivity estimate was, however, based on only 12 patients (13% 
of the 90 patients investigated) who were found to have acute cerebral haemorrhage. 
Similarly, the Oppenheim study26 reported 1.00 (95% CI 0.91 to 1.00) for both the 
sensitivity and specificity of diffusion-weighted MRI and 1.00 (95% CI 0.91 to 1.00) 
sensitivity and 0.98 (95% CI 0.87 to 1.00) specificity for gradient-echo MRI 
performed within six hours of symptoms onset, but with no CT comparator in most 
of the patients. However, the high proportion (50%) of patients with haemorrhage in 
this study as compared to the proportion of intracerebral haemorrhage observed in 
the typical clinical population (10% to 15%) indicated the presence of spectrum bias 
(highly selected patient sample) that was likely to have increased sensitivity and 
influenced specificity. 
Figure 4.7. Forest plots of sensitivity and specificity estimates for DWI and GRE sequences for 
the two studies on haemorrhagic stroke. The squares represent each individual study; the black 
horizontal lines represent the 95% CIs 
 
 
Note: TP = true positives; FP = false positives; FN = false negatives; TN = true negatives. The 
‘Sensitivity’ and ‘Specificity’ columns list the numerical values of sensitivity and specificity 




4.4 Discussion  
The emergency management of patients with acute stroke relies heavily on accurate 
and rapid diagnosis. Early identification of patients with stroke and the distinction 
between ischaemic and haemorrhagic stroke are crucial for therapeutic decision 
making and, in particular, for selecting patients for thrombolytic treatment. CT and 
MRI are both used in clinical practice to identify patients with acute stroke who 
might benefit from thrombolytic therapy (which is absolutely contraindicated in 
patients with stroke due to intracerebral haemorrhage). We conducted a systematic 
review to compare the accuracy of these two imaging methods for detection of acute 
ischaemic and haemorrhagic stroke. Six studies for the detection of ischaemic stroke, 
one study for the detection of haemorrhagic stroke, and one study which assessed 
both haemorrhagic and ischaemic stroke fulfilled our inclusion criteria. For the 
assessment of ischaemic stroke we included only comparative studies that evaluated 
both imaging techniques in the same patients, as they provide the best evidence on 
which to judge the relative performance of CT and MRI for the detection of 
ischaemic stroke lesions. In this limited cohort of studies MRI had higher sensitivity 
than CT but similar specificity (see Figure 4.5). The two studies that contributed to 
the assessment of haemorrhagic stroke provide similar sensitivity and specificity 
estimates for MRI (see Table 4.1 and Figure 4.7). We could not assess whether CT 
and MRI were equally good at identifying stroke mimics as the majority of studies 
excluded non-stroke patients. 
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4.4.1 Findings on ischaemic stroke 
Our findings are in line with the well-established claim in the literature that, in 
patients subsequently confirmed to have acute stroke, diffusion-weighted MR 
sequences are more sensitive for detecting acute ischaemia than plain CT; especially 
in the first hours after symptoms onset and chiefly in patients with mild stroke.28-32 
There are, however, important considerations to be made. The characteristics of the 
patient population varied between studies and all but one study included a very 
narrow spectrum of stroke patients. The study with a broader spectrum of patients27 
still only included mostly mild strokes (median score on NIHSS = 3 – a scale with a 
maximum score of 44) and, therefore, was not representative of the typical 
population being assessed for thrombolysis. The evaluation of mild cases may 
increase the sensitivity of DWI, which is known to be particularly useful in detecting 
small ischaemic lesions.33 The exclusion of more severe cases may further 
disadvantage CT; more severely affected patients are more likely to have a CT-
visible lesion, which may help to explain the large difference between CT and DWI 
sensitivity estimates in this study.27 The severity of stroke was rarely reported in the 
remaining included studies. It is also known that many patients with severe stroke do 
not tolerate MRI.34 Information related to the patients who were excluded because 
they either could not tolerate MRI or had contraindications was provided in only 
three studies. Of these, the largest study reported that about 11% of the patients 
initially screened for inclusion were subsequently excluded due to MRI 
contraindications.27 Moreover, the majority of included studies enrolled only patients 
with typical anterior circulation stroke. Negative DWI findings have been reported to 
occur more often in posterior circulation stroke during the first 24 hours.35,36 Thus in 
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an unselected population of stroke patients, the inclusion of posterior circulation 
strokes could well reduce the apparently greater diagnostic accuracy of DWI 
compared with CT. In all but one study, CT was performed about an hour before 
DWI. Thus since ischaemic lesions become more visible with the passage of time, 
the lesions on CT could have been less conspicuous and more difficult to detect than 
they would have been at a later stage (a more rigorous approach would have been to 
determine the sequence of tests by random allocation). Variable timing of CT and 
DWI could also have contributed to the variability in the observed CT sensitivity 
estimates. Studies generally had very small sample sizes, which may have 
jeopardised blinding and had an effect on the estimates of accuracy, especially for 
sensitivity. Furthermore, CT and DWI were evaluated in a highly selected group of 
patients in all but one study. Most of the patients had a final diagnosis of ischaemic 
stroke or TIA. TIA cases were usually counted as 'stroke negative' cases, except in 
one study27 where TIA cases with evidence of ischaemic lesions on DWI were 
reclassified as 'strokes' (true positive cases). This 'reclassification' might have added 
a negative effect on CT and did clearly switch the reference standard to an MRI 
diagnosis. The incorporation of DWI findings in the reference standard 
(incorporation bias) was likely to have inflated the observed DWI estimates of 
sensitivity.  Moreover, although it has been demonstrated that DWI may show an 
apparent acute cerebral infarction in approximately half of patients with TIA37 the 
clinical significance of DWI-positive TIAs remains uncertain. Since DWI-positive 
lesions can resolve, the subsequent scans may reveal no evidence of infarction. 
Specificity estimates were very high in all studies. Indeed, in most of the studies 
stroke mimics (for example cerebral neoplasms, systemic infections) or patients with 
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other cerebrovascular lesions were not included in the spectrum of patients assessed. 
This renders the sample poorly representative of the acute patients typically seen in 
clinical practice, where 15% to 30% of patients with an initial clinical diagnosis of 
stroke are ultimately found to have stroke-mimic pathologies.8,38-40 In turn, this 
makes it difficult to be certain that these estimates of accuracy apply in routine 
clinical practice to a wider spectrum of patients and provides no information on the 
accuracy of CT and MRI in detecting mimics. 
 
4.4.2 Findings on haemorrhagic stroke 
CT is the imaging modality most commonly used to distinguish the acute 
presentation of intracerebral haemorrhage from ischaemic stroke in the evaluation of 
potential candidates for thrombolytic therapy. More recently, it has been suggested 
that MRI, including diffusion-weighted and gradient-echo sequences, could detect 
haemorrhage in the first hours after stroke.10,13,41-43 However, methodologically 
rigorous data on haemorrhagic stroke are scanty and even the two studies that met 
our pre-defined inclusion criteria26,27 suffered from major methodological biases and 
limitations. Hence, there is insufficient evidence on which to draw any sound 
conclusions on the accuracy of MRI for detection of haemorrhagic stroke in routine 
practice. In both included studies the reference standard was a hospital discharge 
diagnosis which incorporated all available clinical and imaging data (including acute 
imaging data) but without CT in many cases, thereby leading to a comparison of 
MRI with itself. The presence of this incorporation bias may have overestimated the 
reported MRI diagnostic accuracy. Furthermore, in both studies patients with non-
 
104 
stroke lesions were not assessed and it would have been useful to know how well 
MRI (compared with CT) could distinguish haemorrhagic lesions from non-stroke 
lesions (for example neoplasms). Thus, while the ability of CT to distinguish acute 
haemorrhagic lesions from non-stroke lesions is well established the accuracy of 
MRI assessment of suspected acute stroke is still somewhat unclear.   
 
4.4.3 Summary of main results  
In conclusion, we identified only a limited number of studies that directly compared 
MRI versus CT for the early detection of stroke lesions. The overall methodological 
quality of these studies was poor. Our results suggest that diffusion-weighted MRI is 
probably more sensitive than CT, but not more specific, for the early detection of 
ischaemic stroke in highly selected patient populations. Our data do not allow any 
comments to be made on the merits of MRI for the detection of haemorrhagic stroke. 
Moreover, estimates of diagnostic accuracy of CT and MRI were obtained from well-
defined groups of patients with a final diagnosis of stroke so may be of limited 
clinical utility as they may not be applicable to the broad range of patients with 
suspected acute stroke usually seen in routine clinical practice. Neither practicality 
nor cost-effectiveness was effectively taken into consideration in the included 
studies. Additional well-designed studies are needed to estimate more reliably 
whether MRI can be used as the primary imaging modality for patients presenting 




4.4.4 Strengths and weaknesses of the review  
For the detection of ischaemic stroke, we focused exclusively on comparative studies 
that evaluated both CT and MRI versus a reference standard of clinical diagnosis and 
imaging follow up in the same patients, which is known to provide the best evidence 
about the diagnostic accuracy of two different methods. We searched major 
electronic databases to identify all relevant studies. Three review authors with 
different expertise (a methodologist and two neurologists) independently selected 
studies and extracted data. Four review authors (a methodologist, two neurologists, 
and a radiologist) independently assessed the quality of the included studies. 
 
Our review has some limitations. Overall, our findings are limited by the relatively 
small number of comparative studies available in the literature; incomplete reporting 
of studies' characteristics and results; limited methodological quality; and relatively 
small sample sizes. Diagnostic imaging studies seem to be particularly prone to these 
problems.44,45 Shortcomings in study design may affect the estimates of diagnostic 
accuracy resulting in an overestimation, particularly in studies including non-
representative samples of patients and invalid reference standards.44,45 Future studies 
should include an appropriate spectrum of patients; a consistent reference standard 
independent of the imaging modalities under investigation, to reduce incorporation 
bias; and blind interpretation of tests results. They should also comply with the 
Standards for Reporting of Diagnostic Accuracy (STARD) recommendations for 




With regard to our literature searches to identify relevant studies to include in our 
review, a couple of points are worth raising. We included a methodological search 
filter in our MEDLINE and EMBASE searches to identify studies of diagnostic 
accuracy. The use of a search filter, even though it may have reduced the overall 
sensitivity of the MEDLINE search, was justified by the fact that a literature search 
combining MeSH terms and text words for the target condition with those for the 
diagnostic tests under evaluation (as for the current recommendation of the Screening 
and Diagnostic Tests Methods Group) would have retrieved an unmanageable 
number of hits; CT is an imaging test used very frequently in clinical practice and 
therefore referred to in many research papers. We did not search additional electronic 
databases, such as BIOSIS, LILACS, or Science Citation Index, firstly because the 
number and relevance of indexed journals in these databases are limited compared to 
those indexed in MEDLINE and EMBASE and secondly we are confident we have 
enhanced the sensitivity of our literature searches by searching 'specialised' databases 
(for example MEDION for systematic reviews of diagnostic accuracy) and 
professional bodies' websites (for example National Stroke Association, American 
Stroke Association, Royal College of Radiology), handsearching all conference 
proceedings of two major international stroke conferences for a 10-year period, and 
contacting experts in the field. In this way, even though relying on limited resources 
we have maximised sensitivity and specificity for identifying comparative studies on 
the use of CT and MRI for detection of acute stroke lesions. 
 
We could not use the currently recommended summary ROC curve methodology to 
compare the performance of CT and DWI for the early diagnosis of ischaemic stroke 
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as our data were insufficient to fit this complex statistical model.18,19,47 Similarly, due 
to the limited number of identified studies, we were not able to perform sensitivity 
analyses to assess which methodological aspects may have contributed to clinical 
heterogeneity (for example time of imaging, characteristics of patient population) or 
heterogeneity related to study design (for example prospective versus retrospective 
studies, presence of incorporation bias). 
 
We were unable to address practicality and applicability issues as only three studies 
mentioned the number of patients who were excluded because they could not 
undergo MRI. However, practical difficulties in performing MRI, instead of CT, 
have been documented in about 20% of stroke patients and many patients with severe 
stroke do not tolerate MRI.34,48,49 Similarly we did not assess the cost-effectiveness 
of MRI compared with CT as a first-line test for the early detection of stroke and we 
did not consider the relative impact on clinical outcomes of a policy of routine MRI 
versus routine CT. However, in deciding whether MRI could substitute for CT as the 
primary method for early imaging of patients with suspected ischaemic or 
haemorrhagic stroke it is important to consider the relative diagnostic accuracy of 
each imaging test together with practicality and cost-effectiveness issues. In many 
countries CT is known to be rapid, easy to tolerate, and more readily available in 
most emergency settings. On the other hand MRI is not immediately available in 
many hospitals and is more expensive, contraindicated for patients with pacemakers 
and metal implants, and can be unpleasant or difficult to tolerate especially for 
patients with more severe strokes. A recent survey conducted in the UK showed that 
even though 78% of all acute hospitals that admitted patients with acute stroke had 
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access to MRI facilities, MRI was rarely performed either at all or sufficiently 
quickly to be of value in the acute management of stroke.50 A European survey 
suggests that similar problems exist in the rest of the EU and, in fact, placed the UK 
at the top of the table for comprehensive stroke centres.51 
 
4.4.5 Applicability of findings to clinical practice and policy  
We reviewed the diagnostic accuracy of MRI compared with CT for acute ischaemic 
stroke, and the accuracy of MRI for early detection of haemorrhagic stroke. There is 
some evidence that MRI is more accurate than CT for the detection of mild 
ischaemic strokes. However, the use of MRI in the management of acute patients 
needs to take into consideration practicality and cost-effectiveness. In many countries 
CT is quicker to perform, inexpensive, applicable to a higher proportion of acutely ill 
stroke patients, and more readily available in most emergency care settings. MRI is 
contraindicated in patients with pacemakers and some metal implants. In acutely ill 
stroke patients it may be difficult to monitor their condition while they are being 
MRI scanned (which increases the risk of any developing respiratory difficulty or 
cardiovascular compromise being detected during the scan and so may have adverse 
effects for the patient). If the patient is confused or restless as a result of the stroke, 
the patient may not be able to co-operate for the longer scan times required for MRI. 
Furthermore, in clinical practice CT is the most used imaging technique for the 
diagnosis of acute intracerebral haemorrhage (and therefore for selecting patients for 
thrombolytic therapy). The role of MRI as the first choice modality for patients 
presenting with stroke symptoms requires further investigations. 
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4.5 Authors’ conclusions 
4.5.1 Implications for practice  
It is likely that, in the future, both CT and MRI techniques will be more widely 
available in many countries. Pending further evidence, both techniques should be 
used in a complementary way with CT for the majority of strokes pre-thrombolysis 
and MRI for milder strokes, according to local, specific clinical needs. 
 
4.5.2 Implications for research  
Future research should focus on a robust and objective cost-effectiveness comparison 
of CT and MRI with particular attention to the evaluation of patients in broader and 
unselected patient populations more relevant to routine clinical practice in non-
specialist stroke centres. In particular, further studies are needed to provide clear 
evidence that MRI can be used as the imaging modality of first choice for patients 
with suspected acute stroke in routine practice, and that patients without evidence of 
acute intracerebral haemorrhage on MRI really do not have acute intracranial 







4.5.3 Implications for the Cochrane Handbook for Systematic 
Reviews of Diagnostic Test Accuracy 
 
This review was used to pilot the methods for Cochrane diagnostic test accuracy 
reviews. It was thus assembled, written and analysed on the basis of guidance in the 
draft version of the Handbook for Systematic Reviews of Diagnostic Test Accuracy.  
The Screening and Diagnostic Tests Working Group has used these pilot data to 
inform the development of the Handbook and to test the new proposed methodology. 
However, as the complete version of the Handbook has not been fully published yet, 
the impact of this thesis on the final version of the Handbook cannot be judged yet. 
 
4.5.4 Summary of this review’s findings 
Chapter 5 assesses two possible approaches to producing a brief convenient summary 
of the complex evidence presented in this systematic review of diagnostic test 
accuracy. The Summary of Findings table in Appendix 4 was developed to 
summarise the review results of the seven included studies on ischaemic stroke.  
This review has been conducted as a pilot Cochrane systematic review of diagnostic 
test accuracy and published in the Cochrane Library: 
Brazzelli M, Sandercock PAG, Chappell FM, Celani MG, Righetti E, Arestis N, 
Wardlaw JM, Deeks JJ. Magnetic resonance imaging versus computed tomography 
for detection of acute vascular lesions in patients presenting with stroke symptoms. 
Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007424. DOI: 
10.1002/14651858.CD007424.pub2 
A short version of the review has also been published in the journal Stroke: 
Brazzelli M, Sandercock PAG, Chappell FM, Celani MG, Righetti E, Arestis N, 
Wardlaw JM, Deeks JJ. MRI versus CT for detection of acute vascular lesions in 
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5. To assess the usefulness of two forms of 




The correct use of one or more diagnostic tests and the interpretation of their results 
are crucial steps in determining the need for a particular medical intervention. The 
choice of the wrong diagnostic test or inaccurate interpretation of its results may lead 
to incorrect diagnosis and inappropriate medical care. A correct diagnosis is essential 
for providing effective treatments and establishing proper patients’ management. 
With each new technological advancement in diagnostic techniques, clinicians are 
constantly challenged to master information from studies that evaluate the accuracy 
and applicability of new and existing diagnostic tests, and frequently have to choose 
one of several possible alternative tests or diagnostic strategies. 
 
In particular, many clinicians struggle to apply information on quantitative measures 
of diagnostic test accuracy correctly. The term ‘diagnostic accuracy’ is used in the 
medical literature to indicate the ability of a test to categorise patients accurately 
according to the presence or absence of a specified disease. To establish accuracy, 
the results of a test are compared with the results of a reference standard, in other 
words, the accepted or best available method for finding out whether or not patients 
have the target disease. Test accuracy is often expressed in terms of sensitivity and 
specificity, predictive values, and likelihood ratios. Even though clinicians are 
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familiar with the definitions of sensitivity and specificity of a test, only a minority of 
them seem to consider these measures of accuracy before ordering a test in clinical 
practice or prove to apply them correctly.1-2 Recommended methods which require 
formal calculations to estimate the probability of disease (e.g. Bayesian and 
likelihood ratio transformations), are very rarely used.1 This difficulty in applying 
knowledge of measures of diagnostic test accuracy raises the question of which is the 
most effective way to communicate the results of a formal assessment of a particular 
test to clinicians. This is now even more relevant in view of recent developments in 
the science of evaluating the performance of diagnostic tests.  Firstly, there is now a 
degree of consensus on how individual studies of diagnostic accuracy should be 
reported (Standards for Reporting of Studies of Diagnostic Accuracy (STARD) 
initiative). Secondly, the Cochrane Collaboration has recently established a 
framework for the conduct and reporting of systematic reviews of test accuracy. The 
Cochrane Collaboration decided to include “diagnostic accuracy” within the scope of 
Cochrane reviews in March 2003 and the first diagnostic accuracy review conducted 
according to the current recommended methodology was published in the Cochrane 
Database of Systematic Reviews in October 2008.9 This development has occurred at 
the same time as a number of methodological papers on the methodology of 
systematic reviews of diagnostic test accuracy.3-8 
Systematic reviews of diagnostic accuracy provide clinicians with a convenient 
summary of the best available evidence on the performance of a diagnostic test and 
on its potential to be used alongside alternative tests. However, if the findings of 
such systematic reviews are to be applied correctly in clinical practice this requires 
the clinicians to have a good understanding of: the measures used to assess test 
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accuracy; the methodological quality of the included primary studies; the context in 
which the test is performed. Furthermore, clinicians should also consider the 
implications of any false negatives (cases missed by the diagnostic test) or false 
positive (cases wrongly identified by the diagnostic test) results when making 
decisions about the use of a specific diagnostic test. 
 
Busy clinicians often tend to rely on the information provided in the ‘Abstract’ of a 
systematic review rather than read its methods, results, and conclusions in detail. The 
abstract, as a concise summary of the review methods and findings, provides, 
however, only limited information and decisions based on that alone may be 
inaccurate.10  
 
To provide a more informative summary of the data from a systematic review that 
illustrates the clinical impact of the findings when applied in different (high and low 
risk) populations, the Cochrane Collaboration has recently decided to include a 
Summary of Findings (SoF) table within the structure of Cochrane reviews. SoF 
tables have been proposed as a way to increase usability of reviews and help 
clinicians to make better informed clinical decisions. Review authors of systematic 
reviews of randomised controlled trials may create their SoF tables using the 
recommendations contained in the (Cochrane Handbook for Systematic Reviews of 
Interventions.11 The template of standard Cochrane SoF tables includes six elements 
and a specific format: i) a list of all important outcomes, both desirable and 
undesirable; ii) a measure of the typical burden of these outcomes (e.g. illustrative 
risk, or illustrative mean, on control intervention); iii) absolute and relative 
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magnitude of effect (if appropriate); iv) numbers of participants and number of 
studies addressing the listed outcomes; v) a rating of the overall quality of evidence 
for each outcome (using the GRADE approach);12-13iv) space for comments.11 An 
additional software (GRADEprofile) is available to reviews authors for the 
preparation of SoF tables (website of GRADEpro). At present, however, there is not 
empirical evidence on how clinicians interpret SoF table for reviews of randomised 
controlled trials. The template for preparing SoF tables for systematic reviews of 
diagnostic accuracy has not yet been established and review authors are responsible 
for creating their own SoF tables.   
 
The Cochrane systematic review of diagnostic accuracy,14 which I presented in 
Chapter 4, had served as a pilot review for the development of Cochrane diagnostic 
accuracy reviews. It was undertaken in collaboration with the Screening and 
Diagnostic Tests Methods Group. Performing this review enabled us to develop and 
test the methods for Cochrane systematic reviews of diagnostic test accuracy. We 
therefore had the opportunity to develop and test the design of a SoF table for 
diagnostic test accuracy studies. In the SoF table we included information on the 
characteristics and main results of the review, together with the major limitations 
identified and implications for clinical practice. To some extent, the information 
shown in the SoF table duplicates that of the Abstract. In the proposed SoF table, the 
information is presented in both tabular and graphical format and additional details 
are provided to enable the reader to put the review results in context and judge their 




At present, there is very little evidence on the best way of presenting summary 
results of diagnostic accuracy reviews to clinicians and on how clinicians interpret 
results of such reviews. For this reason I decided to carry out a study to evaluate two 
alternative strategies for presenting the results of systematic reviews of diagnostic 
test accuracy to clinicians. 
 
The aim of this study was to gather clinicians’ opinion on two different ways of 
presenting the summary results of a systematic review of diagnostic test accuracy 
and to assess their ability to interpret information contained in both the SoF table and 
the Abstract of my pilot systematic review. 
 
5.1.1 Objectives 
To determine whether two different forms of summary of a systematic review of 
diagnostic test accuracy may influence clinicians’ ability to interpret its results, and 
to assess their preferences about the format of the summary. 
 
5.2 Methods 
5.2.1 Study Design  
At a series of small group meetings of clinicians, I presented two forms of summary 
of my pilot systematic review assessing the accuracy of MRI and CT for the 
detection of acute ischaemic lesions in patients presenting with stroke symptoms:14 a 
conventional Abstract and our proposed format of a SoF table. I presented each 
participant individually with the two forms of summary in alternate order (some 
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participants received the Abstract first and then the SoF table whilst other 
participants received the SoF table first and then the Abstract). For each format I 
asked the clinicians to complete a short questionnaire (see Appendix 5).   
 
5.2.2 Participants 
I recruited groups of neurologists, radiologists, and neuroradiologists (at different 
seniority in their professional career) at the Western General Hospital in Edinburgh 
(UK) at a series of meetings held between June and November 2009. I also 
administered the questionnaire to neurologists, radiologists, and general medicine 
physicians in Perugia (Italy) at a series of seminars organised by the Cochrane 
Neurological Network. I selected these clinicians as being reasonably representative 
of the types of medical practitioners most likely to need to read and correctly 
interpret Cochrane systematic reviews of test accuracy relevant to stroke. 
 
5.2.3 Development of Abstract and Summary of Findings table 
I initially developed and tested the SoF table by seeking the views of a small group 
of experienced neurologists and radiologists who provided information on the 
aspects they deemed important to include in a summary of findings table. In 
particular, they stressed the need for: the review question to be specified in an 
unambiguous and precise way; more information concerning the main limitations of 
the studies included in the review; a clear formulation of the implications of findings 
for clinical practice; the results to be shown by a graphical as well as a numerical 
representation. I re-designed the SoF table in the light of this initial feedback and 
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further tested it in a group of clinicians outside the study cohort with the aim to 
ensure consistency, ease of use, and better presentation of results. I structured the 
content of the SoF table in four main sections. In the title of the SoF I specified the 
clinical question in terms of the tests under investigation, the population studied and 
the clinical condition assessed; in the first part of the table, I provided general 
information on the number of studies included in the systematic review, geographical 
location of the studies, clinical setting, total number of participants, type of 
diagnostic (index test and comparator test) and reference standard; in the second part 
of the table, I listed all major limitations of included studied and provide an overall 
assessment of their methodological quality; in the third part of the table, I displayed 
the main results of the review using both a numerical summary of estimates and a 
graphical representation (forest plot); finally in the fourth part of the table, I 
presented some information on the applicability of results into clinical practice and 
on costs (see Box 5.1). The Abstract was prepared in accordance with the Cochrane 
Collaboration guidelines.11 It was limited to 400 words and summarised the key 
methods, results, and conclusions of our pilot review. I used a simple and precise 
terminology, and I included only well known abbreviations, which referred to the 
type of imaging tests. The content of the Abstract was structured as follows: 
Background; Objectives; Search methods, Selection criteria, Data collection and 
analysis, Results, and Authors’ conclusions (see Box 5.2). Compared to the Abstract, 
the SoF table contained more details on the limitations of the included studies and 
applicability of results in clinical practice. Moreover, it included a numerical as well 




5.2.4 Development of a questionnaire to assess clinicians’ 
demographics, understanding of results, and preferences 
I developed a short questionnaire and then tested it in a group of 21 clinicians 
outwith the study cohort (see Appendix 5). The first part allowed me to collect 
clinicians’ demographic information: speciality (e.g. General Radiology, Neurology, 
Neuroradiology, Stroke Medicine, Geriatric Medicine); postgraduate qualifications 
(e.g. MD, PhD); years of experience in clinical practice; time spent in the previous 
year managing stroke patients; research involvement (as a percentage of Full Time 
Equivalency); and gender. 
 
The second part of the questionnaire consisted of: 
 A visual analogue scale (i.e. Likert scale) to determine the clinicians’ 
confidence in interpreting measures of test accuracy;  
 Six multiple choice questions to evaluate the clinicians’ ability to interpret the 
main findings and implications for clinical practice of my systematic review 
of diagnostic accuracy presented either in the Abstract or in the SoF table. 
Each of the six questions was structured in five possible answers. The 
wording of the five answers was consistent across questions. For each 
question a neutral response was included amongst the five possible answers. 
The five possible answers were present in a different order in each question. 
The six questions aimed at assessing whether: i) MRI was more accurate than 
CT for the early detection of ischaemic lesions, ii) MRI was more accurate 
than CT for the early detection of mild ischaemic stroke, iii) MRI was more 
accurate than CT for the early detection of non-stroke lesions, iv) MRI was 
more sensitive but not more specific than CT for the early detection of 
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ischaemic lesions, v) either MRI or CT could be used for the early detection 
of ischaemic lesions, vi) more diagnostic studies comparing MRI with CT in 
acute stroke patients were needed. 
 
For each question only one answer was considered correct. The correct answers were 
developed in discussion with two clinical experts (including a very experienced 
neuroradiologist), who contributed to the pilot systematic review, on the basis of the 
results and conclusions of the review. 
The second part of the questionnaire was presented after each summary document 
(Abstract and SoF table). 
 
The third part of the questionnaire sought the clinicians’ preference for the format of 
presentation: 
 Two visual analogue scales (i.e. Likert scales) to assess their opinion on 
whether information in the Abstract and SoF table were clearly presented;  
 Three open questions to determine which ‘summary’ (Abstract or SoF table) 
they favoured and whether there was any additional information they would 
have liked to have included in it;  
 A multiple choice question to assess their opinion on whether the two 
summaries contained useful information 
 Two additional questions to assess their preference regarding terms used to 
describe results. Tests results were provided in two possible versions: a 
simple numerical description (e.g. “The test has a sensitivity of 99%) and a 
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verbal description (e.g. “Out of 100 patients with a diagnosis of acute stroke 












Review question: Comparison of diffusion-weighted magnetic resonance imaging with conventional computer tomography 
for the early detection of ischaemic brain lesions in patients suspected of stroke 
 
Patient population: Adults suspected of acute stroke                                                          Setting: Hospital departments 
Geographical location: Studies were conducted in Europe (3 studies), the USA (3 studies), and in Australia (one study) 
Index test: Diffusion-weighted magnetic resonance imaging (DWI) performed within 12 hours of stroke onset 
Alternative test: Computer tomography (CT) performed within 12 hours of stroke onset 
Reference standard: Clinical assessment and imaging follow-up (CT or MRI) in all patients 
Included studies: Seven comparative studies that evaluated DWI and CT in the same patients 
Total number of patients assessed: 226 
LIMITATIONS OF INCLUDED STUDIES 
 Limited number of included studies (7 studies); small sample sizes; 
presence of incorporation bias 
 DWI and CT were evaluated in highly selected patient samples (patients 
with high probability of stroke), which therefore are not representative of 
the typical population of patients presenting with 'suspected acute stroke' 
to an emergency department (poor generalisabilty of results) 
 The stroke vascular territory was not reported in the majority of included 
studies although it is likely that they enrolled patients with typical anterior 
circulation stroke  
 Only a minority of the studied patients had severe strokes (in whom DWI 
might be contraindicated) 
 The high proportion of mild strokes and reclassification of TIA cases with 
a positive DWI lesion as strokes might have inflated the DWI sensitivity 
estimate 
 In most of the studies stroke mimics were not included 
 In all but one study, CT was performed before DWI (reducing the 






Summary Effect (95% CI) 
 
DWI sensitivity 0.99 (0.23 to 1.00) 
DWI specificity 0.92 (0.83 to 0.97) 
CT sensitivity 0.39 (0.16 to 0.69) 
CT specificity 1.00 (0.94 to 1.00) 
 
CONCLUSIONS AND COMMENTS: In the small cohort of included studies, DWI is more sensitive than CT - but not more 
specific - for the early detection of ischaemic stroke. The small amount of data and the presence of methodological biases 
preclude any reliable calculation - from the sensitivity and specificity estimates of CT and DWI - of a positive/negative stroke 
diagnosis at different rates of stroke prevalence. 
 
APPLICABILITY OF TESTS IN CLINICAL PRACTICE:  
None of the studies addressed practicality. CT is known to be quicker to perform and more readily available in most emergency 
care settings than magnetic resonance imaging (MRI). MRI is contraindicated in patients with pacemakers and some metal 
implants. In acutely ill stroke patients, it may be difficult to monitor the patient's clinical condition while being MR scanned. If 
the patient is confused or restless as a result of the stroke, the patient may not be able to cooperate for the longer scan times of 
MRI. 
 




Box 5.2: Abstract of the pilot review  
 
Review question: Comparison of diffusion-weighted magnetic resonance imaging with 
conventional computer tomography for the early detection of ischaemic brain lesions in patients 





In clinical practice, computed tomography (CT) is extensively used in the management of acute 
stroke, especially for the rapid exclusion of intracerebral haemorrhage. Magnetic resonance imaging 
(MRI) has been claimed to be more sensitive for the diagnosis of acute ischaemic stroke, even though 
its sensitivity for the early detection of intracerebral haemorrhage is still debated.  
 
Objecitves  




We searched MEDLINE and EMBASE for articles published from January 1995 to March 2009 and 
we perused bibliographies of relevant studies for additional references. 
 
Selection Criteria 
We selected studies that compared DWI and CT for detection of ischaemic stroke in the same patients; 
had imaging performed within 12 hours of stroke onset; and presented sufficient data to allow 
construction of contingency tables. 
 
Data Collection and Analysis 
Three authors independently extracted data on study characteristics and measures of accuracy. Data 
were assessed by random-effects and fixed-effect meta-analyses. 
 
Results 
Seven studies with a total of 226 participants, met our inclusion criteria. The spectrum of patients was 
relatively narrow in all studies, sample sizes were small, there was substantial incorporation bias, and 
blinding procedures were often incomplete. Amongst the patients subsequently confirmed to have 
acute ischaemic stroke (161/226), the summary estimates for DWI were: sensitivity 0.99 (95% CI 0.23 
to 1.00), specificity 0.92 (95% CI 0.83 to 0.97). The summary estimates for CT were: sensitivity 0.39 
(95% CI 0.16 to 0.69), specificity 1.00 (95% CI 0.94 to 1.00). We were not able to assess practicality 
and cost-effectiveness. 
 
Authors’ conclusions  
DWI appears to be more sensitive than CT for the early detection of ischaemic stroke in highly 
selected patients. However, the variability in the quality of included studies and the presence of 
spectrum and incorporation biases render the reliability and generalisability of observed results 
questionable. Further well-designed studies, without methodological biases, in more representative 
patient samples, with practicality and cost estimates, are now needed to determine which patients 






5.2.5 Planned Analyses 
I analysed data from the questionnaires which were fully completed in their second 
part and fully or partly completed in their first and third parts. I entered the data into 
an Excel spreadsheet.  
I summarised the demographic characteristics of participants in a narrative way. I 
summarised the clinicians’ responses to both the multiple choice questions and the 
open questions quantitatively (mean scores with 95% CIs or proportions). For the 
second part of the questionnaire, I calculated, for all participants, the average number 
of correct answers to the six multiple choice questions presented after the Abstract 
and the SoF table as well as the mean difference between the number of correct 
answers to each summary document. I also calculated the distribution of correct 
answers to each of the six multiple choice questions after each summary document. I 
checked for the possible existence of an order effect (i.e. whether the number of 
correct answers varied according to the order of presentation of the two summary 
documents). I presented results as mean values with either 95% confidence intervals 
or standard deviation as the normality assumption for the data proved to be valid. I 
tested within-person differences between Abstract and SoF table results by means of 
one sample t-test and the differences between Abstract and SoF results by paired t-
test. I also assessed whether the proportions of correct answers varied according to 
clinicians’ speciality or according to their degree of confidence in understanding 
measures of diagnostic accuracy. For all analyses I set statistical significance at 




5.3.1 Response Rate 
Overall 65 clinicians were presented with the two forms of summary and the short 
questionnaire. Six questionnaires were subsequently excluded because they were 
returned blank; five were excluded because the six multiple-choice questions were 
not fully answered; and 18 were not returned. Thirty-six questionnaires (response 
rate of 55% 36/65) were included in this study. 
 
5.3.2 Demographics of participants 
Thirty-six participants (14 males and 22 females) from two countries (UK and Italy) 
completed the short questionnaire.  Twenty-four participants (67%) were from Italy 
and twelve (33%) from UK. Thirteen participants (36%) classified themselves as 
neurologists, twelve (34%) as radiologists or neuroradiologists, and eight (22%) as 
emergency medicine physicians. Three participants (8%) were from “other” medical 
specialities (e.g. neuropsychiatry). Overall the participants spent a median of 10% of 
their clinical time providing stroke patients care; and a median of 25% of time in 
research activities. About two-third of the participants (25/35) were experienced 
clinicians with ten or more years of clinical practice whilst 10 out of 35 participants 
were less experienced clinicians or novices with nine or less years of clinical 
practice. One participant did not provide this information. On average the years of 
clinical practice were similar between neurologists (mean 14.6 years) and 
radiologists (mean 12.7 years). Overall the participants were not particularly familiar 
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with the seven papers on ischaemic stroke included in our pilot review. The mean 
number of papers known by the participants was two (median = 1). 
 
Figure 5.1. Mean number of participants’ correct answers to the six multiple-choice questions 
for the 1st summary document and the 2nd summary document. (Interval plots show mean 
values and 95% CIs for the mean) 
 






































        Mean 3.08          Mean 2.94 
 
 
5.3.3 Summary documents: Abstract versus SoF table 
All 36 participants completed the six multiple-choice questions of the second part of 
the questionnaire, which aimed at evaluating the clinicians’ ability to interpret the 
main findings of our systematic review presented in summary format (25 participants 
completed the Abstract first and 11 participants completed the SoF table first). As 
participants were presented with both documents (Abstract and SoF) in alternate 
order and asked to reply to the six multiple-choice questions after each document, I 
initially assessed whether the order of presentation of the two documents might have 
affected the number of correct answers. Figure 5.1 shows the interval plots (with 
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95% CIs) of the correct answers to the multiple-choice questions after reading the 
first summary document versus the correct answers after reading the second 
summary document.  
 
No statistically significant differences were detected between the two groups 
(p=0.377), indicating that a substantial order effect was not present. I therefore 
decided to compare all participants’ answers to the Abstract and all participants’ 
answers to the SoF table independently of their order of presentation. Table 5.1 
shows the differences between participants’ correct answers to the Abstract and SoF 
table. Most participants (17/36, 47%) provided the same number of correct answers 
to both documents. Twelve participants (33%) had a better performance at the SoF 
table compared with the Abstract and, on the contrary, seven participants (20%) had 
a better performance at the Abstract compare with the SoF table. The mean 
difference in score between Abstract and SoF table was not statistically significant 
(Abstract - SoF table mean was -0.194 CIs -0.506 to 0.117; one sample t-test 
p=0.213). Figure 5.2 illustrates that, overall, the number of correct answers for both 
documents was low with no significant differences between the number of correct 
answers to the Abstract (mean 2.92 - 95% CIs 2.54 to 3.29) and the number of 








Table 5.1. Difference in scores between Abstract and SoF table results for all 36 participants 
 
Difference in scores  Number of participants (%) 
- 2 3 (8) 
- 1 9 (25) 
0 17 (47) 
1 6 (17) 
2 1 (3) 
Note: Negative scores indicate a better performance at the SoF table; “0” indicates that the number 
of participants’ correct answers’ was the same for the Abstract and the SoF Table; positive scores 




Figure 5.2. Mean number of participants’ correct answers to the six multiple-choice questions 
for the Abstract and the SoF table. (Interval plots show mean values and 95% CIs for the 
mean). 






































Mean 2.92 Mean 3.11
 
 
The distribution of the correct answers for the six multiple-choice questions for both 
summary documents amongst the 36 participants is shown in Figure 5.3. For each 
question the number of correct answers for the Abstract and the SoF table was 
similar even though the information contained in the two documents was slightly 
different. The findings of questions 2 and 3 were quite unexpected as these questions 
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were related specifically to the use of CT and MRI for detection of mild strokes and 
stroke mimics. As the information on mild strokes and stroke mimics was reported to 
some extent in the SoF table but not in the Abstract, I expected to detect a difference 
in the number of participants’ correct answers between the two summary documents. 
The low rate of correct answers to question 5, which was related to the use in clinical 
practice of the two imaging tests, CT and MRI, for detection of early ischaemic 
lesions, was probably due a certain level of ambiguity of this specific question. Most 
of participants opted for a neutral answer (i.e. “evidence provided is not enough to 
inform clinical practice”) instead of choosing correctly that “either CT or MRI 
should be used for the early detection of ischaemic lesions”.   
 
For both summary documents the average number of correct answers provided by 
more experienced clinicians (with 10 or more years of clinical practice) was similar 
to that provided by novices (with 9 or less years of clinical practice) - see Table 5.2. 
Similarly, the participants’ degree of confidence in understanding measures of 
diagnostic accuracy did not result in better answers. Table 5.3 shows the mean 
number of correct answers to the Abstract and the SoF table according to the 
participants’ degree of confidence in understanding measures of diagnostic accuracy 
(see Figure 5.4). For the SoF table - but not for the Abstract - the number of correct 
answers increased according to the participants’ degree of confidence. Given the 
small number of participants in each group for the sake of the analyses I have 
collapsed Likert scale points 0 and 1, and Likert scale points 2 and 3. There was not 
significant difference (p = 0.302) between participants who declared themselves to 
have confidence in understanding measures of diagnostic accuracy (score 2 and 3 at 
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the Likert scale - mean 3.22 SD 0.74 ) and those who felt less confident (score 0 and 
1 at the Likert scale - mean 2.92 SD 0.86). 
 













































Note: Height of bars corresponds to the number of participants who answered that question correctly 




Table 5.2. Mean number of correct answers at the six multiple-choice questions for the Abstract 
and the SoF according to clinicians’ years of clinical practice  
 
Note: Experts = 10 or more years of clinical practice; Novices = 9 or less years of clinical practice. SD: 
standard deviation.This analysis is based on a total of 35 participants who provided information on 






Mean score (SD) 
 
Comparison between Experts 
and Novices for Abstract and 
SoF table results (P) 
 




  p = 0.956 
Abstract Novices (no. 10) 2.90 (1.10)  
   
SoF Experts (no. 25) 3.08 (0.80)  
  p = 0.681 
SoF Novices (no. 10) 3.20 (0.79)  
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Figure 5.4. Likert scale assessing the participants’ degree of confidence in understanding 








Note: Partcipants who scored 0 or 1 were considered ‘less confident’ and participants who scored 2 




Table 5.3. Participants' mean number of correct answers at the Abstract and SoF table  










Abstract mean score (SD) 
to the six multiple-choice 
questions 
SoF mean score (SD) to 







































SD: standard deviation 
 
5.3.4 Clinicians’ preference: Abstract versus SoF table 
Most of the participants regarded the information reported in both the Abstract and 
the SoF table as clearly presented (69% versus 75%). Figure 5.5 shows that a slightly 
higher percentage of participants considered the SoF table more informative than the 
Abstract (55% versus 39%). This preference was clearly confirmed by the answers to 
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the multiple-choice question that aimed at assessing whether the clinicians judged the 
information contained in the SoF table more useful than that contained in the 
Abstract (see Figure 5.6). The participants did not show a clear preference as regards 
to the way diagnostic results should be phrased. Twenty out of the 36 participants 
favoured a more verbal description of results, whilst 14 opted for a more simple 
numerical description of results. Some participants provided ‘free’ comments on the 
way the Abstract and the SoF table could have been improved. For the Abstract some 
participants suggested adding more information on: i) limitations and biases of the 
included studies; ii) spectrum of patients; iii) applicability of results; and including a 
graphical representation of results. For the SoF table the comments included: i) 
explanation of findings in bullet points; ii) a legend for the smiley faces related to the 
grading of evidence; iii) a less ‘busy’ format; iv) no forest plot of results of included 
studies, as they were too difficult to interpret. 
 





































Figure 5.6. Participants’ answers to the multiple-choice question which compared the usefulness 





































This is the first study that has tried to assess i) the ability of clinicians to interpret the 
findings of a Cochrane systematic review of diagnostic accuracy presented in two 
summary documents: a conventional Abstract and a Summary of Findings table 
(SoF), as well as ii) the clinicians’ preference for the format of presentation of the 
two summary documents. The SoF table is a new tool for summarising information 
that the Cochrane Collaboration now encourages authors to include in systematic 
reviews published in the Cochrane Library. For systematic reviews of interventions, 
the general template for a SoF table is reasonably well developed but difficult to 
implement since it requires the use of a separate and complex software package 
(GradePro).11 Moreover, the general template of SoF tables for systematic reviews of 
interventions has not yet been tested amongst clinicians and there are as yet no 
empirical data on whether the clinicians find it easy to interpret the information 
contained in the SoF tables and whether this information has any impact on their 
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clinical decisions (Phil Wiffen personal communication, 15th Annual Meeting of the 
UK & Ireland Based Contributors to the Cochrane Collaboration, March 2010). The 
format of SoF tables for systematic reviews of diagnostic accuracy within the 
Cochrane Collaboration has not yet been agreed and at present GRADEPro is not 
designed to handle this type of reviews. In preparing my Cochrane systematic review 
of diagnostic test accuracy,14 I developed, in collaboration with lead clinicians, my 
own SoF table using a simple tabular format (as described in the Methods section). 
This study is an attempt to determine which form of summary (conventional Abstract 
or SoF table) best captures and communicates the findings and implications of a 
systematic review of diagnostic accuracy; which is easier to understand, and displays 
the best layout.  
 
The findings of this study indicate that the number of correct answers was low for 
both summary documents (the means were 2.92 for the Abstract and 3.11 for the SoF 
table respectively) and the mean difference between the participants’ correct answers 
to the Abstract and SoF table was not statistically significant. There are a number of 
possible reasons which might explain the participants’ low rate of correct answers.  
 
i) The summary documents might have lacked clarity, failing to communicate 
the relevant information in a transparent and easy way. However, both documents 
were vetted by experienced clinicians. 
ii) It is possible that the six multiple choice questions used to evaluate the ability 
of clinicians to interpret the information contained in the two summary documents 
failed to present concise interpretations of the review findings or were somehow 
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ambiguous. However, I took several steps to ensure that the questions were clear, 
unambiguous and formulated and structured to reflect the main findings of my pilot 
review. Firstly, the questions were developed in discussion with two experts, and 
revised in the light of subsequent discussions. They were then tested in a group of 
knowledgeable clinicians outside the study cohort. Of course, such precautions 
cannot ensure complete clarity and a certain level of ambiguity among questions is, 
however, a common problem when designing a questionnaire. It is always difficult to 
anticipate the participants’ attitude towards even the most carefully worded 
questions. The correct answers to the six multiple choice questions were decided, in 
discussion with the same two experts, on the basis of the main results, conclusions, 
and implications of my pilot test accuracy review. Even though this choice involved 
an inevitable degree of arbitrariness, I considered it the best possible way to gather 
information on how clinicians interpret findings of systematic reviews of test 
accuracy presented in summary documents.  
 
iii)  Notwithstanding the care taken, participants might have found some 
questions open to interpretation and opted for neutral answers. This could explain, 
for example, the very low response rate to question 5 in both summary documents 
(about 56% percent of participants opted for the neutral answer). However, this did 
not apply to other questions and in particular to question 1, where instead a neutral 




iv) Clinicians could have skimmed through Abstracts and SoF tables rather than 
read their contents meticulously, and therefore providing quick, incorrect answers – 
especially in a testing situation.  
 
v) Clinicians could have answered according to their accrued clinical knowledge 
and pre-existing preference for a particular type of imaging (CT or MRI) irrespective 
of the information contained in the summary documents. Interestingly, the mean 
number of correct answers was similar between Abstract and SoF table and also the 
distribution of the participants’ correct answers to each of the six multiple-choice 
questions was similar for both documents (see Figures 5.2 and 5.3). This outcome 
was unexpected as the two summary documents contain different information: in the 
SoF table the limitations of the included studies and information on the applicability 
of results in clinical practice are more clearly reported than in the Abstract (for 
example it is possible to derive information on mild strokes and stroke mimics).  In 
other words I had reasons to expect a higher number of correct answers after 
presentation of the SoF table. The lack of difference in the answers to the Abstract 
and to the SoF, despite the dissimilarities between the two documents, might support 
the hypothesis that clinicians tend to skim quickly through summary documents and 
provide biased answers based on their pre-existing preferences and clinical 
experience.  
 
There was no consistent pattern in any of the clinicians’ demographic variables to 
predict their response to either document. The number of correct answers for both 
documents was similar between experienced clinicians, with more years of clinical 
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practice, and novices (see Table 5.2). Similarly, for both documents the clinicians’ 
confidence in understanding measures of diagnostic accuracy did not result in a 
better interpretation of the review findings (see Table 5.3).  
 
Overall, the clinicians preferred the SoF table format and found the information 
contained in the table more useful than that contained in the Abstract. The summary 
of findings table differed from the abstract mainly due to the information on the 
limitations of the included studies and applicability of tests results in clinical 
practice. This information is likely to be particularly useful to clinicians for deciding 
about the validity and generalizability of findings and about the use of imaging tests 
in clinical practice. This assumption is also confirmed by the opinion of the 
experienced clinicians who participated in the pilot phase of this study and 
underlined the importance of reporting information on the main limitations of the 
included studies and on applicability of imaging tests in clinical practice in the 
summary of findings table. Furthermore, it is worth noting that when participants 
where asked to comment on which information they thought necessary to add to the 
abstract and SoF table, they stated specifically that the abstract should contain more 
explicit details on the limitations of included studies and applicability of results. 
The clinicians’ preference for the format of the SoF table, however, did not translate 
into a better performance at the multiple choice questions after its presentation.  
 
5.4.1 Limitations of the study 
Only about half of the clinicians I recruited (55%), returned a completed 
questionnaire. This participation rate might indicate a moderately sized and 
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potentially selected study sample. This modest response rate may also reflect the 
difficulty of the task as well as the limited resources available. If future research is to 
be done in this field, response rate might well improve if, for example, the testing 
sessions provided more interactive one-to-one support for participating clinicians, or 
if more advanced ways for testing participants are implemented (e.g. 
electronic/internet randomised survey). I did not have the resources to determine 
whether non-responders were naturally different from responders. However, if 
response is a measure of willingness to participate and invest energy in attempting to 
understand diagnostic test accuracy reviews, it is plausible that non-responders were 
less enthusiastic or confident about the task and likely to have a lesser level of 
understanding of the correct answers and therefore of diagnostic data. The number of 
females and males and the years of clinical practice were not evenly distributed 
among participants. However, I am not aware of any evidence in the literature 
indicating that these participants’ characteristics are associated with a better 
knowledge of diagnostic test accuracy concepts and a better application of these 
concepts in clinical practice. Both summary documents were administered to 
clinicians in alternate order in the same testing session. In theory, to avoid a possible 
‘contamination’ effect in the answers provided by the clinicians to each document, I 
should have adopted a randomised or a cross-over design with a washout period. A 
randomised study would have, however, required a much larger number of clinicians 
ideally stratified by clinical speciality and years of clinical practice. A cross-over 
design in which clinicians receive one summary document in one testing session and 
the other summary document in a different session after a washout period was 
somehow difficult to organise as clinicians are not particularly keen to fill in 
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questionnaires and I was concerned about the possible attrition rate in the second part 
of the cross-over. Moreover, presentation of both summary documents in the same 
testing session was justified by the fact that one of the objectives of this study was to 
ascertain participants’ preference for the format and content of the two documents, 
and therefore allow them to scrutinize both documents at the same time.  
 
5.4.2 Implications for research and for the Cochrane 
Collaboration 
Diagnostic results are not easy to interpret. Researchers and health professionals 
need to be aware that summary information from systematic reviews of diagnostic 
accuracy, presented either in a traditional abstract format or in a simple tabular 
format (summary of findings table), pose some problems to clinicians who may draw 
simplistic or erroneous conclusions. This survey involved mainly neurologists and 
neuroradiologists. Overall, the main relevant finding is a strong qualitative 
impression that these clinicians found the task of interpreting results of systematic 
reviews of diagnostic test accuracy difficult, especially if under pressure of time. It is 
likely that this would be the case for clinicians working in other medical disciplines, 
but this does require further research. Further research is needed to decide what is the 
best way to communicate the findings of systematic reviews of test accuracy to 
clinicians and what is the best format for summarising such findings. In particular 
future studies might consider the following points: 
 Simplify the format of the Summary of Findings table further; 
 Develop alternative graphical approaches to presenting data and test results 
which are most easily understood; 
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 Pilot the questions to be used with questionnaire more extensively to reduce 
ambiguity in wording; 
 Consider alternative methods for testing clinicians and health professionals (e.g. 
head-to-head interviews; electronic survey);  
 Present the summary documents to a wider range of health professionals with 





1. Reid MC, Lane DA, Feinstein AR. Academic calculations versus clinical 
judgments: practicing physicians’ use of quantitative measures of test 
accuracy. Am J Med 1998; 104: 374-80  
 
2. Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G. Communicating 
accuracy of tests to general practinioners: a controlled study. BMJ 2002; 
324:824-6 
 
3. Irwig L, Tosteson AN, Gatsonis CA, Lau J, Colditz G, Chalmers TC et al. 
Guidelines for meta-analyses evaluating diagnostic tests. Ann Inter Med 
1994; 120:667-76 
 
4. Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytical methods for 
diagnostic test accuracy. J Clin Epidemiol 1995: 48: 119-30 
 
5. Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. 
BMJ 2001; 323: 157-62 
 
6. Leeflang MMG, Deeks JJ, Gatsonis CA, Bossuyt PMM, on behalf of the 
Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of 




7. Bossuyt PMM, Reitsma JB, Bruns DE, Gatsonins CA, Glasziou PP, Irwig 
LM, Lijmer JG, Moher D, Rennie D, de Vet HCW for the STARD Group. 
Towards complete and accurate reporting of studies of diagnostic accuracy: 
the STARD initiative. Radiology 2003; 226: 24-8 
 
8. Smidt N, Rutjes AWS, van der Windt DAWM, Ostelo RWJG, Bossuyt 
PMM, Reitsma JB, Bouter LM, de Vet HCW. The quality of diagnostic 
accuracy studies since the STARD statement. Has it improved? Neurology 
2006; 67: 792-7 
 
9. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Sholten RJ, Hooft L, 
Bijlmer HA, et al. Galactomannan detection for invasive aspergillosis in 
immunocompromized patients. Cochrane Database of Systematic Reviews 
2008, Issue 4. Art. No.: CD007394. DOI: 10.1002/14651858.CD007394 
 
10. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of 
published research articles. JAMA 1999; 281:1110-1 
 
11. Schunemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH 
on behalf of the Cochrane Applicability and Recommeandations Methods 
Group and the Cochrane Statistical Methods Group. Presenting results and 
‘Summary of Findings’ tables. In: Higgins JPT and Green S (editors), 
Cochrane Handbook for Systematic Reviews of Interventions. Chichester 
(UK): John Wiley & Sons, 2008 
 
152 
12. GRADE Working Group. Grading quality of evidence and strength of 
recommendations. BMJ 2004; 328: 1-8 
 
13. GRADE Working Group. GRADE: an emerging consensus on rating quality 
of evidence andstrength of recommendations.  BMJ 2008; 336: 924 
 
14. Brazzelli M, Sandercock PAG, Chappell FM, Celani MG, Righetti E, Arestis 
N, Wardlaw JM, Deeks JJ. Magnetic resonance imaging versus computed 
tomography for detection of acute vascular lesions in patients presenting with 
stroke symptoms. Cochrane Database of Systematic Reviews 2009, Issue 4. 





6. General Discussion  
This Chapter seeks to draw together the implications of this methodological thesis 
for all stakeholders in future diagnostic test accuracy reviews. By stakeholders I 
mean authors, journal editors and publishers, peer reviewers, and the wide variety of 
health professionals who will need to apply the results of systematic reviews of test 
accuracy to their clinical practice. 
 
6.1 Methodological relevance of this thesis 
The methods for performing systematic reviews of diagnostic test accuracy studies 
have only recently been introduced and are still undergoing development. This 
makes performing such reviews rather challenging. In the research work carried out 
to prepare this thesis, I have addressed four specific methodological areas related to 
assembling systematic reviews of diagnostic test accuracy in stroke medicine:  
i) The quality of reporting of studies of diagnostic test accuracy,  
ii) The extent and direction of publication bias in studies of diagnostic test 
accuracy,    
iii) The optimal methods for preparing reviews of test accuracy, (by 
undertaking a pilot systematic review according to the draft 




iv) The best way to summarise findings of Cochrane reviews of diagnostic 
test accuracy for clinicians and policy makers. 
 
6.1.1 Evidence of reporting bias 
The purpose of systematic reviews of diagnostic accuracy is to inform decisions 
about the use of diagnostic tests in clinical practice. To fulfill this end, systematic 
reviews of diagnostic accuracy need to provide valid and reliable results. The major 
threats to the validity of a systematic review of test accuracy arise from the quality of 
the individual studies included in the review. It is a recognized problem that the 
quality of reporting of diagnostic accuracy studies is less than satisfactory. For 
randomised controlled trials, the criteria for deciding what constitutes a high quality 
study are well established. By contrast, in studies of diagnostic accuracy, authors 
have greater freedom to make discretionary choices1 (such as the decision about what 
constitutes true positive and true negative test results, about the referral pattern of 
patients, or about which characteristics patients should possess for being enrolled in 
the study). Therefore, the quality of reporting is complementary to the evaluation of 
study methodology and conduct. There is some evidence in the literature that poor 
methodological quality of diagnostic studies may result in an overestimation of test 
accuracy2-4 which, in theory, could lead to an association between poor quality of 
reporting and overestimation of test performance. Despite the STARD initiative and 
the publication of the STARD guidelines for reporting results of studies of diagnostic 
accuracy, I found that the design and conduct of studies of diagnostic accuracy 
varied considerably in the stroke literature, indicating that the editorial control on 
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what constitutes a high-quality diagnostic study is perhaps weak. Lack of 
methodological rigour in the conduct of diagnostic accuracy studies is a cause of 
concern, as it may jeopardize the effective application of diagnostic tests in clinical 
practice. This is particularly worrying if we consider that current recommendations 
on the use of imaging tests for the diagnosis of stroke may be based on limited and 
poorly reported evidence. Reporting of study characteristics and results is important 
for several reasons, since it helps to:  
i) make the study design and conduct transparent and reproducible;  
ii) explore potential sources of heterogeneity across studies in meta-analyses;  
iii) improve our understanding of the relationship between quality of reporting and 
methodological quality;  
iv) allow replication of study findings and promote further research.   
The findings of this thesis indicate that more efforts are needed to improve the 
accuracy of reporting and the methodological quality of diagnostic research. 
Implementation of available guidelines such as the STARD and the QUADAS 
checklists should facilitate this process. A collaborative involvement of journal 
editors, publishers, peer reviewers, professional organizations, and Cochrane Groups 
could promote adherence to current guidelines and ensure transparency in diagnostic 
research. Reviews authors should receive strict and precise guidance on which 
criteria individual studies of diagnostic test accuracy should comply with. Efforts to 
ensure study reports are as complete as possible should be considered an ethical 
principle in medical research.  In particular, journal editors and publishers should i) 
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explicitly require authors to adopt the current available guidelines when designing 
and reporting their study and, more importantly, ii) should not accept manuscripts 
reporting diagnostic studies unless they clearly comply with current guidelines. 
 
6.1.2 Evidence of publication bias 
Another methodological aspect I have considered in this thesis is the occurrence of 
publication bias in diagnostic accuracy reviews. There is little empirical evidence in 
the literature on the frequency and characteristics of publication bias in systematic 
reviews of studies of diagnostic test accuracy. I carried out a study to capture the 
extent of this problem by evaluating the proportion of abstracts of diagnostic studies 
presented at two major international stroke conferences which were later published in 
full. This study was the first to focus on the time interval between abstract 
submission and full publication and on the study characteristics associated with 
publication. I did not find evidence of substantial bias in the publication processes 
which occurred after abstract acceptance. However, it would be interesting to 
ascertain whether publication biases are more likely to occur at the level of abstract 
submission or selection. Apart from inter-observer agreement between test readers, I 
did not find other methodological aspects or study characteristics clearly associated 
to full publication of diagnostic studies in stroke medicine. In particular, I did not 
detect a ‘positive findings’ bias across the diagnostic abstracts identified. It is worth 
observing that the majority of identified abstracts generally reported high estimates 
of diagnostic accuracy. It is plausible that authors of studies with less favorable 
results would be less willing to submit their work or that reviewers who selected 
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abstracts for presentation at international stroke meetings would be more inclined to 
accept those with high estimates of accuracy. In diagnostic research it is probably 
more likely that investigators who do not get positive test results would not pursue a 
publication - the test is not good, it is clinically useless, hence it is not worth further 
work or does not attract any sponsors. Research on publication bias of randomised 
studies is facilitated by the existing ethical approval system and the registration 
constraints related to the conduct of clinical trials in human subjects. Many journals 
would not now publish reports of trials that were not registered on a trial registry at 
inception. Similar constraints are not yet in place for studies of diagnostic test 
accuracy.  I believe there is a case for the creation of a future prospective register for 
studies of diagnostic test accuracy, which would allow better evaluation of 
publication bias as well as help to enforce adherence to current guidelines with 
regard to quality of reporting and methodological standards - although it may not be 
suitable for studies which are undertaken using a retrospective design. Hemingway 
and colleagues have recently suggested that all human research studies should have a 
study protocol detailing the methods of data collection and analysis, and that these 
protocols should be registered in advance.5 Registration of protocols prior to the 
conduct of studies of diagnostic test accuracy could be an effective way to improve 
quality and reduce the risk of potential methodological biases such as spectrum bias 
and publication bias. Research on the extent and direction of publication bias for 
diagnostic test accuracy is still at a very early stage. Further empirical evidence is 
needed on the existence, magnitude and impact of publication bias in diagnostic 
research. While waiting for further evidence, the potential existence of publication 
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bias should always be considered when preparing systematic reviews of diagnostic 
test accuracy and all relevant sources of literature should be thoroughly searched. 
 
6.1.3 Evidence of methodological biases in systematic reviews of 
test accuracy  
Variability between studies included in systematic reviews of diagnostic test 
accuracy may be larger than that observed between studies included in systematic 
reviews of interventions. In particular, I found a huge variability between studies 
included in the Cochrane pilot review reported in Chapter 4 in the selection of the 
study population and the methods used for the study. The most important sources of 
bias I detected were spectrum bias, selection bias, and incorporation bias. Most of the 
studies included patients with a high pre-test probability of stroke or an already 
established diagnosis of stroke (especially for studies with retrospective data 
collection where patients were selected on the basis of their final diagnosis and if 
they had received the imaging tests under investigation - MRI and CT).  Moreover, 
in some studies patients were preselected on the basis of the absence of haemorrhagic 
brain lesions and the presence of mild symptoms. These spectrum and selection 
biases are likely to have inflated the sensitivity estimates and therefore affected the 
overall reliability of the review findings. In some studies the results of the imaging 
tests under investigation were ‘incorporated’ in the final diagnosis and hence they 
may have further increased the estimates of accuracy. I was surprised by the 
generally low quality of the studies included in my systematic review. Brain imaging 
is essential to distinguish between the different pathological causes of stroke and to 
 
159 
determine the brain territory affected by the vascular lesion, since the management of 
an individual patient will depend heavily upon accurate diagnosis of these aspects of 
his stroke. The continuous advances in diagnostic imaging technology can often 
make reliable large-scale studies assessing a particular version of a specific imaging 
test difficult to complete before it is implemented in clinical practice (or undergoes 
further development). However, assessing the accuracy and cost-effectiveness of 
these imaging technologies to determine their applicability in clinical practice is 
fundamental, in the light of the current constraints on health care resources and the 
need to optimize medical interventions. To achieve this goal diagnostic accuracy and 
cost-effectiveness studies should be conducted according to current guidelines, and 
evaluate broader and unselected patient populations. As already stated, I am 
convinced that journal editors and peer reviewers, as well as professional 
organizations have a great responsibility to set quality standards of diagnostic 
research in stroke medicine. Nowadays, there are many general problems affecting 
the quality of research. As Sørensen pointed out in a recent editorial: “among the 
many factors that influence research quality throughout the spectrum of biomedical 
studies are the consistency and quality of training, the vagaries of research funding, 
the independence of investigators, and the adequacy of peer review. Also pervasive is 
a system of academic promotion influenced more by the number of publications than 
by quality, which increases the demand for output of whatever quality.” The results 
of my study clearly endorse his view that a “continuing education efforts focused on 





6.1.4 Complex issues in systematic reviews of diagnostic test 
accuracy 
Systematic reviews of diagnostic test accuracy are more complex, challenging, and 
time consuming than systematic reviews of randomised clinical trial. In conducting 
the Cochrane pilot review reported in Chapter 4, using the methods developed by the 
Cochrane Screening and Diagnostic tests Working Group, I had to consider three 
important methodological aspects: the searching for evidence; the assessment of 
individual studies of test accuracy, and the synthesis of results. Firstly, to develop a 
search strategy to identify relevant studies in the literature was not easy. At present, 
in the major electronic bibliographic databases there are no unequivocal indexing 
terms to identify studies of diagnostic accuracy with high sensitivity and specificity. I 
developed and refined the search strategies following the recommendations 
contained in the draft Chapter 7 “Searching for Studies” of the Handbook that the 
Screening and Diagnostic Working Group is currently preparing (available online at 
http://srdta.cochrane.org/handbook-dta-reviews). I used both database subject 
headings and text words to search major electronic databases for the imaging tests 
under investigation and for ‘stroke’ as clinical condition. Although the use of a 
search filter is usually discouraged because it could reduce the overall sensitivity of 
the search,7 I deemed it necessary to include a methodological search filter to 
identify diagnostic accuracy studies of imaging in the stroke literature. A search 
which had combined the keyword ‘stroke’ with terms for the imaging tests under 
investigation would have retrieved an unmanageably large number of citations (i.e. it 
would have high sensitivity but unacceptably low specificity). This is probably the 
case for many other clinical conditions assessed by imaging. Therefore, I opted for 
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the inclusion of a recent validated filter with optimal sensitivity and specificity for 
the retrieval of imaging studies.8 This methodological filter became available in the 
literature in 2008 and therefore was not included amongst those considered by 
Leeflang and colleagues in their study assessing the usefulness of methodological 
filters in search strategies developed to identify diagnostic studies to be included in 
systematic reviews, which was published in 2006.7 In the light of my experience in 
preparing the pilot systematic review for this thesis, I would suggest the use of such a 
filter for the preparation of further diagnostic test accuracy reviews which focus 
specifically on imaging studies.  
Secondly, the critical assessment of individual studies selected for inclusion in the 
pilot review was difficult due to the recognised problem of the poor reporting and 
poor methodological quality of diagnostic studies in the literature, as I have already 
discussed in previous sections.  
Thirdly, summarizing and synthesizing results of studies of diagnostic accuracy can 
be challenging. There are a range of approaches to the meta-analysis of studies of 
diagnostic test accuracy but all involve complex statistical modelling.  So the process 
of selecting the most appropriate approach and then undertaking the statistical 
modelling is far more complex and difficult to perform and interpret than that of 
systematic reviews of randomised controlled trials. The decision about whether or 
not it is legitimate to pool data from studies of diagnostic accuracy is again 
complicated by the poor reporting and methodological standards of the diagnostic 
literature. In my pilot review I included only comparative studies where both 
imaging tests were performed on the same stroke patients against a reference 
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standard of clinical diagnosis and imaging follow-up. The recommended method for 
combining data from comparative studies, which takes into account the underlying 
relationship between sensitivity and specificity is the SROC curve. The hierarchical 
and bivariate methods are considered the most robust for fitting SROC curves.9-10 
However, these models rely heavily on statistical modelling (and on modelling 
assumptions that may be difficult to verify) and require sophisticated programmes to 
be fitted (they cannot be fitted using the Cochrane software RevMan 5). The use and 
interpretation of both the hierarchical and bivariate SROC models in systematic 
reviews of diagnostic accuracy is far from straightforward and can be problematic.11 
These models do not work well when the number of studies is small and when there 
is little heterogeneity amongst estimates of accuracy across studies. In my pilot 
review, I was not able to compare the diagnostic performance of the imaging tests 
under investigation using these models, because there was too little variation in the 
true positive rates and false positive rates across the different studies. Experience 
with the hierarchical SROC methods is still indeed very limited and warrants further 
evaluation. In particular, further investigations to assess the use of these methods in 
clinical practice are needed before statisticians and researchers can really understand 
their strengths and weaknesses.12 Furthermore, it would be interesting to verify how 
these methods are used and interpreted by clinicians. SROC curves are not very 
popular amongst clinicians and health professionals because their underlying 




6.1.5 The challenge of summarising findings of systematic 
reviews of test accuracy for clinicians 
Another challenge that systematic reviews of diagnostic test accuracy present is to 
understand how well clinicians and health professionals interpret their findings and 
whether these findings have appropriate impact on their clinical decision-making. 
Knottnerus maintains that, in clinical practice decision making problems often do not 
depend so much on the lack of research findings but on the lack of a good summary 
of those findings.14 For this thesis I studied how clinicians interpreted the 
information contained in two forms of summary of a Cochrane systematic review of 
diagnostic test accuracy - a traditional verbal Abstract and a newly developed 
Summary of Findings table. I did this by means of a survey questionnaire developed 
ad hoc for the purpose of the study.  Under these conditions, the clinicians who 
participated did not do well in interpreting summary results of the systematic review 
of MRI and CT for the early diagnosis of stroke reported in Chapter 4. The overall 
number of correct answers was low and they failed to detect the main differences 
between the two summary documents. My interpretation to explain the observed low 
rate of correct answers is that clinicians tend to provide answers based on their pre-
existing preference and clinical experience rather than on the real contents of the 
summary documents. This may pose some concerns, if we consider that busy 
clinicians often rely on information presented in a summary format rather then going 
through the whole content of a systematic review. Clinicians appeared also to favour 
the format and the type of information contained in the summary of findings table 
rather than those of the traditional abstract. I believe that abstracts are often too 
succinct to picture the characteristics and complexity of systematic reviews and in 
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particular of systematic reviews of diagnostic test accuracy. Summary of findings 
tables, which contain information on the main limitations of the included studies as 
well as applicability of results, may be a more useful summary of review findings. 
However, it is not yet clear how best to format this information and how it should be 
displayed and presented to clinicians and health professionals. This deserves further 
investigation to improve the translation of findings of systematic reviews of test 
accuracy into better clinical practice and enhanced patients care. 
 
6.2 Implications of this thesis for research 
 The quality of reporting of studies of diagnostic accuracy of imaging for the 
diagnosis of stroke is poor.  
 Investigation of publication bias in systematic reviews of diagnostic test 
accuracy requires further research. It would be useful to assess whether there is 
evidence of publication bias of diagnostic accuracy studies in other clinical 
specialities and whether there is evidence of bias in abstract submission or 
acceptance. Further research on the methods for detecting and dealing with 
publication bias is clearly needed. 
 Important methodological biases are present in diagnostic accuracy studies of 
imaging. In particular, spectrum and selection biases and incorporation biases 
may affect validity and generalisability of findings of systematic reviews of test 
accuracy. There is the need for assessing further the quality of medical imaging 
studies in the literature. 
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 Summary information (abstract or summary of findings table) may be 
erroneously interpreted by clinicians who may process this information 
according to their pre-existing knowledge and experience. Further investigations 
on the way to present and communicate summary results of systematic reviews 
of diagnostic accuracy are needed. 
 
6.3 Implications of this thesis for authors and consumers of 
diagnostic test accuracy reviews  
 Diagnostic test accuracy reviews are methodologically challenging and time 
consuming 
 Searching for diagnostic evidence in the literature is not easy and consultation 
with an information scientist is recommended. For specific topics (e.g. imaging 
studies) it is worth considering the use of a validated search filter (to avoid an 
unmanageable number of references). 
 The quality of reporting and the methodological quality of imaging test accuracy 
studies in the literature is poor and this could compromise the validity and 
generalisabilty of systematic review findings. 
 The statistical models for summarising diagnostic results are difficult to 
interpret. Review authors should seek the advice of a statistician with relevant 
expertise to in the complex models required for the statistical synthesis of 
diagnostic data. Further evaluation of the hierarchical models required for meta-
analysis in clinical settings is needed. Further evidence is needed on how 
clinicians interpret these sophisticated statistical models. 
 
166 
 Further development is needed to improve presentation and interpretation of 
systematic reviews of test accuracy. Clinicians may struggle to interpret 
diagnostic results presented in summary format. Further investigation is needed 
to study the best way to present and display diagnostic information to clinicians 
and health professionals. 
 
 
6.4 Implications of this thesis for journal editors, 
publishers, professional organizations, peer reviewers 
 As the technologies for new diagnostic tests become ever more complex, it is 
important to establish high quality methodological standards. Journal editors, 
publishers, professional organizations, and peer reviewers should consider the 
quality of reporting and the quality of study design in diagnostic research of 
great importance. 
 They should require authors to adhere to current specific guidelines such as the 
QUADAS and the STARD checklists and they should reject manuscripts which 
do not comply with these guidelines. 
 Journal editors should also consider inviting methodological experts in 
diagnostic research among the members of their editorial teams. 
 To reduce occurrence of publication bias and ensure transparency all primary 
diagnostic test accuracy studies should be prospectively registered in publicly 
accessible and easy searchable databases. This register would inform the 
‘diagnostic community’ about the most up-to-date ongoing studies. The 
International Committee of Medical Journal Editors, once the registry is 
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established, could require that diagnostic accuracy studies be registered at 
starting as conditio sine qua non for being considered for publication. 
 
6.5 Implications of this thesis for the Cochrane 
Collaboration  
The results of this thesis are, in a sense, disappointing, since it did not prove possible 
with the resources available, to establish clear guidance on several important 
methodological points. The conduct of the pilot diagnostic test accuracy review 
reported in Chapter 4 proved very time consuming (the review required an estimated 
2000 hours of work). Similarly, the work for each methodological project included in 
this thesis involved a considerable amount of time (estimated time 1300 hours per 
project). In other words, this review of diagnostic test accuracy appears to have been 
unusually resource intensive (based on my own experience of conducting systematic 
reviews of interventions), though this is necessarily a qualitative conclusion, since 
there is little data available on the resources that were required for the pilot Cochrane 
Diagnostic test accuracy  reviews conducted in other areas. The work of identifying 
studies to be included in the review, assessing their methodological quality and 
obtaining agreement on the data to be extracted was considerable, and compounded 
by the generally incomplete reporting of studies in publications.  





Cochrane Groups capacity 
Cochrane groups planning to undertake diagnostic test accuracy reviews will need to 
ensure they have: 
 sufficient methodological and statistical expertise to support the conduct of the 
review; 
 sufficient time and capacity to provide editorial support, to help authors deal 
with: 
i) complex review methods (e.g. development of comprehensive 
search strategies; models for statistical analyses) 
ii) issues for which there is not methodological consensus yet (e.g. 
summary of findings tables) 
Cochrane Groups 
The editorial base teams have finite resources, so when prioritising and selecting the 
topics which are to be registered for diagnostic test accuracy reviews, they should 
bear in mind the following constraints: 
As a result of the complexity and statistical demands of diagnostic test accuracy 
reviews, each Cochrane Review Group is likely to be able to support only a limited 
number of such reviews.  
Reviews should therefore be restricted to those high priority topics where:  
 the diagnosis it is likely to lead to significant changes in patient management and 
hence 
 influence clinical outcome. 
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Cochrane groups planning to recruit authors to undertake diagnostic test accuracy 
reviews will need to ensure any potential authors are competent not only in the 
content area of the medical disorder and the test under evaluation, but also in the 
methods of systematic reviews and the statistics of diagnostic test accuracy.  Again, 
speaking from my own perspective as an individual with: prior professional 
experience of the medical disorder (stroke); experience of systematic review methods 
and statistics, and having very high-level support on medical imaging, the process of 
overcoming some of the challenges was significant.  Whilst the development of the 
RevMan software and the section of Handbook on diagnostic test accuracy reviews 
will facilitate the process of such reviews, my qualitative conclusion is that review 
groups will need to enquire closely about the expertise of potential authors before 
accepting them.  Naïve reviewers might well be easily disheartened at the scale of the 
task, and inexperienced reviewers might generate unreasonably high demand on the 
resources of the editorial base team! 
Impact of the work of this thesis on the Cochrane Stroke Group 
The experience with my pilot diagnostic accuracy review and its related 
methodological work has led to the Cochrane Stroke Group formulating its editorial 
policy on diagnostic test accuracy reviews. This policy has already been of benefit to 
the Stroke Group to enable it to accept one high priority diagnostic test accuracy 





6.6 Implications of this thesis for clinical practice  
Although the focus of this thesis was on methodological aspects related to systematic 
reviews of diagnostic test accuracy, I feel the findings I have found have also some 
clinical value.  
In Chapter 4, I have demonstrated that comparative studies of diagnostic test 
accuracy assessing MRI and CT for the diagnosis of stroke are hampered by 
important methodological biases (spectrum and selection bias; incorporation bias).  I 
have presented some evidence that MRI is more sensitive, but not more specific, than 
CT for the early detection of mild stroke. I found very little evidence on the 
diagnostic performance of MRI compared to CT for the early detection of 
haemorrhagic stroke. There is a need for further comparative studies on the cost-
effectiveness of MRI and CT for the early diagnosis of stroke. In particular, further 
studies - in unselected patient populations - are needed to provide clear evidence on 
whether MRI can be used as the imaging modality of first choice for the majority of 
stroke patients in routine practice. In Chapter 5, I have showed that the way findings 
of systematic reviews of diagnostic test accuracy are currently presented may be 
difficult for clinicians to interpret and implement.  
6.7 Future developments  
The methodological problems I encountered and underlined in this thesis could be 
priority topics for specific methodological projects to inform diagnostic research 
methods (e.g. development of summary of findings tables; assessment of publication 
bias; using quality assessment of included studies to adjust estimates of diagnostic 
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Diagnostic tests are used in clinical practice to help the diagnosis making process and 
hence improve patients care and management. In stroke medicine effective patient 
management depends on a rapid and precise diagnosis. Brain imaging with CT and 
MRI is necessary to identify the exact vascular territory of the brain affected by the 
lesion and to determine the pathological type of stroke. The demand for evidence on 
which imaging test is the more accurate for the rapid diagnosis of acute stroke has  
increased because appropriate use of the recently developed emergency treatments 
for acute ischaemic stroke (e.g. thrombolysis, neuro-interventional treatment) depend 
heavily on accurate diagnosis. Systematic reviews of diagnostic test accuracy may 
therefore help clinicians and health professionals to decide about the best use of 
diagnostic tests in clinical practice and to choose between alternative tests. The 
Cochrane Collaboration has recently included systematic reviews of diagnostic test 
accuracy within its remit. However, to prepare Cochrane systematic reviews of 
diagnostic test accuracy is still quite challenging because the methods for such 
reviews are still developing. The research work undertaken for this thesis addresses 
some relevant methodological issues and contributes to inform the development of 
the methods for Cochrane systematic reviews of test accuracy.  
 
Chapter 1 considers the importance of using imaging tests for the diagnosis of 
stroke, introduces some basic concepts of diagnostic test evaluation, and addresses 
some of the methodological challenges in preparing systematic reviews of diagnostic 




The validity and reliability of findings of systematic reviews of diagnostic test 
accuracy depend on the availability and the quality of the included studies. 
Methodological characteristics of included studies may be, however, difficult to 
ascertain if the quality of reporting of such studies is poor.  
 
The aim of the study reported in Chapter 2 was to evaluate the extent to which 
studies on magnetic resonance imaging for the diagnosis of stroke published between 
1999 and 2008 complied with the current STAndards for the Reporting of Diagnostic 
accuracy studies (STARD) criteria and to explore whether the introduction of the 
STARD statement in 2003 has contributed to a better quality of reporting. I identified 
18 studies published between 1999 and 2003 and 7 studies published between 2004 
and 2008. The findings of this study were limited by the small number of studies 
available in the literature. However, they were comparable to those of other fields of 
medicine. There was a wide variation in the quality of reporting of individual 
STARD items. The mean number of reported STARD items in diagnostic articles 
published between 2004 and 2008 was not significantly different to that of diagnostic 
articles published between 1999 and 2003. In particular, diagnostic articles pre- and 
post-STARD lacked several important items: a description of the study population 
and demographic characteristics of the patient population; cross tabulation of results 
of the index test by the results of the reference standard; a description of how 
indeterminate results were handled; a description of diagnoses in patients without the 
target condition; and a description of any adverse events related to performing the 
index test or the reference standard. Overall, in stroke medicine diagnostic accuracy 
articles on brain imaging were not uniformly reported and there is still ample room 
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for further improvement. I therefore recommend a broader use of the STARD criteria 
by authors, journal editors, and professional bodies to improve the standards of 
diagnostic research.  
 
Chapter 3 focuses on a review of the empirical evidence of publication bias in 
studies of diagnostic test accuracy in stroke medicine. I evaluated the proportion of 
abstracts on diagnostic tests presented at international stroke meetings that were later 
published in full. I investigated which study features were associated with full 
publication. Of the 160 identified diagnostic abstracts, 76% were subsequently 
published in full. Sixty-two percent were published in full within 24 months of 
presentation. The only factor that predicted full publication was whether or not inter-
observer agreement between test readers had been assessed. No other studies features 
(including the clinical utility of results, the country of origin of the corresponding 
author, the multi-centre status, or Youden’s Index) was associated with subsequent 
full publication.  I found no clear evidence of bias in the processes of publication that 
occur after abstract acceptance. I was, however, unable to assess bias in the process 
of abstract submission or acceptance. Overall, diagnostic abstracts fail to report 
relevant methodological aspects. 
 
In Chapter 4 I systematically compared the diagnostic accuracy of diffusion-
weighted magnetic resonance imaging and computed tomography (CT) for acute 
ischaemic stroke, and estimated the diagnostic accuracy of magnetic resonance 
imaging (MRI) for acute haemorrhagic stroke. MRI is increasingly used for the 
diagnosis of acute ischaemic stroke but its sensitivity for the early detection of 
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intracerebral haemorrhage has been debated. CT is extensively used in the clinical 
management of acute stroke, especially for the rapid exclusion of intracerebral 
haemorrhage. Only eight studies met my inclusion criteria. Seven studies contributed 
to the assessment of ischaemic stroke and two studies to the assessment of 
haemorrhagic stroke. The spectrum of patients was relatively narrow in all studies, 
sample sizes were small, there was substantial incorporation bias, and blinding 
procedures were often incomplete. Among the patients subsequently confirmed to 
have acute ischaemic stroke (161/226), the summary estimates for DWI were: 
sensitivity 0.99 (95% CI 0.23 to 1.00), specificity 0.92 (95% CI 0.83 to 0.97). The 
summary estimates for CT were: sensitivity 0.39 (95% CI 0.16 to 0.69), specificity 
1.00 (95% CI 0.94 to 1.00). The two studies on haemorrhagic stroke reported high 
estimates for diffusion-weighted and gradient-echo sequences but had inconsistent 
reference standards. I did not calculate overall estimates for these two studies. I was 
not able to assess practicality or cost-effectiveness issues. MRI had a better 
sensitivity than CT for the early detection of ischaemic stroke in highly selected 
patients. However, the variability in the quality of included studies and the presence 
of methodological biases rendered the reliability and generalisability of observed 
results questionable. Further well-designed studies without methodological biases, in 
more representative patient samples, with practicality and cost estimates are required 





Chapter 5 addressed the issue on how to summarise findings of systematic reviews 
of diagnostic test accuracy. At present, there is very little evidence on the best way of 
presenting summary results of diagnostic accuracy reviews to clinicians and on how 
clinicians interpret results of such reviews. I carried out a study to evaluate the 
usefulness to clinicians of two forms of summaries (a traditional abstract and a new 
developed summary of findings table) of a systematic review of diagnostic test 
accuracy.  I developed a questionnaire to ascertain the clinicians’ ability to interpret 
the information contained in either documents and to assess their preference about 
the format of the two summaries. Overall, the number of correct answers to both 
documents was low with no significant differences between the correct answers at 
the abstract and the correct answers at the summary of findings table. In particular, 
clinicians did not differentiate their answers according to the information contained 
in the two documents. They showed the tendency to provide the same answers for 
both documents even though the information contained in the two summaries was 
dissimilar. One possible explanation is that clinicians tended to provide biased 
answers due to their pre-existing preferences and clinical knowledge. I did not 
observe any difference in the rate of correct answers between clinicians with more 
years of clinical practice compared to clinicians with less years of clinical practice. 
Similarly, the clinicians declared confidence in understanding measures of diagnostic 
accuracy did not result in a better interpretation of the systematic review findings. 
Further investigations are needed to determine the way to improve summaries of 




Chapter 6 discusses the main findings reported in this thesis and their implication for 
practice and research. 
In conclusion, methodological issues concerning the validity and reliability of 
findings of studies included in systematic reviews of diagnostic accuracy remain of 
fundamental importance. More empirical evidence is needed to address potential 
biases such as reporting bias and publication bias. To allow dissemination of 
diagnostic reviews findings in clinical practice better ways of communicating main 
characteristics and key results of systematic reviews of diagnostic accuracy should be 
considered. 
In the current literature, the quality of reporting and methodological quality of 
imaging studies for the diagnosis of stroke is less than satisfactory and leaves room 
for improvement. This is worrying, especially if current health imaging policies are 
in fact based on poor quality evidence and hence scarce health resources may not 
being deployed as effectively as they could be.  
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My contribution to this thesis 
 
I was awarded a Research Fellowship from the Chief Scientist Office (CSO) to study 
the methodology of systematic reviews of diagnostic test accuracy. 
 
I conducted the study reported in Chapter 2, which assessed the quality of reporting 
of studies on MRI for the early diagnosis of stroke. In particular, I developed the 
search strategy to identify relevant diagnostic accuracy studies in the literature; I 
personally assessed the quality of reporting of all included studies; and performed the 
analyses.  
 
For the study reported in Chapter 3 on publication bias of diagnostic accuracy studies 
in stroke medicine, I reviewed all conference proceedings of two major international 
stroke meetings published as abstracts between 1995 and 2004. I extracted 
information on study characteristics from all identified abstracts. I then searched 
MEDLINE and EMBASE to identify how many abstracts were published in full in 
the literature. For abstracts for which a full-text publication could not be located I 
sent a questionnaire to the corresponding author. I entered data in Excel and SAS and 
performed the statistical analyses.  
 
I performed the pilot systematic review that formed the basis of Chapter 4. I wrote 
the initial protocol; I developed the search strategies for identifying relevant 
diagnostic studies of CT and MRI for the early diagnosis of stroke; I assessed the 
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quality of all identified studies; I extracted the data; I entered the data in RevMan 5 
and performed the statistical analyses.  
 
I designed the study reported in Chapter 5, which assessed two forms of summary of 
the systematic review findings presented in Chapter 4. I developed the layout and 
content of a summary of findings table to present in a simple tabular format the main 
results of systematic reviews of diagnostic test accuracy. I tested the table in a small 
group of experienced clinicians. I developed the questionnaire to evaluate clinicians’ 
ability to interpret the main findings of a diagnostic test accuracy review. I recruited 
clinicians (mainly neurologists, radiologists, and neuroradiologists) in the UK 
(Edinburgh) and in Italy (Perugia), and organised the data collection. I entered the 
data in Excel and Minitab. I analysed results of all completed questionnaires and 
interpreted them. 
 
Work from Chapter 3 and 4 formed the basis of oral presentations at the XIV 
Cochrane Colloquium in Dublin (Ireland) in 2006 and at the Methods for Evaluating 
Medical Tests - First International Symposium in Birmingham (UK) in July 2008. 
Work from Chapter 5 has been presented in research seminar meetings at the Stroke 
Research Group as part of the activities of the Centre for Clinical Brain Sciences in 
Edinburgh (UK). The study presented in Chapter 3 was published in full in the 
Journal of Clinical Epidemiology. The systematic review presented in Chapter 4 was 
published in full in the Cochrane Library and in brief in the journal Stroke. 
I entirely composed this thesis while I was in place at the Division of Clinical 
Neurosciences, University of Edinburgh. My position was funded by a CSO 
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Research Fellowship. This thesis has not been submitted for candidature for any 
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Appendix 1 Details of the search strategies 
 
DWI for the diagnosis of ischaemic stroke 
MEDLINE (Ovid) search strategy - January 1999 to January 2009 
 
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain 
ischemia/ or carotid artery diseases/ or carotid artery thrombosis/ or cerebrovascular 
accident/ or exp brain infarction/ or exp hypoxia-ischemia, brain/ or intracranial 
arterial diseases/ or cerebral arterial diseases/ or exp "intracranial embolism and 
thrombosis"/ 
 
2. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior 
circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypoxi$)).tw. 
 
3. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or 
attack$)).tw. 
 
4. 1 or 2 or 3 
 
5. exp Magnetic Resonance Imaging/ 
 
6. (magnetic resonance or MR or NMR or diffusion weighted or T2-weighted).tw. 
 
7. (MR or NMR).tw. 
 
8. (MRI or DWI).tw. 
 
9. 5 or 6 or 7 or 8 
 
10. 4 and 9  
 
11. ("1999$" or "200$").yr. 
 
12. 10 and 11 
 
13. exp "Sensitivity and Specificity"/ 
 




16. (sensitiv$ distinguish$ or differentiat$ or enhancement or identif$ or detect$ or 
diagnos$ or accura$).tw. 






19. 12 and 18 
 




DWI for the diagnosis of ischaemic stroke  
EMBASE (Ovid) search strategy - January 1999 to January 2009 
 
1. cerebrovascular disease/ or cerebral artery disease/ or cerebrovascular accident/ or 
stroke/ or vertebrobasilar insufficiency/ or carotid artery disease/ or exp carotid 
artery obstruction/ or exp brain infarction/ or exp brain ischemia/ or exp occlusive 
cerebrovascular disease/ 
 
2. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior 
circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypoxi$)).tw. 
 
3. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or 
attack$)).tw. 
 
4. 1 or 2 or 3 
 
5. exp nuclear magnetic resonance imaging/ 
6. ((magnetic resonance or MR or NMR or diffusion weighted or T2-weighted) adj2 
imag$).tw. 
 
7. ((MR or NMR) adj2 tomography).tw. 
 
8. (MRI or DWI).tw. 
 
9. 5 or 6 or 7 or 8 
 
10. 4 and 9 
 
15. ("1999$" or "200$").yr. 
 
16. 10 and 15 
 
17. "sensitivity and specificity"/ 
 




19. (sensitiv$ or distinguish$ or differentiat$ or enhancement or identif$ or detect$ or 
diagnos$ or accura$).tw. 
 




22. 16 and 21 
 




Appendix 2 Details of the search strategies 
 
CT and MRI for the diagnosis of ischaemic and haemorrhagic stroke 
MEDLINE (Ovid) search strategy - January 1995 to March 2009  
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain 
ischemia/ or carotid artery diseases/ or carotid artery thrombosis/ or 
cerebrovascular accident/ or exp brain infarction/ or exp hypoxia-ischemia, brain/ 
or intracranial arterial diseases/ or cerebral arterial diseases/ or exp "intracranial 
embolism and thrombosis"/ 
2. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior 
circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypoxi$)).tw. 
3. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or 
attack$)).tw. 
4.1 or 2 or 3 
5.exp Magnetic Resonance Imaging/ 
6. ((magnetic resonance or MR or NMR or diffusion weighted or T2-weighted) adj2 
imag$).tw. 
7. ((MR or NMR) adj2 tomograph$).tw. 
8. (MRI or DWI).tw. 
9. 5 or 6 or 7 or 8 
10.exp Tomography, X-Ray Computed/ 
11. (CT or CAT).tw. 
12. (comput$ adj3 tomograph$).tw. 
13. 10 or 11 or 12 
14. 4 and 9 and 13 
15. ("1995$" or "1996$" or "1997$" or "1998$" or "1999$" or "200$").ed. 
16. 14 and 15 (most sensitive search - ischaemic stroke) 
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17. cerebrovascular disorders/di or basal ganglia cerebrovascular disease/di or exp 
brain ischemia/di or carotid artery diseases/di or carotid artery thrombosis/di or 
cerebrovascular accident/di or exp brain infarction/di or exp hypoxia-ischemia, 
brain/di or intracranial arterial diseases/di or cerebral arterial diseases/di or exp 
"intracranial embolism and thrombosis"/di 
18. exp *Magnetic Resonance Imaging/ 
19. exp *Tomography, X-Ray Computed/ 
20. 17 and 18 and 19 and 15 (SET DOWNLOADED 1) 
21. exp "Sensitivity and Specificity"/ 
22. false negative reactions/ or false positive reactions/ or diagnostic errors/ 
23. (sensitiv$ or specificity or distinguish$ or differentiat$ or enhancement or 
identif$ or detect$ or diagnos$ or accur$).tw. 
24. (predictive adj4 value$).tw. 
25. (false adj (positive$ or negative$)).tw. 
26. (receiver operat$ adj (characteristic$ or curve or analysis)).tw. 
27. (ROC or SROC).tw. 
28. comparative study/ 
29. (compared or comparison or correlat$ or versus).tw. 
30. or/21-29 
31. (16 and 30) not 20 (ischaemia + MRI + CT + years + diagnostic filter - set 
downloaded) (SET DOWNLOADED 2) 
32. exp basal ganglia hemorrhage/ or exp intracranial hemorrhages/ 
33. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or putaminal or 
putamen or posterior fossa) adj10 (haemorrhage$ or hemorrhage$ or haematoma$ or 
hematoma$ or bleed$)).tw. 
34. 32 or 33 




36. exp basal ganglia hemorrhage/di or exp intracranial hemorrhages/di 
37. 36 and 18 and 15 (haemorrhage diagnosis/di + exp MRI + years) 
38. or/21-27 (diagnostic filter) 
39. 35 and 38 (MRI + haemorrhage + years + diagnostic filter) 
40. 37 not (20 or 31) (haemorrhage diagnosis/di + exp MRI + years - downloaded 
sets 1 and 2) (SET DOWNLOADED 3) 
41. 39 not (20 or 31 or 37) (MRI (not exp MRI) + haemorrhage (not haemorrhage 
diagnosis/di) + years + diagnostic filter - downloaded sets 1 and 2) (SET 
DOWNLOADED 4) 
The above search strategy has been designed to cover both MRI and CT for the 
detection of ischaemic stroke and MRI for the detection of haemorrhagic stroke. In 
theory two separate search strategies could have been designed but we preferred to 
combine the searches to avoid looking at duplicate references. 
Summary of the MEDLINE search strategy 
 Line 16 of the search strategy identifies all records related to ischaemic stroke 
(broad terms) and the use of both MRI and CT for the period 1995 – 2009; 
 Line 20 of the search strategy identifies records that focus specifically on 
MRI and CT for the diagnosis of ischaemic stroke (stroke terms searched 
with the subheading /di) for the period 1995 – 2009; 
 Line 31 of the search strategy employs a diagnostic filter to identify  records 
related to ischaemic stroke (broad terms) and the use of both MRI and CT for 
the period 1995 – 2009; 
 Line 35 of the search strategy identifies all records related to haemorrhagic 
stroke (broad terms) and the use of MRI for the period 1995 – 2009; 
 Line 37 of the search strategy identifies records that focus specifically on 
MRI for the diagnosis of haemorrhagic stroke (stroke terms searched with the 
subheading /di) for the period 1995 – 2009; 
 Line 39 of the search strategy employs a diagnostic filter to identify  records 
related to haemorrhagic stroke (broad terms) and the use of MRI for the 
period 1995 – 2009. 
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The most sensitive search for ischaemic stroke would have been to assess all the 
references at line 16 (approximately 2800 hits from 1995). However, as CT and MRI 
are routinely used in clinical practice and the terms occur very frequently in 
abstracts, we tried to limit the search specifically to imaging diagnostic studies in 
two ways: (a) by using the subheading diagnosis (/di) on the stroke MeSH terms and 
the focused imaging MeSH terms, and (b) by developing a search filter for diagnostic 
studies to increase precision. In order to test this approach we intended to scan the 
remaining references from line 16 to see if any relevant papers were missed and not 
identified by (a) or (b). However, due to the limited resources available this approach 
proved unfeasible. 
The above comments apply to the search section on haemorrhagic stroke with line 35 








CT and MRI for the diagnosis of ischaemic and haemorrhagic stroke  
EMBASE (Ovid) search strategy - January 1995 to March 2009 
 
Adapted from the MEDlINE search strategy 
1. cerebrovascular disease/ or cerebral artery disease/ or cerebrovascular accident/ or 
stroke/ or vertebrobasilar insufficiency/ or carotid artery disease/ or exp carotid 
artery obstruction/ or exp brain infarction/ or exp brain ischemia/ or exp occlusive 
cerebrovascular disease/ 
2. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior 
circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypoxi$)).tw. 
3. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or 
attack$)).tw. 
4. 1 or 2 or 3 
5. exp nuclear magnetic resonance imaging/ 
6. ((magnetic resonance or MR or NMR or diffusion weighted or T2-weighted) adj2 
imag$).tw. 
7. ((MR or NMR) adj2 tomography).tw. 
8. (MRI or DWI).tw. 
9. 5 or 6 or 7 or 8 
10. exp computer assisted tomography/ 
11. (CT or CAT).tw. 
12. (comput$ adj3 tomograph$).tw. 
13. 10 or 11 or 12 
14. 4 and 9 and 13 
15. ("1995$" or "1996$" or "1997$" or "1998$" or "1999$" or "200$").em. 
16. 14 and 15 (most sensitive search - ischaemic stroke) 
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17. cerebrovascular disease/di or cerebral artery disease/di or cerebrovascular 
accident/di or stroke/di or vertebrobasilar insufficiency/di or carotid artery disease/di 
or exp carotid artery obstruction/di or exp brain infarction/di or exp brain ischemia/di 
or exp occlusive cerebrovascular disease/di 
18. exp *nuclear magnetic resonance imaging/ 
19. exp *computer assisted tomography/ 
20. 17 and 18 and 19 and 15 (SET DOWNLOADED 1) 
21. "sensitivity and specificity"/ 
22. laboratory diagnosis/ 
23. prediction/ 
24. "prediction and forecasting"/ 
25. receiver operating characteristic/ or roc curve/ 
26. diagnostic accuracy/ 
27. diagnostic value/ 
28. reliability/ 
29. (sensitiv$ or specificity or distinguish$ or differentiat$ or enhancement or 
identif$ or detect$ or diagnos$ or accur$).tw. 
30. (predictive adj4 value$).tw. 
31. (false adj (positive$ or negative$)).tw. 
32. (receiver operat$ adj (characteristic$ or curve or analysis)).tw. 
33. (ROC or SROC).tw. 
34. comparative study/ 
35. exp controlled study/ 
36. intermethod comparison/ 
37. correlation analysis/ 




40. (16 and 39) not 20 (ischaemia + MRI + CT + years + diagnostic filter - set 
downloaded 1) (SET DOWNLOADED 2) 
41. basal ganglion hemorrhage/ or brain hemorrhage/ or brain ventricle hemorrhage/ 
or cerebellum hemorrhage/ 
42. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or 
intraventricular or infratentorial or supratentorial or basal gangli$ or putaminal or 
putamen or posterior fossa) adj10 (haemorrhage$ or hemorrhage$ or haematoma$ or 
hematoma$ or bleed$)).tw. 
43. 41 or 42 
44. 9 and 15 and 43 (MRI + years + haemorrhage) (most sensitive search - 
haemorrhagic stroke) 
45. basal ganglion hemorrhage/di or brain hemorrhage/di or brain ventricle 
hemorrhage/di or cerebellum hemorrhage/di 
46. 45 and 18 and 15 (haemorrhage diagnosis/di + exp MRI + years) 
47. 46 not (20 or 40) (haemorrhage diagnosis/di + exp MRI + years - downloaded 
sets 1 and 2) (SET DOWNLOADED 3) 
48. or/21-33 (diagnostic filter) 
49. 44 and 48 (MRI + years + haemorrhage + diagnostic filter) 
50. 49 not (20 or 40 or 47) (MRI + years + haemorrhage + diagnostic filter - 
downloaded sets 1,2 and 3) (SET DOWNLOADED 4) 
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Appendix 3 Study Design and Data Extraction Form 
 
Reviewer initials:      Date information extracted: 
   
 
Type of publication: 
____________________________________________________________________ 





(First author and year of publication) 
 
 
Number of studies included in this paper: 
_________________________________ 
(if more than one, complete separate extraction forms for each, and add letters A, B, 
C etc to the study identifier) 
 
 
Language of report:___________________________________________________ 
 
 




Aim of the study:_____________________________________________________
           
  
 
Did the study focus on ischaemic stroke          haemorrhagic stroke        or both? 
 
 
Geographical location of study 
centre(s):____________________________________________________________ 
 




Setting: Tertiary    Academic Unit:   Yes          No 
  Secondary 













Systematic Review                                      Prospective     
Randomised controlled study                       Retrospective  
Cross-sectional study        
Case-control study     
 
 
Other_________________________________   
 
 
Characteristics of the participants 























Selection by stroke type (e.g. restricted to MCA stroke, PACS) 
 
 



















MRI          
 
Total     
                     
No. patients enrolled (e.g. all consecutive patients who entered the study) 
 
CT                               
 




No. patients assessed (e.g. all patients for whom data are reported) 
 
CT                                
 




No. of patients included in the 2x2 results tables 
 
CT                               
 
 MRI   
                                
No. of patients who underwent the reference standard 
 
CT                                
 
MRI  
                                 
No. of patients who underwent a different reference standard  
 
CT                                
 
MRI     
                            
 
198 









No. of patients with previous history of stroke 
 
 
No. of patients who could not or did not undertake the test(s) or whose images were 










































For studies assessing more than one imaging test what was the order of tests? 
 
 
Was the order of tests strictly randomised? 
 
 




















Time of imaging after symptom onset 
 
CT (mean, median, range) 
 
MRI (mean, median, range) 
 
200 
Characteristics of the diagnostic assessment 









Who did assess and interpret imaging results (i.e. qualification and experience of the 
assessor)? 
 
Was there a neuroradiologist amongst the study authors? 
 
 
Were assessors of imaging results blinded to patients’ clinical symptoms? 
 
 
For each patient were scans from different imaging tests assessed separately? 
 
 
Was inter-rater agreement assessed? 
 
























Comments on reference 
standard   
True positives 
 
   
False positives 
 
   
True negatives 
 
   
False negatives 
 
   
Sensitivity 
 
   
Specificity 
 
   
Positive predictive value 
 
   
Negative predictive value 
 
   
Positive likelihood ratio 
 
   
Negative likelihood ratio 
 
   
Diagnostic odds ratio 
 
   
Diagnostic accuracy 
 


















APPENDIX 4 Modified QUADAS Checklist 
 
Extractor initials:     Date information extracted:    
 
Study identifier: _________________________________________________ 
(First author + year of publication) 
Item Yes No Unclear 
1. Was the spectrum of patients representative of the patients who will 
receive the test in practice? (e.g. female and male patients of all ages 
presenting with light, mild, or severe stroke symptoms, with or without 
previous history of stroke, scanned within a few hours of onset) 
   
2. Were selection criteria clearly described? 
 
   
3. Is the reference standard likely to correctly classify the target condition? 
(e.g. expert clinical assessment coupled with clinical and imaging 
follow-up) 
   
4. Is the time period between reference standard and index test short 
enough to be reasonably sure that the target condition did not change 
between the two tests? 
   
5. Did the whole sample or a random selection of the sample, receive 
verification using a reference standard of diagnosis? 
   
6. Did patients receive the same reference standard regardless of the index 
test result? 
   
7. Was the reference standard independent of the index test (i.e. the index 
test did not form part of the reference standard)? 
   
8. Was the execution of the index test described in sufficient detail to 
permit replication of the test? 
   
9. Was the execution of the reference standard described in sufficient detail 
to permit its replication? 
  
10. Were the index test results interpreted without knowledge of the results 
of the reference standard? 
   
11. Were the reference standard results interpreted without knowledge of the 
results of the index test? 
  
12. Were the same clinical data available when test results were interpreted 
as would be available when the test is used in practice? 
   
13. Were uninterpretable/ intermediate test results reported? 
 
   
14. Were withdrawals from the study explained? 
 
   
15. Was the study prospective? 
 
   
16. For retrospective studies 
Were the original scans re-examined by study investigators? 
   
17. Is the technology of the index test(s) likely to be changed since the study 
was carried out? 
  
18. Was the expertise of the clinician(s) assessing results of the diagnostic 
tests reported? 
   
 
19. 
For studies with a direct comparison of diagnostic tests: 
Was the sequence of the diagnostic tests (index test + comparator) 
determined at random? 
   
20. Were the scans read blind to clinical data? 
 




Appendix 5 Characteristics and references of 
excluded studies  
 
 
Study ID Reasons for exclusion 
Allkemper 2004  
 
No direct comparison MRI with CT. 
Arenillas 2002  
 
Focus on ‘early neurological deterioration’ in patients with 
proven MCA and ICA occlusion. Beyond the scope of this 
review. 
Arnould 2004  
 
Focus on haemorrhagic transformation in hyperacute 
ischaemic stroke. Beyond the scope of this review. 
Ba-Ssalamaha 2000  
 
Heterogeneous sample. Vascular lesions in only 9 patients. 
No suitable diagnostic accuracy data. 
Barber 2005  
 
Comparison of CT and DWI in acute ischaemic stroke using 
the Alberta Stroke Programme Early Computed Tomography 
Score (ASPECTS criteria). No suitable diagnostic accuracy 
data. 
Bartylla 1997  
 
German study. No direct comparison of CT with DWI. Only 




Focus on FLAIR images - not on DWI. No suitable imaging 
test. 
Buckley 2003  
 
Audit of MRI as first-line neuroimaging for stroke patients. 
Patients scanned within 48 hours. Not suitable diagnostic 
data. 
Chung 2002  Four single cases of ischaemic stroke assessed by DWI. 
 
Chung 2003  
 
Five single cases of haemorrhagic stroke assessed by DWI . 
Dorenbeck 2005  
 
Assessment of ADC values obtained using DWI. No suitable 
diagnostic accuracy data. 
Dylewski 2000  
 
Use of MRI in acute intracerebral haemorrhage. 
Heterogeneous etiologies of haemorrhage. No suitable patient 
population. 
Eastwood 2003  
 
Correlation of dynamic CT perfusion imaging and MR 
diffusion and perfusion imaging in acute stroke. No direct 




Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Ebisu 1997  
 
No suitable diagnostic accuracy data. 
Egelhof 1998  
 
German study. MRI to detect acute ischaemic cerebral 
infarcts. Imaging performed within 48 hours of stroke onset 
(and within 24 hours only in a subgroup of patients).  
Eliasziw 2005  
 
Letter/comment with no suitable diagnostic accuracy data. 
Etgen 2004  
 
Study looking at stroke in one anatomical region (brainstem 
infarcts). Only DWI assessed. 62% of patients were scanned 
outside 24 hours. 
Fazekas 1996  
 
Frequency and type of TIA-related infarcts shown by MRI. 
Beyond the scope of this review. 
Fiebach 2001  
 
No enough data to allow construction of a 2x2 contingency 
table. 
Fiebach 2002  
 
Only sensitivity and specificity estimates reported. No 
enough data to construct a 2x2 contingency table 
Fiebach 2004  
 
No enough data to allow construction of a 2x2 contingency 
table. 
Fitzek 1998  
 
Comparison of CT with DWI for detection of acute ischaemic 
stroke. Imaging performed within 11 days after stroke onset. 
Flacke 1998  
 
German study. Assessment of diffusion-weighted and 
perfusion imaging in addition to FLAIR-TSE and T2W-
GraSE and MR angiography for the diagnosis of acute stroke. 
No direct comparison of MRI with CT. 
Flacke 2000  MCA susceptibility sign compare with hyperdense MCA sign 
on CT. No suitable test comparison. 
Girot 2003  
 
Focus on inter- and intra-observer reproducibility. No 
suitable diagnostic accuracy data. 
Greer 2004  
 
Evaluation of DWI versus CT for the detection of 
haemorrhage after thrombolysis. Beyond the scope of this 
review. 
Griffiths 2000  
 
Assessment of patients with neurological symptoms and signs 
(not limited to stroke patients). Imaging performed within 18 





Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Hacke 2000  
 
Letter/comment with no suitable diagnostic accuracy data. 
Haraguchi 2000  
 
Japanese study. No suitable diagnostic accuracy data. 
Heidenreich 2008  
 
MRI in addition to CT for the diagnosis of hyperacute stroke. 
MRI protocol included T2-W, DWI, PWI, and MRA. No 
direct comparison of DWI with CT. 
Hermier 2001  
 
DWI for the detection of post-ischaemic haemorrhage. 
Beyond the scope of this review 
Jager 2000  
 
Narrative review of the literature. No suitable diagnostic 
accuracy data. 
Jaillard 2002  
 
Early CT signs in acute stroke. Beyond the scope of this 
review. 
Kamal 2003  
 
Tissue response of the brain to intracranial haemorrhage as 
shown by DWI. Beyond the scope of this review. 
Keir 2000  
 
Systematic review of diffusion and perfusion imaging in 
acute ischemic stroke. No suitable diagnostic accuracy data. 
Kidwell 2008  
 
Discussion paper on neuroimaging for the diagnosis of 
intracranial haemorrhage. No suitable diagnostic accuracy 
data 
Kimura 1999  
 
Duration of symptoms in TIA. Beyond the scope of this 
review 
Kloska 2004  
 
No direct comparison of CT with DWI. Only CT assessed. 
Koennecke 2001  
 
Not suitable diagnostic data. Only positive cases on DWI 
analysed. 
Krasnianski 2001  
 
German study. MRI findings in patients with brainstem 
infarctions. Imaging performed within 7 days of stroke onset. 
No suitable time of imaging. 
Krasnianski 2002  
 
Brainstem infarctions in patients with normal MRI. Beyond 
the scope of this review. 
Köhrmann 2007  
 
Discussion paper on acute stroke imaging for thrombolytic 
therapy. No suitable diagnostic accuracy data 
Laloux 1995  
 
Mean interval of MRI: 11 days. No suitable time of imaging. 
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Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Lam 2003  
 
CT and DWI for the detection of haemorrhagic stroke. 
Imaging performed within 40 hours of stroke onset. No 
enough data to allow construction of a 2X2 contingency 
table. 
Lam 2005  
 
Use of B0 echo planar imaging (EPI) for the detection of 
intracerebral bleeds. Imaging performed within 48 hours. 
Beyond the scope of this review. 
Lansberg 2000  
 
Comparison of DWI with CT for the detection of ischaemic 
stroke. No enough data to allow construction of a 2x2 
contingency table. 
Lansberg 2000a  
 
Conventional MRI versus DWI. No direct comparison of 
DWI with CT. 
Lee 2000  
 
No direct comparison of MRI with CT. 
Lee 2001  
 
Assessment of the Yonsei Stroke Registry. No suitable 
diagnostic accuracy data. 
Lev 2000  
 
Focus on CTA. No suitable test comparison. 
Lin 2001  
 
Only a non-random subset of patients underwent MRI and 
CT. Imaging performed within 4 days after stroke. No 
suitable time of imaging. 
Linfante 1999  
 
Description of five cases with intracerebral haemorrhage. 
Linfante 2001  
 
DWI in acute posterior circulation stroke. No suitable 
diagnostic accuracy data. 
Linfante 2004  
 
Letter/comment with no suitable diagnostic accuracy data 
Lövblad 1998  
 
No direct comparison of CT with DWI. Only DWI assessed. 
Imaging performed within 24 of stroke onset. 
Lövblad 1998a  
 
Comparison of diffusion-weighted spin-echo with diffusion-
weighted HASTE sequences in ischaemic stroke. No data on 
CT. 
Marx 2004  
 
German study. DWI in vertebrobasilar ischaemia. Only 
posterior circulation strokes included. Imaging performed 





Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Masdeu 2006  
 
Guideline on neuroimaging in acute stroke. No suitable 
diagnostic accuracy data. 
Mayer 2000  
 
Focus on haemorrhagic transformation. Beyond the scope of 
this review. 
Melhem 1998  
 
Dual-echo gradient- and spin-echo and fast spin-echo MRI 
for haemorrhagic lesions. Heterogeneous patient population. 
Causes of haemorrhage included ischemia, trauma, vascular 
malformations, hypertension, and brain tumors. 
Mohr 1995  
 
T1-T2 versus CT. No suitable test comparison 
Mullins 2002  
 
Retrospective studies on CT and DWI for detection of acute 
stroke. Ischaemic and haemorrhagic cases were not reported 
separately. No direct comparison of CT and DWI. 
Mullins 2002a  
 
Retrospective studies on CT and DWI for detection of acute 
stroke. Ischaemic and haemorrhagic cases were not reported 
separately. No direct comparison of CT and DWI. Same data 
as in Mullins 2002. 
Na 1998  
 
Evaluation of MCA occlusion using triphasic helical CT. 




Focus on haemorrhagic transformations. Beyond the scope of 
this review. 
Olszycki 2007  
 
CT and MRI in patients with acute stroke. Imaging 
performed between 3 and 15 hours of stroke onset. No 
suitable time of imaging. 
Oppenheim 2000  
 
Assessment of DWI and FLAIR sequences for the diagnosis 
of ischaemic stroke. No data on CT. 
Patel 1996  
 
MRI for the detection of intraparenchimal haemorrhage. 
Description of five cases. 
Poniatowska 2007  
 
No direct comparison of DWI with CT. DWI performed only 
on negative cases. No suitable test comparison. 
Powers 2000  
 







Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Rajajee 2008  
 
Clinical and CT criteria versus MRI for the diagnosis of 
small deep infarcts. DW and MRA imaging used to exclude 
large-vessel stenosis or occlusion (reference standard). No 
suitable test comparison. 
Razumovsky 1999  
 
TCD, MRA, and MRI in acute cerebral ischemia. No data on 
DWI. 
Read 1998  
 
CT at admission and DWI for the diagnosis of ischaemic 
stroke. Delay between CT and DWI varied from 11 to 36 
hours. No suitable time of imaging. 
Restrepo 2004  
 
Assessment of TIA with diffusion and perfusion MRI. No 
suitable test comparison. 
Rincon 2004  
 
Dynamic CT perfusion for acute ischemia. No suitable 
imaging test. 
Roberts 2001  
 
Focus on CT perfusion. No suitable imaging test. 
Rovira 2000  
 
No direct comparison of CT with DWI. Imaging performed 
within 48 hours of stroke onset. No suitable time of imaging. 
Rovira 2002  
 
DWI in acute TIA. Patients studied with MRI within 10 days. 
No suitable time of imaging. 
Schellinger 1999  
 
Selected sample (9 patients with ICH). Assessment of 
hematoma size on CT and MRI. Beyond the scope of this 
review. 
Schellinger 2000  
 
Practicality of MRI in acute ischemia. Beyond the scope of 
this review. 
Schellinger 2001  PWI and DWI lesion volumes in hyperacute ischaemia. 
Beyond the scope of this review. 
 
Schramm 2002  
 
Focus on CTA versus MRA. Assessment of blood volumes. 
No suitable test comparison. 
Singer 1998  
 
No direct comparison of CT with DWI. Only DWI assessed. 
Mean time from stroke onset to imaging: 48.1 hours (range 7 
hours - 4 days). No suitable test comparison. 
Smajlovic 2004  
 
DWI and CT in acute ischaemic stroke. DWI performed 48 





Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Stapf 2000  
 
No direct comparison of CT with DWI. Only CT assessed. 
Sunshine 2001  
 
No direct comparison of CT with DWI. Only DWI assessed. 
Sunshine 2004  
 
Discussion paper on the use of CT, MRI and MRA in the 
evaluation of acute stroke. No suitable diagnostic accuracy 
data. 
Tei 1997  
 
Japanese study. No direct comparison of DWI with CT. 
Toyoda 2001  
 
Use of FLAIR for detecting intra-arterial signal of ischaemia. 




No direct comparison of CT with DWI. Only DWI assessed. 
Verro 2002  
 
Focus on CT angiography. Beyond the scope of this review 
Von Kummer 2000  
 
Letter/comment with no suitable diagnostic accuracy data 
von Kummer 2001  
 
No direct comparison of CT with DWI. Only CT assessed. 
Von Kummer 2002  
 
Letter/comment with no suitable diagnostic accuracy data. 
Wang 1997  
 
Chinese study. Not a diagnostic accuracy study. 
Warach 1995  
 
No direct comparison of CT with DWI. Only DWI assessed. 
Imaging performed within 48 of stroke onset. 
Warach 1996  
 
No direct comparison of CT with DWI. Only DWI assessed. 
Imaging performed within 48 of stroke onset. Same data as in 
Warach 1995. 
Wardlaw 2003  
 
Impact of delays in CT of the brain on the accuracy of stroke 
diagnosis. Beyond the scope of this review. 
Watanabe 2000  
 





Characteristics of excluded studies - continued 
Study ID Reasons for exclusion 
Weber 2003  
 
German study. No direct comparison of DWI with CT. 
Wintermark 2005  
 
Accuracy of dynamic perfusion CT. No suitable imaging test. 
Wycliffe 2004  
 
MRI for detection of haemorrhagic transformations. Beyond 
the scope of this review. 
Zivin 1997  
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Appendix 4 Summary of findings table  
Results of studies on ischaemic stroke  
 
 
Review question: Comparison of diffusion-weighted magnetic resonance imaging with 
conventional computer tomography for the early detection of ischaemic brain lesions in 
patients suspected of stroke 
 
Patient population: adults suspected of acute stroke 
Setting: hospital departments 
Geographical location: studies were conducted in Europe (3 studies), the USA (3 studies), and 
in Australia (1 study) 
Index test: diffusion-weighted magnetic resonance imaging (DWI) performed within 12 hours 
of stroke onset 
Alternative test: computer tomography (CT) performed within 12 hours of stroke onset 
Reference standard: clinical assessment and imaging follow up 
Included studies: 7 comparative studies that evaluated DWI and CT in the same patients 
Total number of patients assessed: 226 
 
 
Limitations of included studies 
 Limited number of included studies (7 studies); small sample sizes; presence of 
incorporation bias 
 DWI and CT were evaluated in highly selected patient samples (patients with high 
probability of stroke), which therefore are not representative of the typical population of 
patients presenting with 'suspected acute stroke' to an emergency department (poor 
generalisability of results) 
 The stroke vascular territory was not reported in the majority of included studies 
although it is likely that they enrolled patients with typical anterior circulation stroke 
 Only a minority of the studied patients had severe strokes (in whom DWI might be 
contraindicated) 
 The high proportion of mild strokes and reclassification of TIA cases with a positive 
DWI lesion as strokes might have inflated the DWI sensitivity estimate 
 In most of the studies stroke mimics were not included 








Summary of Findings Table - continued 
 
CT results 
TP       73 
FP        0 
FN       88 
TN       65 
Total   226 
  
 
DWI results  
TP       147 
FP        5 
FN       14 
TN       60 
Total   226 
 
Summary effect (95% CI) 
DWI sensitivity 0.99 (0.23 to 1.00) 
DWI specificity 0.92 (0.83 to 0.97) 
CT sensitivity 0.39 (0.16 to 0.69) 
CT specificity 1.00 (0.94 to 1.00) 
  
 
Conclusions and comments 
In the small cohort of included studies, DWI is more sensitive than CT - but not more specific - 
for the early detection of ischaemic stroke. 
The small amount of data and the presence of methodological biases preclude any reliable 
calculation - from the sensitivity and specificity estimates of CT and DWI - of a positive or 
negative stroke diagnosis at different rates of stroke prevalence.  
 
Applicability of tests in clinical practice 
None of the studies addressed practicality. CT is known to be quicker to perform and more 
readily available in most emergency care settings than magnetic resonance imaging (MRI). MRI 
is contraindicated in patients with pacemakers and some metal implants. In acutely ill stroke 
patients it may be difficult to monitor the patient's condition while being MR scanned (and this 
increases the risk of any respiratory difficulty or cardiovascular compromise that develops 
during the scan which passes undetected and may have adverse effects for the patient). If the 
patient is confused or restless as a result of the stroke, the patient may not be able to co-operate 
for the longer scan times of MRI.  
 
Costs 
None of the studies included a cost-effectiveness evaluation. MRI is known to be more 
expensive than CT.  
 
CI: confidence interval; CT: computed tomography; DWI: diffusion-weighted magnetic resonance 
imaging; FN: false negative; FP: false positive; MR/MRI: magnetic resonance imaging; TN: true 
negative; TP: true positive. 
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Comparison of diffusion-weighted magnetic resonance imaging with conventional 
computer tomography for the early detection of ischaemic brain lesions in patients 




1. Please complete the ‘Demographic Information’ sheet  
2. Please read the first ‘summary’ document of the above review  
3. Please complete multiple-choice questions  
4. Please read the second ‘summary’ document of the above review 
5. Please complete multiple-choice questions 








Please provide the following information: 
Gender:   Male  Female 
 
What is your clinical speciality? 
  General Radiology 
  Neurology 
  Neuroradiology 
  Stroke Medicine 
  Geriatric Medicine 
  Other (Please specify) ________________________________ 
 
Please specify your postgraduate qualifications (e.g. MD, PhD) 
__________________________________________________________________ 
Please specify how many years of clinical practice after MD/speciality training 
do you have__________ years 
Please specify what proportion of your time (as a percentage of Full Time 
Equivalency) you spent routinely managing acute stroke patients in the last year 
__________%      
Please specify your research involvement (as a percentage of Full Time 






Have you read the following published papers?  
(Papers are listed in alphabetical order) 
Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T, et al. Identification of 
major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 
1999; 30: 2059-65 
 
NO         YES 
          
Bozzao A, Floris R, Giuliani V, Baviera ME, Montanaro M, Salvatore C, Simonetti G. 
Efficacia clinica della risonanza magnetica con sequenze pesate in diffusione nella 
valutazione dell’ischemia cerebrale acuta. La Radiologia Medica 1999; 98: 144-50 
          
NO         YES 
 
 
Chalela JA, Kidwell CS, Nentwich LN, Luby M, Butman JA, Demchuk AM, et al. Magnetic 
resonance imaging and computed tomography in emergency assessment of patients with 
suspected acute stroke: a prospective comparison. Lancet 2007; 369: 293-8 
          
NO         YES 
 
Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G, et al. 
Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of 
stroke symptoms onset. Radiology 1999; 210: 155-62 
         
NO         YES 
  
Saur D, Kucinski T, Grzyska U, Eckert B, Eggers C, Niesen W, et al. Sensitivity an interrater 
agreement of CT and diffusion weighted MR imaging in hyperacute stroke. Am J 
Neuroradiol 2003; 24: 878-85 
           
NO         YES 
 
Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, et 
al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and 
hemodynamically weighted echo-planar MR imaging. Radiology 1996; 199: 391-401. 
   
NO         YES 
          
          
Urbach H, Flacke S, Keller E, Textor J, Berlis A, Hartmann A, et al. Detectability and 
detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. 
Neuroradiology 2000; 42: 722-7 
          









Likert Visual Analogue Scale 
 
How confident are you in understanding the following measures of diagnostic 
accuracy: sensitivity and specificity, likelihood ratios, predictive values? Please 




















Not confident at all                               Very confident 
 








The following questions are related to the information contained in the 







1. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice:  
 
i. CT is more accurate than MRI for the early detection of ischaemic lesions 
 
ii. MRI is more accurate than CT for the early detection of ischaemic lesions 
 
iii. CT and MRI have similar accuracy for the early detection of ischaemic 
lesions  
 
iv. Neither CT nor MRI is accurate for the early detection of ischaemic 
lesions 
 
v. Evidence provided is not enough to inform clinical practice 
 
2. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. CT and MRI have similar accuracy for the early detection of mild 
ischaemic strokes 
 
ii. CT is more accurate than MRI for the early detection of mild ischaemic 
strokes  
 
iii. Evidence provided is not enough to inform clinical practice 
 
iv. Neither CT nor MRI is accurate for the early detection of mild ischaemic 
strokes 
 








3. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. Evidence provided is not enough to inform clinical practice  
 
ii. Neither CT nor MRI is accurate for the early detection of non-stroke 
lesions  
 
iii. MRI is more accurate than CT for the early detection of non-stroke lesions 
 
iv. CT and MRI have similar accuracy for the early detection of non-stroke 
lesions 
 
v. CT is more accurate than MRI for the early detection of non-stroke lesions 
 
4. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. MRI is more sensitive but not more specific than CT for the early detection 
of ischaemic lesions  
 
ii. Evidence provided is not enough to inform clinical practice  
 
iii. CT is more sensitive but not more specific than MRI for the early 
detection of ischaemic lesions 
 
iv. Neither CT nor MRI has a high sensitivity and specificity for the early 
detection of ischaemic lesions  
 
v. CT and MRI have similar sensitivity and specificity for the early detection 
of ischaemic lesions 
 
5. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. Neither CT nor MRI should be used for the early detection of ischaemic 
lesions  
 
ii. Either CT or MRI should be used for the early detection of ischaemic 
lesions  
 
iii. Evidence provided is not enough to inform clinical practice 
 
iv. CT should be used instead of MRI for the early detection of ischaemic 
lesions 
 




6. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. More diagnostic studies comparing CT versus MRI in acute stroke patients 
are needed 
 
ii. More diagnostic studies on CT in acute stroke patients are needed  
 
iii. More diagnostic studies on MRI in acute stroke patients are needed  
 
iv. No more diagnostic studies comparing CT versus MRI in acute stroke 
patients are needed 
 
v. I do not know 
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I disagree         I agree 
 











  I disagree         I agree 
 
































6. If you were asked to compare the information contained in the Abstract with 
that contained in the Summary of Findings table, would you say that: (Please 
tick only one answer) 
 
i.. Both the Abstract and the Summary of Findings table show the same 
information 
 
ii. Amount of information in either document is not enough to inform clinical 
practice 
 
iii. Information contained in the Summary of Findings table is more useful 
than that contained in the Abstract 
 
iv. Neither the Abstract nor the Summary of Findings table contained useful 
information 
 
v. Information contained in the Abstract is more useful than that contained in 
the Summary of Findings table 
 
 
7. To interpret results, which of the following descriptions do you find easier to 
understand? (Please circle your preference) 
 
a) The test has a sensitivity of 99% 
or 
b) Out of 100 patients with a diagnosis of acute stroke imaged with 
the test, 1 will not show a true lesion 
 
 
8. To interpret results, which of the following descriptions do you find easier to 
understand? (Please circle your preference) 
 
a) The test has a specificity of 92% 
or 
b) Out of 100 patients without a diagnosis of acute stroke imaged 


















Appendix 6 Correct answers (underlined) for the 
multiple choice questions of the survey questionnaire 
 
 





1. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice:  
 
i. CT is more accurate than MRI for the early detection of ischaemic lesions 
 
ii. MRI is more accurate than CT for the early detection of ischaemic lesions 
 
iii. CT and MRI have similar accuracy for the early detection of ischaemic 
lesions  
 
iv. Neither CT nor MRI is accurate for the early detection of ischaemic 
lesions 
 
v. Evidence provided is not enough to inform clinical practice 
 
 
2. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. CT and MRI have similar accuracy for the early detection of mild 
ischaemic strokes 
 
ii. CT is more accurate than MRI for the early detection of mild ischaemic 
strokes  
 
iii. Evidence provided is not enough to inform clinical practice 
 
iv. Neither CT nor MRI is accurate for the early detection of mild ischaemic 
strokes 
 









3. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. Evidence provided is not enough to inform clinical practice  
 
ii. Neither CT nor MRI is accurate for the early detection of non-stroke 
lesions  
 
iii. MRI is more accurate than CT for the early detection of non-stroke lesions 
 
iv. CT and MRI have similar accuracy for the early detection of non-stroke 
lesions 
 
v. CT is more accurate than MRI for the early detection of non-stroke lesions 
 
4. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. MRI is more sensitive but not more specific than CT for the early detection 
of ischaemic lesions  
 
ii. Evidence provided is not enough to inform clinical practice  
 
iii. CT is more sensitive but not more specific than MRI for the early 
detection of ischaemic lesions 
 
iv. Neither CT nor MRI has a high sensitivity and specificity for the early 
detection of ischaemic lesions  
 
v. CT and MRI have similar sensitivity and specificity for the early detection 
of ischaemic lesions 
 
5. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. Neither CT nor MRI should be used for the early detection of ischaemic 
lesions  
 
ii. Either CT or MRI should be used for the early detection of ischaemic 
lesions  
 
iii. Evidence provided is not enough to inform clinical practice 
 
iv. CT should be used instead of MRI for the early detection of ischaemic 
lesions 
 





6. According to the information contained in the ‘summary’ you have received, 
would you maintain that in clinical practice: 
 
i. More diagnostic studies comparing CT versus MRI in acute stroke patients 
are needed 
 
ii. More diagnostic studies on CT in acute stroke patients are needed  
 
iii. More diagnostic studies on MRI in acute stroke patients are needed  
 
iv. No more diagnostic studies comparing CT versus MRI in acute stroke 
patients are needed 
  
v. I do not know 
 
